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 Whispering gallery mode (WGM) resonators enable the label-free detection of analytes based 
on refractive index sensing.  These WGM microsphere resonators achieve high sensitivities by confining 
light within their cavity.  This enhances the pathlength amplifying sample-light interactions leading to 
improved sensing metrics.  By taking advantage of their small footprint, high sensitivity and flexible 
design, we have developed a variety of unique label-free analytical platforms. We recently 
demonstrated a large scale multiplexed imaging platform where hundreds of resonators are 
simultaneously characterized by coupling a fluorescent dye to the resonator surface.  This scheme was 
used to quantify several biomarkers of ovarian cancer with detection limits comparable to ELISA.  
Recently, we extended this technique by developing an evanescent scattering approach for 
characterizing the WGM resonances.  Since signal levels scale with excitation power, measurements can 
be done with high temporal resolution using less expensive imaging equipment.  This approach, 
therefore, offers promise for developing fast, inexpensive, sensitive detection for the multiplexed 
detection of disease biomarkers.  
 Making improvements to clinical tools used for diagnosing cancer have been of considerable 
interest as it can drastically improve the prognosis of patients.  One such example is the introduction of 
prostate specific antigen as an early screening tool using ELISA.  Since its introduction prostate cancer 
mortality rates have dramatically decreased due to the detection of the disease in early stages where 
the cancer is more treatable.  The early detection approach can be adopted for all diseases such as 
ovarian cancer and multiple myeloma.  However, challenges in identifying a single biomarker that exists 
in lower, undetectable concentrations have limited the development of early screening tools for many 
types of cancers.  Additionally, immunoassay platforms amenable to routine screening must be quick, 
cost-effective and easily-integrated into the clinic.   
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WGM platforms provide an opportunity to detect and identify protein and non-protein disease 
biomarkers as a sensitive and multiplex approach.  Additionally, WGM can be integrated with numerous 
fluidic platforms that improve the practical aspects of the development of a device which is critical for 
the translation of the tool into a clinical setting.  Here, the integration of WGM detectors into platforms 
such as capillary electrophoresis (CE) and droplet analysis will be presented.  Separation of serum using 
CE presents the advantage of separation non-diagnostically relevant proteins which can reduce non-
specific binding.  The progress of developing a WGM resonators platform for the diagnostics of multiple 
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Chapter 1  
 
 
Introduction and Overview 
 
 
1.1  Motivation for Biosensing in Cancer Diagnostics 
 
Cancer is among the leading causes of death worldwide with over 14 million new cases each 
year.1  In 2016, over 1.6 million new cases of cancer will be diagnosed and more than half a million will 
die from the disease in the U.S. alone.1 It is postulated that with population growth and the 
unelucidated biochemistry of cancer that new cases will rise to 22 million within the next two decades.1   
These devastating statistics continually place a burden in social and economic facets of society and will 
remain a challenge for generations to come.   
 
Figure 1.1. Prostate cancer mortality rates from 1976-2012.  FDA approved the use of PSA as a screening tool in 





To tackle these challenges, improvements in cancer therapeutics alone may be insufficient.  The 
success of prostate specific antigen (PSA) as an early diagnostic marker for prostate cancer 
demonstrates how early diagnosis is directly tied to the patient’s prognosis.3-5  As shown in Figure 1.1, 
since the introduction of the new diagnostic into clinics in 1986, prostate cancer has seen a markedly 
lower mortality rate for the disease.  Since 1992, 4 years after the implementation of PSA for early 
screening, there has been a 50% decline in prostate cancer mortality rates.6-8  Further studies have 
confirmed that the reduced mortality rates are largely due to the effectiveness of the diagnostic tool 
that allowed patients with prostate cancer to be identified at earlier stages.3,7,9  The early detection 
approach, as demonstrated by a clinical implementation of PSA for prostate cancer diagnosis, holds 
considerable promise in improving cancer patient prognosis and thus, reducing cancer burden on our 
society.   
Screening methods for men and women have been established and recommended in an effort 
to detect cancer early.  Women ages from 40 to 44 are recommended to start annual breast cancer 
screening with mammograms.10  Women older than 45 are told they should get mammograms every 
year.  Mammograms are effective in catching 78% of breast cancer cases, however, the chances of a 
false positive after 10 mammograms is 50 to 60 percent.11,12  These false positives prompt biopsies to 
confirm the diagnosis, thus, cause unnecessary discomfort to the patient.  Minimizing false positives and 
reducing the need for invasive tests for cancer diagnosis would be highly beneficial for all cancer types.  
This dissertation is focused on the development of a diagnostics platform using blood tests to detect 
potential biomarkers for various cancers.  In this chapter, we highlight the need for early diagnostics 
using the case study of ovarian cancer.  Then, we discuss the need for a platform amenable for routine 





1.1.1 Case for Early Diagnostics: Ovarian Cancer 
Ovarian cancer is the most prevalent and fatal gynecological cancer.  While it only contributes to 
3% of cancer cases in women, it is the fifth-leading cause of cancer related deaths with a fatality rate of 
over 60%.13-15  These statistics have changed little over the last several decades despite ongoing 
therapeutics development and improved clinical practices.14,16  The high fatality rates are not entirely 
due to the aggressiveness of the disease; as ovarian cancer is entirely treatable when caught early in its 
progression.  However, ovarian cancer is asymptomatic until distant or stage IV category where most 
cases of ovarian cancer are diagnosed.16  Figure 1.2 illustrates ovarian cancer 5-year survival rates (blue) 
and percentage of women diagnosed (red) plotted with respect to ovarian cancer stage: 
 
Figure 1.2. The 5-year survival rates (blue) of ovarian cancer patients and percentage of women diagnosed (red) in 
localized, regional and distant stages of ovarian cancer 
 
This figure illustrates that the survival rates for ovarian cancer diagnosed in localized or stage I/II 
are over 90%, yet only 10% of ovarian cancer cases are identified at this stage.  Greater than 60% of 
ovarian cancer cases are diagnosed in Stage IV (distant) where 5-year survival rates are unfortunately 
less than 30%.13,15-17  Early detection of ovarian cancer, while possible, remains a challenge due to vague, 
non-specific early symptoms and limited ability of existing screening methods.  Ultrasounds and blood 
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tests for cancer antigen-125 (CA-125) are currently used in the clinic as diagnostic tests, however they 
lack the specificity for the disease and more importantly have difficulty in detecting early stages of 
ovarian cancer, where the disease is most treatable.18,19  Ongoing biomarker research have identified 
many other potential biomarkers, however, a single biomarker has yet to have the required specificity to 
be employed as a screening test.  Many have suggested that multiplexing may be a promising approach.  
The current immunoassay technique, enzyme-linked immunosorbent assay (ELISA), used in the clinic is 
not easily multiplexable and exhibit other drawbacks which will be discussed in detail later.  Thus, to 
tackle this disease and improve ovarian cancer patient outcome, new routine screening tools for early 
diagnosis must be developed.19 
 
1.1.2 Case for Screening Platform: Multiple Myeloma 
Multiple Myeloma (MM) is a plasma cell disease that leads to myelomas or plasma cell tumors in 
bone marrow.  Formation and build-up of abnormal plasma cells can lead to anemia, bone and calcium 
problems, impaired immune response, and kidney problems.  MM occurs when plasma cells located in 
the bone marrow become cancerous and exhibit unregulated growth.  They can produce a tumor called 
a plasmacytoma which generally develops in the bone but in rare situations can migrate into the tissue.2  
The production of abnormal plasma cells causes various systematic symptoms in patients.  For example, 
abnormal plasma cells have limited ability to produce antibodies that help fight off infections as part of 
the immune system.  The suppressed immune system can be a symptom of MM patients.20   Another 
indication of MM may be low blood counts due to the overgrowth and crowding of normal blood-
forming cells leading to anemia.  Additionally, abnormal plasma cells signal the breakdown of bones and 
limit new bone formation thus weaken bones.  Fractured bones are a common symptom of MM patients 
with increased calcium levels in blood due to bone breakdown.2,20 
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In 2016, it is estimated that 30,330 new cases of MM will be diagnosed and 12,650 patients will 
die from the disease, making it the fourteenth most deadly cancer.2  In addition, MM is especially 
difficult to manage due to its 100% relapse rate following treatment.  Diagnostic tools for multiple 
myeloma currently exist, but exhibit significant drawbacks.21-23  Patients are recommended for a serum 
protein electrophoresis (SPE) test which stratifies all serum proteins present into zones24-26 as shown in 
Figure 1.3.   
 
 
Figure 1.3. Capillary serum protein electrophoresis profile illustrations of healthy patient (left) and suspected 
multiple myeloma patient (right).  An abnormal gamma band peak indicates a monoclonal gammopathy or M-
spike. 
 
The SPE profiles shown in Figure 1.3 are representative of a healthy patient (left) where the gamma-
globulin zone is low compared to the profile shown on the right, where there is a spike in the gamma-
globulin region due to a monoclonal gammopathy (M-spike).22,25   Only 17% of all M-spikes are found to 
be a result of multiple myeloma and thus, alone is a poor diagnostic tool.26  The initial SPE must be 
paired with immunoassays for free light chains or quantification of immunoglobulin types for a 
confirmed diagnosis.27-30  Furthermore, the quantification of numerous markers that can elucidate the 
tumor initiation, staging and type of the multiple myeloma such as lactate dehydrogenase (tumor 
initiation)31 and β2-microglobulin (staging)
31,32 would requires several separately performed 
immunoassays.   
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An ideal platform for MM diagnosis would couple the advantages of the fast screening of SPE 
with the specificity of biomarker immunoassays.  The 100% relapse rate of MM presents a lifelong fiscal 
burden for current and former MM patients.  The current platform for MM diagnosis with separate SPE 
and immunoassays ties up valuable clinical resources leading to higher patient costs.  In addition, MM 
requires constant monitoring of patients before, during and after treatment thus the fragmented form 
of testing with SPE and several immunoassays is undesirable.21  Therefore, further innovations in MM 
diagnostics must be made to mitigate the patient and clinical burden placed by this disease.  
 
1.2 Desired Qualities of a Diagnostic Test for Cancer 
 
1.2.1 Performance metrics of a Diagnostic 
Large population testing for cancer must have extremely low false positive rates as a false 
positive result can lead to the use of invasive biopsies for confirmation.  A screening tool must exhibit 
high sensitivity and specificity for a particular disease to be effective.  Therefore, it is important to 
characterize a diagnostic tool’s overall screening sensitivity, specificity and positive predictive values 
(PPV).  Sensitivity is defined as the probability of a test that returns a true positive (positive result on an 
ill-patient) indication and is defined as:33  
 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =  
# 𝑜𝑓 𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
# 𝑜𝑓 𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠+# 𝑜𝑓 𝑓𝑎𝑙𝑠𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
   Eq. 1.1 
 
For example, if a test is 100% sensitive, every ill-patient tested would return a positive result, in other 
words, no ill-patient would return a negative test result.  The specificity of a diagnostic test is the 




𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =  
# 𝑜𝑓 𝑡𝑟𝑢𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
# 𝑜𝑓 𝑡𝑟𝑢𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠 + # 𝑜𝑓 𝑓𝑎𝑙𝑠𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
   Eq. 1.2 
 
A 100% specific test would produce no false positives.  This metric is especially important when 
evaluating screening tools for cancer as a false positive can lead to biopsy studies.  The positive 
predictive value (PPV) of a test is the probability that an ill person will exhibit a positive test, as defined 
by:34  
 
𝑃𝑃𝑉 =  
# 𝑜𝑓 𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
# 𝑜𝑓 𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 + # 𝑜𝑓 𝑓𝑎𝑙𝑠𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
   Eq. 1.3 
 
Negative predictive value (NPV) of a test is the probability that a healthy person exhibits a negative test 
result, as calculated by:34 
 
𝑁𝑃𝑉 =  
# 𝑜𝑓 𝑡𝑟𝑢𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
# 𝑜𝑓 𝑡𝑟𝑢𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠 + # 𝑜𝑓 𝑓𝑎𝑙𝑠𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
    Eq. 1.4 
 
The relatively low occurrence rates for deadly diseases such as ovarian cancer (20 in every 
100,000)18 and multiple myeloma (6 in every 100,000)2 pose a challenge when developing a screening 
test for use in the general population.  A consensus of most gynecologic surgeons and patients feel that 
no more than 10 operations in a population should be performed to identify a single case of ovarian 
cancer.  Thus, an effective early screen for ovarian cancer requires a sensitivity of at least 75%, 
specificity greater than 99% and a minimum PPV of 10%.35  Current tests such as a biopsy or other 
imaging tests such as an ultrasound are highly specific, but have low PPV values and thus is hard to 
conceive as a screening test.36  Additionally, early stages of ovarian cancer are less likely to be 
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discovered due to the small sizes of tumor masses.  Therefore, the current screening methods are ill-
suited for early-detection.   
Alternatively, there are blood tests for proteins which show considerable promise.  When 
appropriate markers are identified for cancers, these tests are extremely advantageous due to being 
minimally invasive and information rich.  However, for cancers such as ovarian cancer, a blood test 
specific for early stages of the disease have been difficult to identify.  Other approaches to address this 
challenge are to routinely monitor biomarker levels or identify a panel of biomarkers using a multiplexed 
test to diagnose ovarian cancer.37,38 
 
1.2.2 Multiplexed Biomarker Detection 
The diagnostic performance of detection platforms must also be considered for its practicality 
and potential for clinical implementation.  This section uses ovarian cancer as a case study to illustrate 
the benefits of a multiplexed approach for cancer diagnostics.  Initiatives in biomarker discovery have 
fortunately provided many potential biomarkers for various cancers.  However, biomarkers must exhibit 
high sensitivity and specificity for a particular cancer for clinical use as a screening tool.  For example, a 
screening tool for low occurrence rate cancers, such as ovarian cancer, requires biomarker specificities 
greater than 99% to minimize false positives.35,39  FDA approved markers for ovarian cancer CA-12540, 
HE441,42 and other putative markers still under investigation such as osteopontin43, OVX 144 and 
prolactin45 are shown in Table 1.1.   A viable ovarian cancer screening tool must exhibit sensitivity, 
specificity and a minimum PPV of 75%, 99% and 10% respectively.35   As seen in Table 1.1, none of these 






Table 1.1  Candidate biomarkers for ovarian cancer and their diagnostic capabilities. 
Biomarker Sensitivity Specificity Notes 
CA-125 40 to 78% 77 to 86% 
FDA approved for detecting the most commonly screened 
protein for ovarian cancer diagnosis.  Poor performance 
alone. 46,47 
HE4 80% to 95% 60% to 96% 
Recently FDA approved for post-surgical relapse 
monitoring. 41,42,47 
Osteopontin 70% 90% 
Up-regulated in early stage cancer.  Involved in tumor 
metastasis and progression.  43,48 
OVX-1 40% 83% 
Elevated in Stage 1 carcinoma.  Also implicated in breast 
and prostate cancer. 49 
Prolactin 95% 95% Elevated in ovarian cancer patient serum50  
 
Levels of CA-125 and HE4, two proteins approved by the Food and Drug Administration (FDA) as 
ovarian cancer biomarkers, can assist with diagnosis, used to monitor disease progression or predict 
reoccurrence of ovarian cancer.41,44  Currently, elevated CA-125 or HE4 levels prompt an ultrasound test 
leading the detection of less than 20% of localized ovarian cancer when the disease is most treatable.  
HE4 has shown promise of higher specificity compared to CA-125, yet alone still lacks the specificity to 
be used in a routine screening test for ovarian cancer.41,42  Therefore, these biomarkers combined with 
other diagnostic tests such as ultrasounds, lack the specificity and sensitivity required for early 
detection.     
 
Table 1.2 Biomarker panels for ovarian cancer 
Biomarker Panel Sensitivity Specificity Detection 
Method 
OVA1: Transthyretin, apolipoprotein, A-1, beta 2-




CA-125, HE4, CEA, VCAM-1 86% 98% 
Bead-based 
immunoassay39 
Leptin, OPN, PRL, IGF-II 95% 94% ELISA52 




Identifying groups of biomarkers that together can provide improved sensitivity and specificity 
for ovarian cancer is a promising approach.  Table 1.2 highlights four biomarker panels for ovarian 
cancer being developed for improved detection of ovarian cancer.  The first panel shown in Table 1.2 
shows a highly sensitive test used to generate a malignancy score in women with an identified pelvic 
mass.51  However, the specificity of this panel is lower than CA-125 alone.  A successful implementation 
of multiplexed assays like the simultaneous detection of leptin, osteopotin, prolactin and insulin-like 
growth factor (IGF-II) was able to distinguish early stage ovarian cancer with 95% sensitivity and 94% 
specificity.52  When this panel was used in conjunction with CA-125 and macrophage migration 
inhibitory factor (MIF), the sensitivity and specificity were further improved to 95.3% and 99.4% 
respectively.45  This study, however, only included patients with advanced stages of ovarian cancer thus 
requiring further investigation to explore its utility in early detection of ovarian cancer.45  Regardless, the 
addition of more putative biomarkers to a panel can improve the overall diagnostic ability.38,44,49  More 
importantly, these multiplexed approaches exhibit improved sensitivity and specificity compared to 
tests using a single biomarker validating the multiplexed approach.  
 
1.2.3 Label-free Detection of Biomarkers 
In addition to the protein-based biomarkers for disease detection, recent work has suggested 
that small, noncoding ribonucleotides or microRNAS (miRNAs) can also act as specific indicators of a 
disease state in cancer.53,54  These noncoding RNAs are 19 to 25 nucleotides are believed to be involved 
in many biological processes including cellular transcriptome regulatory roles.53  miRNAs were first 
linked to cancer for chronic lymphocytic leukemia, where they participate in pathways fundamental to B 
cell receptor signaling, migration and adhesion and cell to cell interactions.55  Since then, the role of 
miRNA in many cancers, including ovarian cancer, has been elucidated.  More specifically, numerous 
miRNA targets (miR-2156, miR-29a56, miR-148b57) have been identified at elevated levels during early 
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stages of ovarian cancer.  In one study, miR-148b was shown to be overexpressed in 92.21% of 
asymptomatic women which may be an important early stage biomarker pending further investigation.57   
The accommodation of multiple classes of biomarkers to a diagnostic tool is a challenge in 
analytical platforms such as an enzyme linked immunosorbent assay (ELISA).  The most straightforward 
approach to a multiplexed assay is to develop a label-free detection scheme.  This approach can also 
avoid additional chemistries required to introduce labels which can lead to losses in biomolecular 
function.  Label-free detection can enable a homogeneous platform for the detection of proteins and 
miRNA in a single assay.  Furthermore, label-free platforms can reduce reagent costs, time and 
chemistry which can facilitate the transfer of the assay into the clinic.  To access nucleic acids as a source 
of biomarkers in addition to proteins, new label-free analytical approaches are needed to improve 
clinical diagnostics for cancers.   
 
1.2.4 Detection limits 
ELISA (Enzyme linked immunosorbent assay) is considered the current “gold standard” for 
clinical diagnostics with detection limits in the general range of pM.  While this is sufficient for existing 
blood tests such as PSA in prostate cancer, it may be advantageous to push for lower limits of detection 
for future early stage cancer biomarkers.  This would make possible the detection of upregulated or 
downregulated biomarkers at the earliest stage of pathogenesis.  
Lower detection limits may also aide in applications such as companion diagnostics.  Companion 
diagnostics is generally defined as “a device that provides information that is essential for the safe and 
effective use of a corresponding therapeutic product” by the FDA.58  This technology can be used to 
identify patients who are at increased risk for side-effects as a result of treatment and also monitor the 
patient response to a treatment.  The trends in personalized medicine and companion diagnostics for 
cancer therapeutics require the monitoring of small changes (less than 1 pM) in analyte concentrations 
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which can have significant clinical impact.59  To enable treatment monitoring and the growing role of 
companion diagnostics, we must strive to develop lower detection limit detection platforms.   
 
1.2.5 Other Diagnostic Platform Considerations 
During the development of a diagnostic for cancer, we have already discussed the required 
analytical performance metrics such as sensitivity, specificity and detection limits.  The current blood 
based tests used for ovarian cancer in the clinic have limited diagnostic capabilities as a stand-alone 
exam.  Blood based tests are often cheap and provide some degree of diagnostic capability thus utilized 
as a part of a diagnostic pathway where elevated CA-125 levels, for example, lead to the more expensive 
ultrasound exam.  Since, positive results in the blood test lead directly to another confirmation test, 
ultimately the patient can receive large medical fees.  Therefore, improved diagnostic capabilities for a 
blood based screening test can significantly reduce the cost for the patient and be more accessible for 
the patients.   
ELISAs and blotting techniques are relatively inexpensive but may not provide enough analytical 
performance to precisely identify minute differences in biomolecular profiles.  Additionally, these 
platforms are generally limited to a single analyte per test leading to lower throughput in multiplexed 
assays of biomarker panels.  To make big strides in the field of cancer diagnostics, a platform that is low 
reagent consumption, high throughput, low clinical resource burden and low costs must be developed. 








1.3 Clinical Immunoassay: Enzyme linked immunosorbent assay 
 
 
Figure 1.4. In step 1, the antibodies are coated onto the surface by either covalent attachment or physical 
adsorption.  Then, the target analyte is introduced forming an antibody-antigen complex.  Addition of a secondary 
antibody linked to an HRP enzyme binds to the complex.  Then TMB is introduced in the presence of hydrogen 
peroxide to form a colorimetric product.  
 
ELISA is considered the “gold standard” for diagnostics in the clinic as it provides high analyte 
specificity and robust detection of proteins in biological fluids.  The method utilizes a capture and 
subsequent detection motif taking advantage of antibody-antigen interactions.  Since the development 
of ELISA in the 1970s, there are many versions of the technique.  A popular assay schematic is shown in 
Figure 1.4 that illustrates a typical sandwich-based ELISA method.   
In step 1, the assay wells are coated with the capture antibody bound using either covalent 
chemistries or noncovalent interactions.  In step 2, the target protein within a sample solution is 
captured by the surface immobilized antibody forming the antibody-analyte complex.  After the capture 
of the analyte, a secondary antibody bound to an enzymatic tag, such as horseradish peroxidase (HRP) is 
introduced and incubated with the solution in step 3.  Finally, in step 4, for colorimetric detection, 
3,3’,5,5’-tetramethylbenzidine (TMB) is added.  TMB reacts with HRP as a substrate being catalytically 
oxidized, by hydrogen peroxide, to form a colorimetric, diamine product.60  For protein quantitation, 
absorbance at 450 nm is measured and compared to calibration wells.  
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There are many attractive features of ELISA that contribute to its wide use for biomarker 
diagnostics.  The sandwich-ELISA approach exhibits higher degrees of specificity and reduced cross-
reactivity for the analyte due to the use of a primary capture antibody and a secondary detection 
antibody.  The assay also uses amplification of the colorimetric signal using a high turnover enzyme HRP 
resulting in low detection limits (nM) and high sensitivity.  The assay platform is also simple and easily 
performed in multi-well plates that have now been developed into automated instruments.  Despite 
these advantages, there are some key drawbacks in ELISA that limit its utility for early detection and 
treatment monitoring applications.   
ELISA is a relatively reagent intensive technique that involves numerous incubation steps.  The 
utilization of two binding antibodies as well as an enzymatic reaction to produce the colorimetric species 
all requires long incubation time and several reagents.  The platform is generally limited for the 
detection of proteins due to the use of antibodies.  A drawback of ELISA that labeling of the detection 
antibody with an enzyme can affect its biomolecular function, which may reduce its binding 
performance.  Additionally, the fundamental requirement that the analyte of interest have two binding 
sites is a limitation.  Furthermore, the detection and quantitation of a single protein must be performed 
in its own well due to the general colorimetric signal and thus is not easily amenable for multiplexing.   
Label-free techniques overcome these limitations by allowing a homogeneous and general 
platform for the detection of proteins and nucleic acid biomarkers.  Furthermore, label-free platforms 
reduce reagent usage, cost and time required for biomarker quantitation.  Additionally, they can enable 
the multiplexed detection of biomarker panels for cancers to improve patient prognosis.  However, 
these techniques are not without their drawbacks.  Non-specific binding and reduced specificity due to 
the use of a single antibody versus two in ELISA and signal amplification required for low detection limits 
for label-free techniques are significant challenges.  Therefore, all of the mentioned factors and other 
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criteria such as cost, throughput and detection limits, which can influence the adoption of these 
techniques into the clinic, must be evaluated.     
 
1.4 Review of Current State of Label-Free Biosensors 
 
Label-free techniques allow real-time detection of virtually any biomolecular complex requiring 
minimal sample preparation and reduced assay development.  In these platforms, no additional labels or 
modification of the analyte of interest is required for their detection.  Because of this, label-free 
techniques can be flexibly designed for many applications.  These advantages are well-suited for the 
development of low cost, inexpensive, high throughput and clinically viable diagnostics.  This section will 
highlight particular label-free techniques which have shown considerable promise for clinical 
applications.61  Table 1.3 compares various criteria relevant to clinical diagnostic platform development.  
 
 











Difficult Good fM Moderate High 
Quartz-Crystal 
Microbalance65 
Moderate Limited μM-pM Poor Moderate 
Surface Acoustic 
Wave66 
Moderate Poor pM-fM Poor Moderate 





Moderate Moderate μM-pM Moderate High 





1.4.1 Electrochemical-Based Biosensors 
Label-free electrochemical sensors are based on measuring the change in current, potential or 
conductivity that occurs when a target molecule binds to the functionalized sensor surface.  These 
devices are particularly attractive due to their high sensitivities and simplicity with which they are 
conjugated with miniaturized hardware.  An implementation of a electrochemical antibody-based 
biosensor by Kerman and colleagues measured the binding of human chorionic gonadotropin (hCG) with 
detection limits of 20 pM in human urine.70  This group used a three-electrode system with carbon paste 
electrode as the working electrode, Ag/AgCl as the reference and platinum as the auxiliary electrode.  
More recently, extremely sensitive and multiplexed electrochemical based biosensors have been 
developed using higher conductivity graphene material and improved fabrication of nano-scale 
electrodes.62,63  
Nanowires are mainly employed as miniature electrochemical sensors.  The diameters of these 
nanowires are comparable to the biomolecular species being measured offering excellent signals which 
can ultimately be interfaced to macroscopic instruments.  Biochemically functionalized wires can detect 
biomolecular interactions as changes in the dielectric environment around the nanowire.  Extremely 
high sensitivity has allowed for the detection of a single virus.  These impressive metrics combined with 
the development of nanowire arrays has enabled the simultaneous detection of three cancer 
biomarkers in serum samples.  PSA with detection limits of ~2 fM have been routinely achieved using 
nanowire bionsensors.64  Furthermore, fabrication of an array of nanowires demonstrated the 
multiplexed detection of PSA, carcinoembryonic antigen and mucin-1 with minimal cross-reactivity 
when each antigen was introduced.  They also detected PSA spiked into donkey serum but show 
significantly reduced signal to noise ratios.64  This may be a result of non-specific detection which can be 
a challenge for nanowires as they detect all changes in their dielectric environment.  Though nanowire 
electrochemical sensors hold significant promise, a challenge for the adoption of these sensors is that 
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they require precise nanostructure fabrication equipment which drive up the cost of each sensor and 
limit their use in the clinical setting.   
 
1.4.2 Acoustic-Based Biosensors 
Acoustic sensors are based on vibrating elements which create acoustic waves.  These waves 
can propagate along a surface for surface acoustic wave (SAW) or in the bulk as bulk acoustic wave 
(BAW).  For biosensing, when molecules absorb to the sensor surface, the change in amplitude or 
frequency of the resonator can be measured.  Quartz crystal microbalance (QCM) is a bulk acoustic wave 
device which utilizes a piezoelectric quartz crystal.  When the crystal is electrically excited using two 
electrodes the resonance frequency can be measured.  A functionalized crystal used in this platform can 
detect specific binding events down to the pM level.65  However, bulk acoustic wave devices experience 
losses in detection limits in solution due to acoustic losses caused by longitudinal waves into the liquid 
which limit performance.  
Surface acoustic waves overcome this limitation by utilizing acoustic waves that travel along the 
substrate.  In this platform the electrodes are interdigitated as shown in Figure 1.5 creating confined 
acoustic energy near the surface when a potential is applied across the system.   
 
 
Figure 1.5. A schematic of a surface acoustic wave biosensor.  The interdigitated electrodes are used to produce a 
surface wave along a piezoelectric substrate.  Any binding event on the surface of the material is observed as a 




As shown in Figure 1.5, an input transducer forms a surface acoustic wave that travels through antibody 
functionalized gold surface.  The output transducer detects the resulting surface acoustic wave after 
interrogation of the gold film.  Changes in the surface acoustic wave frequency are related to the mass 
as antigen bind to the surface.  These systems have theoretical mass detection limitations corresponding 
to fM levels which would be extremely competitive among current biosensors.71  However, because the 
frequency change is influenced by many factors such as conductance of the liquid, dielectric and elastic 
constants of the adsorbent which are difficult to control, the implementation of these devices remain a 
challenge for clinical applications.  Additionally, multiplexing is difficult to achieve in these devices 
without the use of more complicated electrode fabrication of additional transducing and detecting 
electrodes.   
 
1.4.3 Optical-Based Biosensors 
Label-free optical biosensors rely on measuring the interaction of light with surface adsorbed 
molecules.  These platforms often rely on measuring refractive index which is a parameter that 
describes how light propagates through a medium.  Refractive index-based sensors that are simple, low 
cost and highly sensitive exist in various platforms.  In general, the sensing mechanism is similar for 
many optical biosensors where biomolecular interactions on a surface can be quantified in real-time by 
monitoring the changes in intensity, wavelength, polarization or phase of the light after being reflected 








1.4.3.1 Surface Plasmon Resonance 
 
Figure 1.6. A schematic of a surface plasmon resonance is illustrated here. Surface plasmons are oscillations in the 
free electron density excited with an incident laser.  A sensor chip with gold is commonly utilized as a substrate.  
The angle of reflection is measured as analyte binding to the sensor chip leading to the sensogram illustrated here. 
 
A common and commercialized refractive index platform is surface plasmon resonance (SPR) 
illustrated in Figure 1.6.  SPR utilizes metal surface plasmons to probe analyte interactions.72,73  Surface 
plasmons are oscillations in the free electron density which are created when a metal coated dielectric 
material is excited with an incident laser.  These resonances can be measured by monitoring the angle of 
reflection of the light that is diffracted on the metal coated dielectric interface.  The angle of reflection 
depends on the refractive index of the surrounding media within the exponentially decaying evanescent 
wave.  By functionalizing the surface with a biocapture molecule, binding events may be measured in 
real time using this approach. SPR is amenable to multiplexed assays by using high quality patterns in a 
SPR imaging approach.74,75  While possible, the need for precise fabrication of microarrays increases the 
cost and reduces the scalability of the device which is a drawback for clinical implementation.   
 
1.4.3.2 Interferometry 
Interferometry based sensors are relatively simple devices that rely on measuring changes in the 
phase velocity of light resulting from the accumulation of biomolecules on a sensing strip.66,76  These 
methods have been developed to sense biomolecules with detection limits in the femtomolar range.77  
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However, most interferometry devices have limited multiplexing capabilities thus reducing throughput.  
Alternatively, biolayer interferometry (BLI) uses white light interferometry at the end of a fiber optic to 
measure the thickness of transparent-thin film and can be easily multiplexed.78  The commercialized 
Octet system (ForteBio, Menlo Park, CA), can measure responses from up to 16 sensors set up in 
parallel, where the sensors are dipped into the sample well.79  The drawback to BLI is that the limit of 
detection is typically higher compared to most other interferometric techniques, which can make it 
difficult for the measurement of early stage biomarkers of cancer.  Optical resonator sensors are 
emerging as an attractive alternative for biosensing for highly sensitive and multiplexed biosensing.  
 
1.4.3.3 Optical Resonators 
Optical resonator based sensors take advantage of a phenomenon referred to as whispering 
gallery mode (WGM) resonances.68  Microcavities made of dielectric materials support the recirculation 
of light within the structure through continuous total internal reflection.  When the resonance condition 
of the resonator is satisfied, the resonant wavelength can be directly related to the surrounding 
refractive index useful for sensing.80-82  The highly efficient light recirculation leads to high sensitivities 
and low detection limits enabling detection of a single virus.69,83  These promising optical resonator 
platforms continue to be developed for multiplexed sensing.84,85  WGM resonators offer low detection 
limits, label-free, small footprint and high sensitivities for biosensing.  Here, the development of WGM 
based biosensors will be discussed in subsequent chapters, including a discussion of their fundamental 







1.5 Motivation for Dissertation 
 
The dire statistics of cancer mortality rates and overall burden placed on society by cancer calls 
for a need for newer diagnostic approaches.  The early detection strategy to improve cancer prognosis is 
highly promising as demonstrated by the 50% reduction in prostate cancer mortality after the 
introduction of PSA as an early detection biomarker.9  For this approach to be adopted for all types of 
cancers, diagnostic platforms must be amenable to multiplexed biomarker panels to overcome the 
challenges in identifying a single biomarker for a given disease.  A screening tool with attributes such as 
lower detection limits, label-free, compatibility with proteins and nucleic acids, and throughput can 
drastically improve cancer patient prognosis.   
Currently, a screening method for most cancers that accommodates all of these criteria is still 
under development.  While ELISA is the most popular clinical diagnostic tool and gold standard for 
diagnostics, it has limited multiplexing capabilities, limited compatibility with nucleic acids and low 
overall throughput.  This creates challenges for developing large scale screens.  To overcome these 
challenges, the development of optical resonator label-free biosensors and their integration in 
microfluidic platforms for small volume, real-time and inexpensive assays will be discussed.  The 
following chapters are devoted to improvements made for WGM label-free diagnostic platforms 
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Chapter 2  
 
 
Whispering Gallery Mode Biosensors 
 
 
Sensors that respond to refractive index changes due to surface binding events offer a flexible, 
sensitive and general detection platform that can be developed for disease biomarker screens.  These 
platforms can enable high throughput and homogeneous detection schemes for proteins and nucleic 
acids without the use of labels.  While many optical biosensors have been developed, optical resonator 
sensors based on whispering gallery mode (WGM) have shown considerable potential as platforms for 
clinical diagnostics.   
 
2.1 Introduction to Whispering Gallery Modes 
It has been known that sound waves spoken at a circular wall, like the dome of St. Paul’s 
Cathedral, could travel long distances.  This phenomenon termed, acoustic whispering gallery mode, 
were first described by Lord Rayleigh in the late 1800’s.1   
 
Figure 2.1. Acoustic whispering gallery mode shown on the left is an illustration of sound waves travelling along the 
circumference of a dome structure, such as the dome of St. Paul’s Cathedral.  The same phenomena are observed 
with light waves along the circumference of a dielectric material shown on the right. 
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In his 1912 publication titled “The problem of the whispering gallery”, he characterized the 
sound intensity of these sound waves in a path along the gallery to discover nodes.  Based on these 
findings he concluded that the circular structure of the gallery had the ability to contain sound waves 
through surface reflections allowing a whisper to travel long distances in a confined manner.1  Likewise, 
light waves experience a similar phenomenon where small, circular dielectric structures confine light 
waves along their diameter as illustrated in Figure 2.1.  These structures, tens of microns in diameter, 
can exhibit highly efficient recirculation of light via continuous total internal reflection.  Concepts 
important to describe the working mechanism of WGM optical sensors are total internal reflection and 
the evanescent wave. 
 
2.1.1 Total internal reflection and the evanescent wave 
Light waves can be confined and recirculated within a whispering gallery mode structure and as 
a result, allow for longer interaction pathlengths between the light and the resonator surroundings.  To 
understand this phenomenon, one must consider Snell’s law which describes how light behaves when 
passing from one material to another: 
 
  𝑛1𝑠𝑖𝑛𝜃1 = 𝑛2𝑠𝑖𝑛𝜃2     Eq. 2.1 
 
where n1 and n2 are the refractive indices of the material (n1 > n2), θ1 and θ2 are the incident and 
refracted angles of the light beam measured from the normal of the interface.  Snell’s law describes that 
as light passes from a high index (n1) to a low index (n2) material, the refracted light waves will be bent 
away from the normal (θ2) at angles greater than the incident angle (θ1) with respect to their interface 
normal as illustrated in Figure 2.2a.  As θ1 is increased, there is a certain incident angle at which all of the 
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refracted light is contained at the boundary of the two mediums (θ2 = 90°).  This angle is defined as the 






)           Eq. 2.2 
 
Any incident angle greater than this critical angle leads to the complete reflection at the 
interface, thus all of the light is reflected back into the same high index material.  This condition is 
referred to as total internal reflection (TIR) and is illustrated by Figure 2.2b.   
 
 
Figure 2.2.  Total internal reflection and the creation of an evanescent wave. 
 
Even though all of light is reflected back into the original medium under TIR, there exists a non-
propagating, exponentially decaying evanescent wave that interacts with the neighboring medium up to 
200 nm beyond the material boundary.2  This phenomenon has been used extensively to excite 
molecules such as fluorophores located near the surface in fluorescence microscopy due to benefits 
such as background reduction and surface sensitivity.3  Additionally, the evanescent wave has been 




with limited propagation depth is advantageous for selectively detecting surface changes against the 
background signals in the bulk solution.  This has allowed for the use of WGM as sensitive detectors for 
specific surface binding events with extraordinary detection limits.4-6   
  
2.1.2 Whispering gallery mode resonance 
 
Figure 2.3. Dielectric structures can exhibit resonance when the conditions described in equation 2.3 are met.  The 
left is an illustration of off-resonance when light does not interfere constructively.  On the right, shows a resonance 
where constructive interference leads to the strong confinement of light. 
 
Whispering gallery mode resonators take advantage of continuous total internal reflection 
leading to the confinement of light within its spherical structure.  The light path along the circumference 
can have a resonance as shown schematically in Figure 2.3.  A resonance light path occurs when the 
roundtrip distance within the structure is an integer multiple of the coupled wavelength.  In this 
instance, the light coherently drives itself by returning in phase leading to constructive interference.  
Constructive interference allows the circulating intensity to grow until the rate at which light is coupled 
into the cavity is balanced by the rate at which it is lost.  This condition is described as the WGM 





                Eq. 2.3 
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where λr, is the resonant wavelength, r is the radius, neff is the effective refractive index surrounding the 
sphere, and m is the integer multiple of the wavelength.  Again, the build-up of an intense 
electromagnetic field due to the recirculation of light confined in these structures lead to sensitive 
interactions with the surrounding media useful for sensing.  This is reflected in equation 2.3 where 
changes in the effective refractive index can be linearly related to the resonant wavelength.  Thus, by 
tracking changes in the resonant wavelength of an optical resonator changes in the local refractive index 
can be measured.  Furthermore, the interaction between the light and the resonator surrounds are 
multiplied leading to long effective pathlengths, due to efficient light recirculation leading to impressive 
detection limits and high sensitivities.  This has generated great interest in utilizing WGM resonators as 
label-free sensors for biological applications.   
 
2.1.3 Schematic for WGM Measurements  
A common approach to measuring the resonant wavelength of a WGM resonator involves a thin 
optical fiber to evanescently couple light.  Thinned optical fibers are prepared by removing the outer 
jacket and pulling the fiber down to approximately 3 μm in diameter.  The fiber is positioned precisely 
near the resonator surface to efficiently tunnel light from the fiber into the resonator via frustrated total 
internal reflection.  The output of the fiber is monitored using a photodetector as the tunable laser is 




Figure 2.4. A typical WGM schematic where a fiber optic carrying light from a tunable source is brought near the 
surface of a spherical dielectric material.  The output of the fiber optic is monitored while the wavelength is tuned.  
At a particular wavelength, light efficiently couples into the sphere leading to a dip in the transmission observed.  
This transmission dip shifts proportionally to the effective refractive index of the sphere’s local environment. 
 
The center of the intensity dip corresponds to the WGM resonant wavelength where light from the 
tunable laser is efficiently coupled into the resonator.  Any changes in the effective refractive index near 
the resonator are observed as a proportional shift (shown in red), which is exploited in sensing 
applications. 6-12    
 
2.1.4 Whispering gallery mode for sensitive detection of biological interactions   
As described in equation 2.3, WGM are utilized as sensors by measuring changes in the local 
refractive index.  Figure 2.5 illustrates how resonators can be implemented as biosensors by attaching 
biological recognition elements to their surface to specifically bind target analytes which change the neff.  
Binding events that occur on the resonator surface cause measurable changes of the resonant condition.  
Most biomolecules have a greater refractive index (n = ~1.5) than buffer solution (n = ~1.33) therefore 





Figure 2.5. Schematic of a WGM biosensor.  Biocapture material, such as antibody, is covalently attached to the 
surface of microspheres.  Subsequent binding events between the antibody and antigen lead to changes in the 
local refractive index of the microsphere which can be monitoring by measuring its resonant wavelength. 
 
The magnitude of the resonant wavelength shift due to binding of surface events has been 









                                   Eq. 2.4 
 
In this equation, αex is the excess polarizability, σp is the surface coverage of target molecules, ns and nm 
are the refractive indices of the sphere and surrounding medium respectively, ε0 is the vacuum 
permittivity and r is the radius of the sphere.  The surface coverage and excess polarizability are directly 
related to the resonant shift.  Furthermore, since the excess polarizability can be related to the 
molecular weight of the target molecule, resonant wavelength shifts can be used to quantitatively 
measure the number of analyte molecules and their bulk concentrations in solution.     
In the process of validating WGM sensors for clinical diagnostics, it is important to understand 
fundamental properties that impact the sensor performance.  It is therefore critical to discuss the 
factors that contribute to the WGM sensitivity and detection limits with respect to the physical 




2.2 Resonator performance relationship to sensor metrics 
 
The recirculation of light due to the resonant condition allows for enhanced light-matter 
interaction resulting in improved sensitivities.  Thus, the efficiency with which light is confined within a 
resonator does affect the overall sensor performance.  Resonator performance with respect to light 
confinement efficiency and pathlength will be discussed in the following section. Furthermore, a 
theoretical discussion of the relationship between quality factor and limits of detection will be 
described.  
 
2.2.1 Quality factor 
While quality factor is a general term applicable to electrical and mechanical oscillator systems, 
here we will focus on quality factors as it pertains to optical systems.  The resonator performance is 
highly dependent on its ability to confine light.  Quality factor is a measure of how efficiently a resonator 
can store light within its structure.   
One way to quantify the quality factor is to measure the instantaneous energy stored in the 
resonator by integrating the density of the electric and magnetic fields over the resonant light path.   
The steady-state energy balance is when the rate of energy lost from the cavity is equal to the rate of 





                                                                          Eq 2.5 
 
where ωR is the resonant angular frequency, W is the total energy and Pc is the power coupled into the 
resonator.  Higher total energy leads to higher quality factors which can be interpreted as higher field 
densities along the circumference of the structure leading to more interactions between the resonator 
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and its local surroundings.  This definition is limited for quantitative assessment of quality factors as 
instantaneous energy measurements are difficult to make.  
An alternative to quantify the quality factor of a resonator is to consider the rate of energy 
dissipation within a resonator structure.  The quality factor can be related to the time required for light 
stored within a cavity to completely dissipate as described by:14,15 
 
𝑄 =  𝜔𝑅𝜏𝑅𝐷                                                                          Eq 2.6 
 
where ωR is the resonant angular frequency and τRD is the cavity ringdown time.  This equation states the 
longer energy dissipation times corresponds to higher quality factors or efficient light confinement.   A 
more accessible method for determining quality factors uses linewidth measurements. 
All quality factors reported here have been measured using the linewidth method.  Quality 





                                   Eq 2.7 
 
where 𝜆𝑟 is the resonant wavelength, and 𝛿𝜆𝑟 is the full width at half maximum of the resonant 
wavelength intensity.  This method provides a simple characterization where finer linewidths 
correspond to high quality factors useful for describing light confinement within a resonator.  All three 
definitions of quality factors combined give a physical description of light being retained within a 
resonator.  High quality factors lead to high energy densities, longer photon lifetimes within the 
structure and narrower linewidths as described by the above equations. 
For sensing, high quality factors are desirable as they improve the interaction of the recirculated 
photons with the resonator surroundings, ultimately leading to higher sensitivities.  Therefore, it is 
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advantageous to improve the quality factors to the highest possible value when developing a clinically 
relevant WGM biosensor.   

















                     Eq 2.8 
 
Here Qrad
-1 describes the radiative losses associated with bending losses from the spherical cavity.  These 
losses are inversely related to the size of the resonator.  As the resonator size decreases, the angles at 
which light approaches the interface become steep resulting in increased light loss.  For resonators with 
diameters greater than 15λ, these losses are negligible.  Qmat
-1 accounts for light losses within the 





                                           Eq 2.9 
 
where n is the refractive index, αmat is the absorption decay constant and λ is the wavelength.  High αmat 
values can diminish the quality factor resulting in poorer resonator performance.  However, using fused 
silica and a wavelength of 633 nm, quality factors are limited by Qmat
-1 to a theoretical maximum value of 
~9 x 109.  These values are more than sufficient for sensitive detection of biomolecular interactions as 
demonstrated in these publications.  Qscat
-1 represents losses due to surface scattering losses on the 
resonator due to surface imperfections.  These losses are minimized in resonators formed from melts 
where the high temperatures create exquisitely smooth surfaces.  Lastly, Qext
-1 describes loss 
contributions from surface contaminants present on the resonator which may act as light absorbing 
species.  All of these contribute to the intrinsic Q-factor of a WGM resonator.   
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2.2.2 Improved light-sample Interaction   
When light is recirculated within a resonator, the evanescent wave at the resonator surface is 
created by continuous total internal reflection interacts with the outside media.  Efficient light 
recirculation or high Q factors therefore contribute directly to the degree to which the light and sample 





                                            Eq 2.10 
 
where Leff is the effective path length, n is the refractive index, λ is the wavelength and Q is the quality 
factor.  This equation states that the path length dependency on quality factors can lead to overall 
interaction lengths on the order of centimeters to meters even though the physical sensor dimensions 
are microns in size.  The small footprint of the sensor with enhanced light-sample interactions leads to a 
flexible detection platform promising low detection limit measurements.  A more in depth discussion of 
the relationship between resonator performance and sensing metrics, however, will include Q factors, 
path length, mode volume, finesse and detection limits in the following sections. 
  
2.2.3 Detection Limits 
The quality factor of WGM resonators influences the minimum measurable shift in resonant 
wavelength.  Recalling the linewidth method for the determination of quality factor, equation 2.7, the 
quality factor increases as the FWHM of the WGM resonance peak becomes narrower.  Narrower 
spectral peaks also allow for the tracking of smaller changes in resonances as a response.   Equation 2.11 
represents the smallest measureable shift accounting for experimental noise and spectral bandwidth of 








where 𝜆𝑟 is the resonant wavelength and F is a “measurement acuity factor” which includes 
experimental noise and spectral bandwidth contributions.  When the limits of detection is determined in 







                 Eq 2.12 
 
where 𝑟 is the radius of the resonator, 𝛼𝑒𝑥 is the excess polarizability of the biomolecule, 0 is the 
vacuum permittivity, and 𝑛𝑟 and 𝑛𝑚 are the refractive indices of the resonator and surrounding 
medium, respectively.  This equation suggests that limits of detection are inversely proportional to the 
quality factor where higher quality factors lead to lower limits of detection.  Additionally, the radius of 
the resonator must be decreased to obtain lower LODs.  However smaller resonator sizes result in more 
radiative losses and thus lowers the quality factor.  As a result, the size of the resonator must be 
optimized to the smallest size while minimizing radiative losses.  Typical resonator diameters used for 
WGM biosensing range from 30 µm to 100 µm.  Equation 2.12 for a resonator of 50 µm in diameter and 
a quality factor, achieved in experiments and by many other groups, of 4.5 x 106, the σLOD for the 
detection of bovine serum albumin (BSA) is calculated to be ~1.7 pg/mm2 which is competitive with the 
best detection limits reported for SPR sensing, at ~1 pg/mm2.  We note here that quality factors up to 
109 measured in the air have been reported in the literature.16,17  However, most WGM resonators in 
solution exhibit quality factors up to 106.  WGM biosensing demonstrates competitive limits of detection 
as a label-free, optical biosensor.  For broader use of the technology in the clinic, environmental noise, 
detector cost and analytical performance must also be considered.   
Consideration of experimental factors such as a data sampling, noise levels and data analysis 
methods can affect the relationship between quality factors and limits of detection.  While previous 
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intuitive discussions where higher quality factors leading to lower detection limits hold true, these are 
often over simplified models.  A more detailed experimental model was described by Silverstone et al. 
where a range of background noise signals using typical spectrometer and tunable laser sources were 
numerically modeled.  The results of their studies proposed this relationship shown here:18,19 
 
∆𝜆𝑚𝑖𝑛(3𝜎) =  
2.2∗10−20∗∆𝑓0.29𝑃0.65
𝑆𝑁𝑅0.51
                                                  Eq 2.13  
 
where Δf is the width of the resonant peak, P is the sampling rate and SNR is the signal to noise ratio.  
Silverstone et al. obtained this relationship by modeling signal to noise signals for heavily oversampled 
white noise within a 3σ level of certainty.  Additionally, this equation is modeled using resonant 
wavelength peaks determined by Lorentzian curve fitting typical for WGM measurements.  The equation 
suggests that when the quality factor, which is related to Δf, is improved by 3 orders of magnitude, the 
limits of detection is lowered by only a factor of 7.5.18  These simulations suggest that improvements in 
quality factor as well as developing new data analysis and WGM peak determination methods must be 
made to develop biosensors with low detection limits.  This will be discussed further in chapter 5 where 
a lock-in detector with WGM is described. 
 
2.2.4 Sensitivity  
 
The spectral sensitivity of a WGM sensor can be defined as:  
 




where Δλ is the shift of the sensor resonance in nm and Δn is the change in the refractive index.  For 
biosensing, biomolecular events that occur on the surface of these resonators induce measurable 
changes in the refractive index.  Here we will discuss the factors that affect WGM sensitivity.  We have 
previously described quality factors in conceptual discussion, where higher quality factors lead to higher 
electric field densities.  A crude but useful approximation assumes that all of the electric field related to 
sensing is contained in the surroundings of the resonator.   
 
 
Figure 2.6. Illustration of large (left) and small (right) mode volumes for a spherical WGM resonator.  Small mode 
volumes are advantageous for sensing due to the high concentrations of electric field at the sensing surface.  
 
Mode volume describes the electric field density along the outer surface of the resonator.20,21  A 
smaller mode volume is advantageous because this enhances the electromagnetic field strength or 
energy density on the sensing surface.  A larger mode volume is related to lower energy densities 
leading to lower sensitivities.  The comparison between larger mode volumes is made in Figure 2.6 
where larger mode volumes results in a more diffuse distribution of electric fields and thus weaker 
energy density.  Smaller mode volumes have more concentrated electric fields in a smaller volume 
leading to higher energy densities.  For sensing applications, small mode volumes are attractive to 
enable higher energy density interaction with the sensing surface.  Mode volumes are related to the 
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wavelength of the excitation light where V ~ λ3.20-22  For the development of sensitive WGM detectors, 
shorter excitation wavelengths may lead to improved sensitivities.  
 
2.2.5 Finesse 
WGM biosensing performance can be summarized by a performance metric known as finesse 
(F).  Finesse includes quality factors as well as mode volume to combine factors that contribute to the 
detection limit and sensitivity for WGM measurements.  Finesse is proportional to the quality factor (Q) 
and inversely proportional to the mode volume (V):21 
 
𝐹 ∝  
𝑄
𝑉
                                                               Equation 2.14 
 
Resonators capable of achieving high finesse can lead to improved biosensor performance.  Maximizing 
the Q-factor and minimizing the mode volume can result in highly sensitive WGM measurements useful 
for cancer diagnostics.  Already there have been numerous demonstrations of WGM detectors 
measuring protein and nucleic acid surface binding with impressive metrics.  These desirable 
characteristics have generated interest in the development of WGM sensing platforms.  Decades of 
development has led to the optimization WGM resonator geometry and materials.   
 
2.3 WGM resonator platforms for biosensing  
 
Whispering gallery mode resonances can be supported in a variety of materials such as 
polymers, glass and diamonds.  The greater the contrast in refractive index of the material and fluid 
solution of interest should result in less light lost leading to higher Q-factors.  The absorption spectra of 




losses.14  The flexibility of the material choice that support WGM resonances can prove beneficial for 
commercialization where cost can inhibit the development of diagnostic tools.  Fortunately, there are 
several geometries for WGM using inexpensive materials such as silicon wafer, silica microspheres and 
glass capillaries shown in Figure 2.7.  The design attributes of each geometry are outlined in Table 2.1 
highlighting their advantages and disadvantages.  
 
 
Figure 2.7. Illustration of WGM geometries employed for biosensing.  The light path for each geometry is 
outlined in the red line. 
 












>108 Difficult Moderate Complicated 
Liquid Core Optical Ring 
Resonator25-27 
10-4 – 10-7 RIU 
nM – pM  
103 to 106 Difficult Excellent Complicated 
Microfabricated Ring 
Resonator11,28 
10-4 – 10-6 RIU 
nM – pM 
103 to 106 Good Good Moderate 
Microsphere4,5,13 
10-7 RIU 
nM – pM 
105 to 109 Moderate Poor Easy 
 
2.3.1 Microtoroid Resonators 
Microtoroid structures are fabricated into a 3-D ring resonator designed to exhibit high Q-
factors.29  Fabrication of these resonators requires a combination of photolithography and wet etching.  
Silicon wafers with 2 μm thermal oxide layer is primed with a coating of photoresist then 
micropatterned with circles using a photomask.  After washing away non-cross-reacted regions and 
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removing the oxide layer, a selective XeF2 dry etch isotopically removes the silicon below the silica disks 
leaving microdisks above the substrate surface.23,29  High quality factors are achieved in this geometry 
due to the 3-dimensional isolation of the resonator structure leading to low light loss.  In this geometry, 
Q-factors greater than 108 have been measured leading to sensitive detection of biomolecules.  Despite 
the high quality factors, drawbacks such as the difficulty of fabrication, fluidic implementation and light 
coupling alignment make this geometry difficult to develop for routine use in the clinic.   
 
2.3.2 Liquid Core Optical Ring Resonator (LCORR) 
Capillary ring resonators known as liquid core optical ring resonators (LCORR) provide a unique 
system where the resonator senses the fluidic located interior to the resonator.  The physics of this 
detection scheme has been studied and modeled extensively.30  The WGM resonance is excited along 
the outer circumference of the capillary using a tapered fiber optic.  To enable the sensing of the fluid 
interior, the capillary wall is thinned to dimensions less than 4 µm via HF etching.26,27  For biosensing 
applications the inner walls of the capillary are coated with a bioaffinity molecule.  This platform 
demonstrates ease of fluidic integration using the capillary as both the resonator and fluid carrier.  
However, the fragile nature of thinned capillaries renders this platform difficult to adapt for clinical 
applications.  Additionally, multiplexing is a challenge without the use of multiple capillaries each coated 
with different biomolecules.  For a more robust platform, microfabricated ring resonators have been 
developed for multiplexed, on-chip immunoassays. 
 
2.3.3 Microfabricated Ring Resonator 
Microfabricated ring resonators are a WGM approach fabricated using common and scalable 
photolithography.  Arrays of WGM supporting ring resonators can be fabricated on a silicon wafer.  
Additionally, waveguides are fabricated tangent to each ring resonator in this configuration resulting in a 
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robust light coupling method with no additional alignment required.  This is an advantage as the 
distance between the resonator and the waveguide can be precisely optimized to maximize light 
coupling efficiency.  Light is initially free spaced coupled into the waveguides either through a grating 
coupler or a focusing optic.  The light is guided near ring resonators via waveguides to excite WGM 
resonances in these structures.28  The ease of fabrication and on-chip design enables mass fabrication of 
these devices into a commercialized Maverick system from Genalyte.31  Many resonators and their 
waveguides can be fabricated onto a single silicon wafer for the multiplexed detection of up to 32 
analytes of interest as demonstrated by Genalyte.32   
Despite the development of a commercial instrument using this robust, multiplexed, fluid-
amenable platform, ring resonators exhibit lower Q-factors which is attributed to the rough surfaces 
inherent to photolithographic processes.  As such their limits of detection tend to be lower compared to 
other geometries.   Higher quality factors can be achieved using a microsphere based WGM resonator. 
 
2.3.4 Microsphere Resonator 
Microsphere resonators are commonly used as WGM resonators due to their low costs, ease of 
fabrication and optimal resonator performance.  Microspheres can be formed on the end of fibers or 
capillaries using a straight forward melting method.   Spheres formed from melts can range in size from 
several microns to 200 µm and can demonstrate high Q-factors up to 106-109.33  This has enabled lower 
detection limits 10-7 RIU compared to microfabricated ring resonators (10-4 to 10-6 RIU).  The impressive 
performance metrics of microsphere resonators combined with ease of fabrication and cost-efficiency 




Figure 2.8. Microsphere cavity sensing of virus particles Adapted from Ref. 9.  A thinned fiber optic carrying light 
from a tunable laser is brought near a microsphere in the sample cell.  The output of the fiber is monitored using a 




The coupling of light into these spheres traditionally require a thinned fiber optic precisely 
aligned with the microsphere structure as shown in Figure 2.8 adapted from Ref 6.  The intensity of the 
fiber output is monitored by a photodetector.  When the wavelength of the light is tuned a decrease in 
the transmission is observed.  It is possible to measure the resonances of multiple spheres by simply 
placing more microspheres along the fiber.  However, distinguishing shifts of multiple resonance spectra 
using a single transmission output is a challenge, thus, multiplexing is limited in this platform.  Second, 
the integration of a fluidic system to these spherical detectors is a challenge as the thinned fiber is 
subject to movement during fluid exchanges required for a label-free biochemical assay.  We believe 
that these drawbacks can be resolved through innovation to take full advantage of the impressive 







2.4 Summary of spherical WGM innovations 
 
Spherical WGM sensors offer high quality factors resulting in impressively low detection limits in 
biosensing.  The microsphere platform for WGM biosensing present challenges for integration into a 
multiplexed system when traditional transmission based tracking of resonances is employed.  In an 
effort to enable multiplexing with the desirable performance metrics inherent to spherical resonators, a 
WGM imaging (WGMi) was developed.5,6  WGMi uses fluorescence imaging scheme which allows the 
simultaneous measurement of individual WGM resonances in a field of spheres as shown in Figure 2.9.   
 
Figure 2.9. WGM imaging.  The image (left) was obtained by a CCD camera.  A field of fluorescent dye labeled 
microspheres is excited using a dove prism.  A ring of enhanced fluorescence indicates a resonance which can be 
measured by monitoring the intensity of the region of interest (right).  
 
A field of spheres is imaged using a CCD camera where fluorescent dye covalently attached to the 
resonator surface is excited exhibiting a ring of fluorescence upon resonance.  Each resonance can be 
analyzed by extracting intensity information from the stacks of images collected.  This WGMi approach 
has provided a new scheme for multiplexing using spherical WGM resonators.6  Furthermore, WGMi 




Despite this advancement, spherical resonators have yet to be easily incorporated into fluidic 
platforms.  The compatibility of these detectors with fluid exchanges critical for any bioassay must be 
improved to translate this technology for routine diagnostics.  The projects outlined in the following 
chapters present solutions to these limitations in hopes of developing a clinical viable cancer diagnostic 
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Chapter 3  
 
 






Whispering gallery mode biosensing platforms are predominantly built around either high index 
glass microsphere resonators or microfabricated planar ring resonators.1-3  The former uses 
commercially available or easily fabricated microspheres while the latter is produced on-chip using 
standard microfabrication techniques.  Microfabricated planar ring resonators have demonstrated 
multiplexing capabilities and are easily incorporated with the fluidics necessary for sample handling and 
delivery.4  Microsphere resonators, on the other hand, have historically suffered by comparison in these 
metrics but offer superior optical characteristics.  Microspheres are formed from melts which yield 
exquisitely smooth surfaces, leading to Q-factors which can be orders of magnitude larger than other 
resonator designs.2   Large Q-factors translate into long effective path lengths which improves the 
sensitivity and limits of detection, both of which are obviously desirable in sensing applications. 
Moreover, microspheres are inexpensive, commercially available, and are offered in a range of sizes and 
materials.   
For sensing it is highly desirable to combine the multiplexing and fluidics capabilities of 
microring resonators with the optical properties of microsphere resonators.  Recently, we reported a 
fluorescence imaging approach that enables the WGM resonances from each microsphere in a field of 
resonators to be simultaneously measured.  This enables large scale multiplexing which removes one of 
the barriers listed above when using microspheres in sensing applications.   
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3.1.1 Summary of initial work 
WGM imaging was introduced as a novel way to track the individual resonances from numerous 
spheres in a single measurement.5,6  In this approach, light is simultaneously coupled into a large 
number of microspheres using the evanescent field created from total internal reflectance in a Dove 
prism.  Each microsphere is labeled with the same fluorescent dye, which acts as marker signaling when 
a particular resonator comes into resonance.  As the excitation wavelength from a tunable diode laser is 
scanned, a ring of enhanced fluorescence is observed around a microsphere when a WGM resonance is 
reached.  This enables the WGM resonance from each sphere in a large field of view to be 
simultaneously measured using fluorescence imaging.5,6  For the detection of several biomarkers in a 
multiplexed assay, each sphere size was functionalized with a different antibody enabling a visual 
indication of the identity of biomolecule.  Huckabay et al. demonstrated the use of spherical resonators 
to detect the binding of prolactin, CA-125 and osteopotin in a multiplexed assay.6  Here, we discuss the 
development of a method that stabilizes microspheres to a substrate without losses in quality factor, to 
address the challenge of fluidic implementation to spherical WGM detection platforms.   
 
3.1.2 Challenges of Fluidics for Spherical WGM sensing 
While WGM imaging enables easily multiplexed WGM detection, developing a sensing platform 
amenable to fluidic exchanges remains a challenge.  Typical biosensing assays require multiple fluid 
exchanges or mixing steps which can perturb spheres resting on a substrate through gravity alone.  This 
creates problems since the resonant wavelength of a resonator is linked to the axis around which the 
WGM resonates.  Any change in the WGM path around the sphere due to reorientations on the 
substrate, therefore, can shift the resonant wavelength and nullify an assay.    
Immobilizing microsphere resonators on a substrate, however, presents challenges for WGM 
sensing since the circumference of the sphere supporting the resonance must remain pristine.  This 
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precludes embedding the spheres in adhesives or other films that would disrupt the coupling of light 
around the sphere.  One can envision loading spheres into microfabricated arrays of wells to hold them 
in place, but this turns out to be problematic in practice.  First, the poor monodispersity of spheres 
complicates matching well size with sphere dimensions for stable immobilization.  The larger issue, 
however, arises from complications associated with efficiently coupling light into the immobilized 
spheres.  It is very difficult to load arrays with spheres such that they are both tightly held and in good 
contact with the substrate, which is necessary for efficient coupling of light into the resonator through 
evanescent field excitation.   
 
3.1.3 Approach and application 
In this chapter, we discuss a method for immobilizing microsphere resonators on glass 
substrates adapted from a calcium-assisted glass-to-glass bonding method.  The latter was initially 
developed for microfluidic glass chip fabrication.7  The method creates a stable contact between the 
high index glass microsphere resonators and a glass substrate, enabling efficient coupling of light into 
the immobilized microspheres.  Measurement of resonator Q-factors confirms that the immobilization 
method does not degrade the WGM resonance or greatly perturb the interface between the sphere and 
the substrate.  To demonstrate the robustness of the immobilized microresonators, lipid bilayers were 
transferred onto the substrate bound microspheres using a combination of the Langmuir-Blodgett (LB) 
and Langmuir Schaeffer (LS) techniques.  Bilayers of the lipid DOPC doped with 5 mol% ganglioside GM1 
were formed using this sequential transfer method where each leaflet was transferred at 25 mN/m.  
GM1 binds cholera toxin, the oligomeric protein secreted by Vibrio cholera which causes the 
dehabilitating diarrhea associated with cholera.8  Here we demonstrate the sensing capabilities of the 
bilayer draped over immobilized microspheres by tracking changes in their WGM resonant wavelength 
upon the addition of cholera toxin.  Analysis of the resulting binding curves yields a measured Kd of 1.5 x 
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10-11, consistent with literature values, and a detection limit of 3.3 pM.9,10  The reported bonding 
scheme, therefore, is shown not to perturb the optical properties of the resonators while immobilizing 
them sufficiently onto the substrate for assay development and implementation.   The novel coupling of 
Langmuir-Blodgett films with WGM resonators also enable the characterization of quality factor losses 
due to dye concentration important for WGM imaging development.   
 
3.1.4 Effect of resonance reporting dye on quality factors 
As previously discussed, WGM imaging requires the incorporation of dye molecules to the 
resonator surface to exhibit a ring of enhanced fluorescence upon resonance.  The addition of a dye to 
the WGM sensing surface, however, may have adverse effects on the optical properties of the 
resonator.  First, steric competition between dye molecules and antibody molecules on the sensor 
surface may reduce the number of available antigen binding sites reducing sensitivity, decreasing 
dynamic range and increasing limits of detection.  Secondly, WGM sensor performance is related to the 
efficiency with which light is recirculate around the resonator.  Thus, any mechanism leading to light loss 
from the resonator can result in lower quality factor and sensitivity.11  Characterization of changes in the 
quality factor with dye concentration can reveal an optimized detection platform using WGM imaging.  
Controlling dye concentrations is difficult using surface functionalization.  However, LB films enable 
excellent compositional control of dye within lipid monolayers useful for this dye loading study.  Here, 
LB films containing a range of 0.25 to 10 mol% TR-DHPE dye as a model to study dye loading effects on 







3.2 Materials and Methods 
 
3.2.1 Microsphere Immobilization 
High refractive index (n = 1.9), barium titanate (BaTiO3) glass microspheres (45 µm ± 7%  
diameter, Mo-Sci, Rolla, MO) were cleaned in a 5% Contrad solution.  The spheres were rinsed in an 
ethanol/water (30/70 v/v) solution and stored in absolute ethanol.  Spheres were exchanged into an 
aqueous PBS solution prior to use.  A glass bonding solution was prepared with 0.125% w/v calcium 
acetate (Fisher Scientific, Hampton, NH) and 0.125% w/v powdered detergent (Alconox Inc., White 
Plains, NY) in nanopure H2O.  Approximately 100 uL of the bonding solution was placed on a clean glass 
cover slip (Fisher Scientific, Pittsburg, PA) and allowed to deprotonate the glass surface for ~5 minutes.  
Approximately 5 µL of the clean microspheres in PBS solution were transferred to the sample slide and 
allowed to dry for 20 minutes at 50°C.  The sample slide was washed thoroughly with nanopure H2O to 
remove any unbound spheres and excess salts from the surface prior to monolayer transfer.   
 
3.2.2 Langmuir-Blodgett trough transfer of lipids 
Dioleoylphosphatidylcholine (DOPC) and ganglioside GM1 (GM1) were obtained at >99% purity 
(Avanti Polar Lipids, Alabaster, AL) and used without further purification.  The fluorescent lipid probe, 
Texas-Red dihexadecanoyl-sn-glycero-3-phosphoethanolamine (TR-DHPE) (Life Technologies, Carlsbad, 
CA), was diluted in methanol to obtain appropriate working concentrations.  DOPC/GM1 (95:5 mol%) 
solutions were prepared at 1 mg/mL concentrations in a 65:35 volume mixture of chloroform and 
methanol.  Lipid mixtures prepared for WGM assays were further doped with 0.25 mol% TR-DHPE to 
enable WGM fluorescence imaging.  Approximately 50 µL of the appropriate lipid solution was dispersed 
on a 18MΩ water subphase in a Langmuir-Blodgett trough (Type 611, Nima Technology, Coventry, 
England).  The solvent was allowed to evaporate for at least 15 min prior to initiating 
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compression/expansion cycles to anneal the film.  Each monolayer was subjected to two 
compression/expansion cycles between surface pressures of 10 mN/m and 40 mN/m with the barrier 
rate held constant at 100 cm2/min.  Following the last expansion, the monolayers were compressed to 
25 mN/m and held for 10 min prior to transfer onto the substrate.  Bilayers were transferred on to the 
immobilized glass microspheres at dipping velocity of 1 mm/min by the Langmuir-Blodgett/Langmuir-
Schaeffer method resulting Y-type bilayers.  All bilayers were transferred and imaged at 22°C. 
 
3.2.3 Assay Preparation 
Prepared glass cover slips were fit into the custom flow cell.  Refractive index matching fluid 
(n=1.514 immersion oil, Olympus, Center Valley, PA) was used between the prism surface and sample 
slide.  A syringe pump (Harvard apparatus, Holliston, MA) was used to fill the flow cell chamber with a 
PBS solution (MP Biomedicals, Solon, OH).  A second syringe pump and fluidic controller (Warner 
Instrument Corp., Hamden, CT) was used to inject aliquots of purified recombinant cholera toxin beta 
labeled with A555 (CTxB-A555) (Molecular Probes, Eugene, OR) into the flow chamber.  Each injection 
was allowed in incubate in the flow chamber for 5 minutes before being flushed with PBS and imaged. 
 
3.2.4 TIR fluorescence imaging 
Fluorescence imaging assays of cholera toxin binding to supported bilayers of DOPC/GM1 
utilized CTxB-A555 (Molecular Probes).  Binding of the CTxB-A555 to the lipid bilayer was imaged with an 
inverted microscope (Olympus IX71) equipped with a 60x PlanAPO objective (1.45 NA, Olympus).  The 
514 nm line from an argon ion laser (Innova 90, Coherent Inc., Santa Clara, CA) was coupled into the 
microscope through the objective using a total internal reflection illumination configuration.  Emission 
from the bound CTxB-A555 was collected with the same objective, filtered to remove the excitation light 
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(Chroma), and imaged onto a cooled CCD (Coolsnap K4).  Image collection was controlled with Slidebook 
software (Intelligent Imaging Innovations).   
  
3.2.5 Fluorescence WGM imaging 
The tunable output from a Vortex II TLB-6900 external cavity diode laser (New Focus, Santa 
Clara, CA) was directed into a N-BK7 Dove prism (n = 1.52, Edmund Optics, Barrington, NJ), on which the 
sample was mounted.  Total internal reflection at the substrate interface creates an evanescent field, 
which was used to launch light into the immobilized microspheres.  At a WGM resonance, an enhanced 
ring of fluorescence from TR-DHPE doped into the LB films and layered onto the microspheres was 
imaged from above.  The fluorescence was collected through a 10X UMPlanFL (0.3 NA) objective 
(Olympus, Center Valley, PA), filtered to remove the residual excitation (Chroma, Bellows Falls, VT), and 
imaged onto a cooled CCD camera (Coolsnap K4, Roper Scientific, Tuscon, AZ).  A LabView program 
controlled scanning of the laser system, which was synchronized with Slidebook image collection 
software (Intelligent Imaging Innovations, Denver, CO).   
   
3.2.6 Dye study for quality factor characterization 
 Monolayers were transferred onto microscope slides with immobilized WGM resonators using 
the same procedures outlined previously.  DOPC lipids were doped with TR-DHPE at increasing 
concentrations of 0.25, 0.5, 0.75, 1, 5 and 10 mol%.  Approximately 50 µL of the lipid solution was 
dispersed on a 18 MΩ water subphase in a Langmuir-Blodgett trough.  The solvent was allowed to 
evaporate for at least 15 min prior to initiating compression/expansion cycles to anneal the film.  The 
monolayers were compressed to 25 mM/m then subsequently transferred on to the immobilized glass 
microspheres at a substrate velocity of 1 mm/min.  The quality factors of at least 20 WGM resonators at 
each condition were measured to provide sufficient statistics.  
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3.3 Results and Discussion 
 
3.3.1 Optimization of sphere bonding 
Allen et al. demonstrated robust glass to glass surface bonding using a 0.5% Alconox/0.5% 
calcium acetate slurry.7  WGM resonator immobilization on glass substrates using this method produced 
rigidly bonded spheres, however, the substrate had residue on the resonator surface which adversely 
affected the quality factors of these resonators.  Alconox and calcium acetate concentrations were 
adjusted adapting the method developed by Allen et al.7 to obtain residue-free resonator surfaces.  We 
systematically lowered the calcium acetate solution (0.25%, 0.125% and 0.0625% w/w) while maintain 
the Alconox concentration (0.5% w/w).  Less salt residue was observed, as expected, however, the 
sphere adhesion to the surface was noticeably impaired.  This is not clearly understood but we suspect 
that since Alconox is anionic, higher concentrations may compete against the silanol groups on the glass 
surfaces and disrupt the calcium to surface silanol interaction.  Thus, we lowered the concentration of 
Alconox and calcium acetate simultaneously.  We discovered that 0.125% w/w of Alconox and 0.125% 
w/w of calcium acetate produced sufficiently bonded spheres with minimal residual salts leading to 
improved quality factors.  We intend to use this method for resonators with antibodies attached on 
their surfaces for WGM immunoassays, thus, we wanted to reduce incubation temperatures and time to 
minimize the potential of antibody denaturation. 
The reported method requires 2 hr incubation at 115°C to form a tight bond between two glass 
slabs.  It was speculated that this is needed to fully remove moisture that may be trapped between the 
two surfaces.  Our sphere and substrate interface has less trapped moisture compared to two flat glass 
slabs, thus, milder temperatures can be utilized to remove moisture.  Both time and temperatures were 
minimized according to Table 3.1. 
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Temperature Incubation Time Sphere immobilization 
90°C 1 hr, 40 mins, 20 mins Good at all incubation times 
70°C 1 hr, 40 mins, 20 mins Good at all incubation times 
50°C 1 hr, 40 mins, 20 mins Good at all incubation times 
22°C (RT) 1 hr, 40 mins, 20 mins Mild at 1 hr, no bonding at 40 and 20 
mins 
 
At incubation times of 20 mins at 50°C had sufficient bonding efficacy of the resonator to the substrate.  
Room temperature bonding at 1 hour may prove more useful for protein integrated WGM resonators to 
lessen the potential for thermal degradation.    
Using these optimized conditions, high index barium titanate (BaTiO3) microspheres were 
bonded to glass substrates using the steps outlined schematically in Figure 3.1.  A glass substrate was 
first rubbed with a slurry of basic detergent (Alconox) containing 8.0 mM Ca2+.  The spheres were then 
deposited on the glass substrate and incubated at 50oC for approximately 20 minutes until dry.  The 
spheres, now bonded to the substrate, were incubated in 18 MΩ water overnight to remove the residual 












3.3.2 Proposed mechanism for glass-glass bonding 
 
 
Figure 3.1. Schematic of the calcium-assisted procedure for immobilizing WGM microsphere resonators to a glass 
substrate.  A drop containing 0.125% (v/v) Alconox and 0.125% (v/v) calcium acetate solution is placed along with a 
cluster of microspheres onto a clean glass substrate.  The sample is then placed in a 50°C oven for 20 minutes.  
Evaporation of the solvent leaves a salt residue which is removed by bathing in deionized water overnight at room 
temperature, leaving a clean glass substrate with microspheres bound to the surface. 
 
Conceptually, one can envision the divalent calcium ion acting as a bridge between the 
negatively charged surface groups on the microspheres and substrate, thus leading to stable bond 
formation.7  However, as the original report showed, a more complicated mechanism is almost certainly 
needed since other divalent cations do not lead to bond formation.  Regardless of the mechanism, this 
approach does successfully immobilize BaTiO3 spheres on the glass substrate.  The bonding scheme 
outlined in Figure 3.1 uses a lower temperature, which was found in the original study to lead to 
reversible bond formation.  However, as will be shown, this gentler bonding method is more than 
sufficient to immobilize spheres for the assay employed in this report.  Additionally, this immobilization 
scheme can be used to adhere dye functionalized spheres without loss of dye function.  This is 




3.3.3 Fabrication of lipid films on WGM resonators 
Another advantage of the microsphere bonding scheme results from the flexibility inherent in 
this approach when designing assays.  Immobilizing microsphere resonators onto a substrate opens new 
opportunities for functionalizing the resonators using techniques that are not compatible for use with 
free spheres.  For example, Langmuir-Blodgett (LB) and related techniques offer extraordinary 
capabilities for creating highly ordered films on substrate surfaces.12-14  These techniques provide 
exquisite layer-by-layer control over film properties such as composition, packing, and constituent 
orientation which has generated interest in using this control to tailor assay properties.12,13  As 
illustrated in Figure 3.2, the LB method involves the transfer of films from an air-water interface onto a 
substrate surface using a dipping method.   
 
Figure 3.2. Schematic of the Langmuir-Blodgett trough used to transfer lipid films onto a substrate.  A 50 uL aliquot 
of the lipid solution is dispersed on the water subphase and a moving barrier compresses the film to the desired 
surface pressure.  A glass substrate with bonded microspheres is slowly pulled through the air-water interface, 
transferring a lipid monolayer onto the substrate surface.  For these experiments, a second monolayer is 
transferred onto the first using the Langmuir-Schaffer technique, creating a bilayer as shown schematically in the 
right panel.   
 
As suggested in Figure 3.2, here we show that the bonded spheres are sufficiently immobilized to 
withstand LB film transfer, thus creating new opportunities for assay development using microsphere 





3.3.4 WGM resonance characterization of immobilized spheres 
To confirm that the immobilization procedure does not interfere with or degrade WGM 
resonances of the microspheres, fluorescence imaging experiments were first performed using LB films 
doped with a fluorescent marker.  For these experiments, immobilized microspheres were coated with a 
DOPC bilayer containing 0.25 mol% TR-DHPE, transferred using the LB/LS method.  The fluorescent lipid 
analog, TR-DHPE, was added to act as a fluorescent reporter of the WGM resonances.  The immobilized 
spheres were mounted on a Dove prism, as shown in Figure 3.3, where light from a tunable diode laser 
experiences total internal reflection at the sample interface.  As the wavelength of the diode laser was 
scanned, the associated evanescent field launches light into the immobilized spheres.  WGM resonances 
are detected as an enhanced ring of fluorescence around the particular microsphere resonator, which is 
detected from above using fluorescence imaging.  The fluorescence was collected and imaged onto a 
CCD camera as shown in Figure 3.3.   
 
Figure 3.3. Schematic of the instrumentation used for the fluorescence imaging of WGM resonances.  Light from a 
tunable diode laser is directed through a Dove prism, which creates an evanescent field at the substrate interface.  
The evanescent field couples light into the immobilized microspheres and WGM resonances are detected through 
fluorescence imaging of a dye marker located on their surface.  As the excitation wavelength is tuned, an enhanced 
ring of fluorescence is observed around the spheres as a WGM resonance is reached.  The fluorescence is collected 
and imaged onto a CCD camera.   
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Figure 3.4 shows a typical series of fluorescence images taken on the same field of microspheres 
as the excitation wavelength from the tunable diode laser is scanned.  These spheres have been 
immobilized onto the substrate surface using the scheme in Figure 3.1 and exhibit bright fluorescence 
rings indicative of WGM resonances.  The excitation spectrum for each resonator can be extracted from 
a series of fluorescence images collected as a function of excitation wavelength.  A typical excitation 
spectrum is shown in Figure 3.4.  The Q-factor calculated from this spectrum is 1.0 x 105 which is 
comparable to measured Q-factors for spheres resting on substrates through gravity alone.  This 
demonstrates that the immobilization process has little effect on the quality of the WGM resonance.   
 
Figure 3.4. (top) Representative fluorescence images of 45 µm spheres extracted from a series of images taken as 
the wavelength of the diode laser is scanned between 632.93 nm and 633.10 nm.  The arrow denotes a sphere that 
undergoes a large change in fluorescence, indicating a WGM resonance near 632.99 nm.  (bottom) Excitation 
spectrum of the WGM resonance for the indicated sphere, extracted from the series of fluorescence images by 






3.3.5 Testing of fluidic system with WGM resonators 
Having shown that the immobilization procedure does not degrade resonator optical properties, 
the utility of membrane coated microspheres for bioassay development was explored.  Bioassays 
require rapid fluid exchanges and the immobilized resonators need to maintain both close contact with 
the substrate surface and not reorient during these processes.  To test the stability of the immobilized 
microspheres during rapid fluid exchanges, the flow cell in Figure 3.5 was fabricated.   
 
Figure 3.5. (left) Schematic of the flow cell used for fluidic exchange and WGM imaging.  The bottom cover accepts 
the Dove prism used to launch light into the small resonators which are imaged from above through the 
transparent window.  An image of the flow cell is shown on the right.   
 
The glass substrate supporting the immobilized microspheres rests on a rigid bottom plate that 
is notched to accept the Dove prism.  An aluminum flow cell body that contains the solution inlet and 
outlet ports is sandwiched between the sample substrate and top coverslip using two silicone o-rings to 
form a water tight seal.  The thickness of the flow cell body dictates the dead volume of the cell which is 
500 uL.  Screws connect a rigid top cover with the bottom PMMA plate and compress the o-rings.  An 
image of the assembled flow cell is shown in Figure 3.5.   
Studies using the flow cell shown in Figure 3.5 indicate that the immobilized spheres remain 
stable at all flow rates studied (up to a maximum flow of 3 mL/min).  This demonstrates that the 
bonding method described above results in resonators compatible with assay fluidics.  As shown above, 
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the resonator immobilization scheme does not degrade resonator optical properties while rigidly 
holding the spheres on the substrate surface under high flow rates.  This approach, therefore, removes a 
significant barrier encountered when integrating microsphere resonators with the fluidics necessary for 
assay development using the WGM imaging method.    
 
 
3.3.6 Lipid bilayer sensing using WGM resonators  
Lipid films containing ganglioside GM1 were transferred onto immobilized microsphere 
resonators to detect the presence of cholera toxin (CTx) using WGM imaging.  CTx is secreted by Vibrio 
cholera and leads to the debilitating diarrhea associated with cholera infection.8  CTx is a 85 kDa protein 
containing one active alpha subunit and five binding beta subunits which bind GM1, an acidic 
glycosphingolipid found ubiquitously in the outer leaflet of cellular membranes.8  The high affinity of CTx 
beta subunit (CTxB), a 11.4 kDa protein, for GM1 is considered a model for protein-sugar interactions 
and has reported Kd values ranging from nanomolar to picomolar depending on the particular system 
studied.10  In our study, a 57 kDa non-toxic pentameric CTxB fluorescently labeled with Alexa 555 (CTxB-
A555) was detected.  
A monolayer of DOPC containing 5 mol% GM1 was transferred onto a microsphere/substrate 
platform at a surface pressure of 25 mN/m using the LB method.  A second monolayer at the same 
surface pressure and composition was deposited on the first using the Langmuir Schaeffer (LS) method, 
creating a bilayer covering the entire surface area of the substrate.  At this surface pressure, both GM1 
and the dye marker distribute homogeneously in the DOPC lipid film matrix.  To confirm that the 
membranes incorporating GM1 were capable of CTxB binding, bulk fluorescence imaging of the bilayers 




Figure 3.6. Bulk fluorescence assay of the binding of fluorescently labeled CTxB (CTxB-A555) to DOPC/GM1 bilayers 
transferred onto a glass substrate at 25 mN/m.  Fluorescence images of the same region of the bilayer are shown 
following incubation with (A) 27.6 pM CTxB-A555 and (B) 110 pM CTxB-A555.  The increase in fluorescence 
indicates specific binding of CTxB-A555 at GM1 sites in the bilayer.  Control studies of bilayers composed of DOPC 
but lacking GM1 (not shown) do not show any significant fluorescence after incubation with CTxB-A555.   
 
Figure 3.6 presents fluorescence images of a DOPC/GM1 bilayer following increasing additions 
of CTxB-A555.  The images are taken in the same region of the bilayer, which was allowed to react with 
the indicated dose of CTxB-A555 for 5 minutes, flushed with PBS buffer, and imaged.  As seen in Figure 
3.6, exposure of the bilayer to increasing aliquots of CTxB-A555 leads to increased fluorescence 
intensity, as CTxB-A555 binds to the GM1.  Control studies using substrates coated with pure DOPC 
bilayers, lacking GM1, exhibited constant background signals over the same CTxB-A555 dosing levels.  
This suggests that the increase in fluorescence observed arises from specific interactions between GM1 
and the CTxB-A555.    
Having confirmed that CTxB-A555 specifically binds to the GM1 in the transferred membranes, 
studies were carried out to explore the WGM response of the membrane coated microspheres.  For this 
study, TR-DHPE was incorporated into the lipid bilayer at 0.25 mol% to provide a fluorescence marker 
for the WGM imaging.  To ensure consistency with the bulk fluorescence studies, the fluorescently 
labeled CTxB-A555 was also used in these binding studies.  However, long pass filters were inserted to 
remove any residual fluorescence from the A555 marker.  Using the WGM fluorescence imaging 
approach outlined in Figure 3.3, WGM excitation spectra were collected as a function of CTxB-A555 
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dose. Figure 3.7 shows a typical series of WGM excitation spectra collected as a function of CTxB-A555 
concentration.  Prior to the addition of CTxB-A555, this particular microsphere resonator had a WGM 
resonance centered at 632.98 nm with a Q-factor of 1.0 x 105.   With the addition of 2.8 pM CTxB-A555, 
the peak red-shifts 6.33 pm as CTxB-A555 binds to the GM1/DOPC bilayer on the sphere surface, which 
changes the effective refractive index around the resonator.   The peak continues to red shift as 
additional CTxB-A555 is added as shown in Figure 3.7. 
 
 
Figure 3.7. Representative WGM excitation spectra extracted from the same microsphere resonator at four 
different CTxB-A555 concentrations.  Specific binding of CTxB-A555 to the GM1 containing bilayer coated around 
the microsphere, changes the effective refractive index and shifts the WGM resonance.   
 
The results in Figure 3.7 are summarized by the binding curve shown in Figure 3.8.  This figure 
plots the WGM resonance shifts as a function of CTxB-A555 concentration, exhibiting the classic binding 
curve shape expected.  The binding curve saturates at approximately 4.0 x 10-11 M CTxB-A555 and fitting 
the curve yields a measured Kd value of 1.5 x 10
-11. This value is in the range of the reported values (7.3 x 
10-10 to 4.6 x 10-12) measured using surface plasmon resonance.9,10   
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The calcium/alconox immobilization protocol adapted for microsphere resonators is compatible 
with lipid bilayers and was used for the detection of GM1 to CTxB-A555 binding.  The high degree of 
compositional control using lipid bilayer films with WGM lends itself to study dye loading effects on 
resonator quality factors.  The next section describes the dye loading effect on quality factors and 
describes the potential impact of dye loading on sensor performance. 
 
Figure 3.8. CTxB-A555 binding curves measured by tracking shifts in the WGM resonance with CTxB-A555 
concentration.  For resonators coated with DOPC bilayers incorporating GM1 (red squares) the binding curve 
shows a saturation response with a detection limit of 3.3 pM.  This is compared with control studies using spheres 
coated with pure DOPC bilayers (blue triangles), which show negligible shifts with CTxB-A555 addition.  The inset 
shows a log plot of the data from which a Kd of 1.5 x 10
-11
 is calculated, which is consistent with literature values.   
 
3.3.7 Relationship between dye concentration and WGM performance 
Model membranes coated on the WGM resonators not only serve as a matrix containing 
capture material in biosensing as discussed previously but also provides a useful tool for assessing 
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resonator performance.  WGM imaging utilizes dye as a resonance reporter enabling the measurement 
of hundreds of WGM resonances in a single experiment.  However, as these fluorophores absorb energy 
from the resonant cavity, they operate as a mechanism of light loss from the resonator.  This can 
potentially limit Q-factor and resonator performance which in turn can diminish sensor metrics.15,16  
Systematically varying concentration is hard to do using dye functionalized spheres.  Whereas, the 
compositional control provided by LB lipid films enables the reliable transfer for a film of known dye 
concentration to the immobilized sphere surface.  Therefore, dye incorporated LB films were used to 
measure the effect of fluorophore absorbance on resonator performance.       
Here, a DOPC monolayer only doped with known concentrations of TR-DHPE dye was deposited 
on the immobilized microsphere substrate.  The WGM resonances of these spheres were measured by 
using the dove prism light coupling method to excite at least 20 spheres simultaneously.  The WGM 
spectra were collected and Q-factors were recorded at each dye concentration. 
 
 
Figure 3.9. A plot of the quality factor versus TR-DHPE concentrations.  The data (n = 10) shows that lower 
concentrations of TR-DHPE are correctly to higher average quality factors.  As dye concentrations reach less than 




Figure 3.9 plots Q-factors observed as the dye concentration is increased from 0.25 mol% to 10 mol% 
TR-DHPE.  The averages of the Q-factors show the expected trend where reducing the number of light 
absorbing molecules from the surface of these WGM resonators leads to improved Q-factors.  For 
sensing applications, higher Q-factors lead to improved sensor performance.  Interestingly, no 
measurable difference in Q-factors was observed in concentrations higher than 1 mol% of TR-DHPE.  But 
at lower concentrations (< 1 mol%) there is a slight increase in the statistical average of quality factors.  
We note that WGM resonance measurements at lower concentrations of TR-DHPE were difficult due to 
low fluorescence signals and photobleaching.  As quality factor improves to push the limits of detection 
lower, the use of dye as a resonance reporter is a limitation for sensing, therefore, an approach based 
on scattering signals will be discussed in the follow chapter.   
 
3.4 Conclusions and Future Directions 
 
This chapter highlighted the development and application of microspheres immobilized on a 
substrate to improve fluidics using WGM imaging.  High index microspheres were immobilized onto 
glass substrates using a calcium-assisted bonding method.  The bonding method did not degrade the 
optical properties of the immobilized resonators, which was confirmed through characterization of 
resonator Q-factors.  The immobilized resonators were stable in the fluidics necessary for assay 
development and amenable to lipid film transfer using the Langmuir-Blodgett and Langmuir-Schaeffer 
methods.  Bilayers transferred onto immobilized spheres using the sequential transfer of monolayers of 
DOPC doped with 5 mol% GM1 were fabricated to detect CTxB-A555 which binds to GM1.  Bulk 
fluorescence studies confirmed the specific binding of CTxB-A555 to GM1.  This was also characterized 
by measuring shifts in the WGM resonance.  Analysis of the resulting binding curves from WGM imaging 
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measurements yielded a Kd value of 1.5 x 10
-11 which is consistent with previous SPR measurements.  
The measured detection limit of 3.3 pM is competitive with other approaches and the small size of the 
microspheres reduces the detection footprint and amount of material needed.   
The LB film was also used to systematically control the dye concentration used in WGM imaging 
to study dye loading effects on resonator quality factors.  We conclude that lower concentrations of dye 
(less than 1 mol%) indeed results in higher quality factors. However, due to the low concentrations of 
these dye molecules, fluorescence signals required for WGM measurement readily photobleach which 
deters any prolonged measurements.  The next chapter summarizes a scattering approach to overcome 
dye loading issues for improved quality factors.   
In summary, the calcium bonding method is shown to lead to stable and immobilized resonators 
that are compatible with the fluidics necessary for assay development.  The simple immobilization 
procedure does not require expensive equipment or elaborate fabrication processes, thus making the 
approach generally applicable.  This, therefore, removes a significant barrier for the development of 
sensitive, multiplexed biosensors using the superior optical properties of high-Q microsphere 
resonators.  The favorable optical properties of spheres coupled with their availability in a wide range of 
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In the previous chapters, we showed that fluorescence imaging can be used to track WGM 
resonances of a field of fluorescent dye labeled spheres.1  This enabled multiplexed detection of three 
putative biomarkers of ovarian cancer in a single assay with minimal cross-talk.  The whispering gallery 
mode imaging approach, in general, provides a flexible, sensitive and label-free approach for biosensing.    
However, additional improvements were needed to develop a robust system that can withstand fluidic 
exchanges required for a clinical test.  Therefore, we described a soft glass-to-glass bonding method 
with a calcium acetate/alconox solution to adhere microspheres to a glass substrate.2  This enabled 
spherical microspheres to resist movement during routine fluid exchanges required for immunoassays.     
In this chapter, we further investigate and demonstrate whispering gallery mode detection using 
a tapered fiber coupling scheme, optical films, and scattering WGM detection in an effort to improve 
quality factors.  We also demonstrate tapered fiber coupled microspheres as a dip sensor for droplet 
sensing.  We propose the use of this dip sensor with fluid handling platforms such as digital 
microfluidics.  Additionally, we introduce several microfluidic prototypes that can integrate WGM 





4.2 Materials and Methods 
 
4.2.1 Thin Film fabrication for Q-factor Study 
Microscope slides (Fisher Scientific) were rinsed with water and dried with nitrogen.  Roughly 
250 µL of AL-2233 material (Fiber Optic Center, New Bedford, MA) was pipetted to the center of the 
substrate on the spin coater.  Spin coating conditions were set at ~5,000 rpm for ~30 sec to ensure 
complete coverage of the substrate and even height profiles.  Post-spin, the substrate was placed in a 
60°C oven to remove residual solvent.  For thicker layers, this procedure was repeated to increase the 
coating thickness in increments of ~60 nm per spin.   
 
4.2.2 Tapered fiber optic coupling  
 Fiber tapers were prepared by the following method.  The jacket of a single mode optical fiber 
(630 HP, Edmund optics) was stripped to expose the cladding.  After cleaning with ethanol to remove 
any residual material, the stripped portion of the fiber was placed in a laser-based micropipette puller 
(P-2000, Sutter Instruments) at the following settings: heat 250, velocity 5, delay 0 and pull 100.  The 
proximal end of the tapered fiber and the distal end of light carrying fiber were fused using a fusion 
splicer (FSM-40S, Fujikura).  The fabricated fiber was coated with PDMS by gently dipping the tapered 
portion of the fiber in a PDMS solution diluted with ethanol (50/50 v/v).  The PDMS mixture of 10:1 
polymer to curing agent (Sylgard 184, Dow Corning) was diluted with ethanol to create a thin but tactile 
coating on the fiber taper.  Microspheres were then placed on the PDMS coated fiber taper and allowed 






4.2.3 Scattering WGM Assays 
Refractive index measurements were made in solutions of NaCl (Fisher Scientific) mixed with 
appropriate amounts of 18 MΩcm water to make 1.332, 1.333, 1.334, 1.336, 1.339 and 1.343 RIU 
calibration standards.  The flow cell illustrated previously in Figure 3.5 was used having a reservoir 
volume of 500 µL.  After each injection of RI solution, the resonant wavelength (n = 3) was measured 
and recorded after a 10 minute incubation.  The images were captured using a CMOS camera (Model 
number 413C, Edmund Optic) through a 10x objective (UMPLanFL, Olympus).  Data analysis was 
automated via custom programmed LabView (National Instruments) software.  The LabView code is 
provided in the appendix.  Bioassays for the detection of interleukin-6 (IL-6, BD Bioscience) in a 
concentration range of 0 to 563 pg/mL were performed.  All IL-6 solutions were diluted in pH 7.4 
phosphate buffer saline (PBS) (27 mM KCl, 15 mM KH2PO4, 1400 mM NaCl and 81 mM Na2HPO4, MP 
Biomedicals) obtained at 10x concentration.   
 
4.2.4 Microfluidic Platform Fabrication 
 Microfluidic photomasks were designed using AutoCad (AutoDesk) software.  “Type D” marks 
two characteristics of the photomask: 1) the chrome layer will be plated on the bottom face of the film. 
2) The desired microchip structures are indicated by white (clear) drawings in the AutoCad software.  
The resulting photomask from Infinite graphics (IGI) are negative films where the clear portions of the 
mask represent UV exposed areas and the dark areas represent unexposed areas.  UV light crosslinks the 
SU-8 polymer thereby creating raised features on the silicon wafer.   
A silicon master was created using SU-8 100 negative photoresist spun onto a 4 inch diameter 
silicon wafer to a thickness of 100 µm using a spin coater (Cee 100, Brewer Science).  The wafer was 
then heated to 65°C for 10 min and ramped to 95°C for 30 min on a programmable hotplate (Thermo 
Scientific).  After this “soft” bake, the negative mask was aligned on top of the photoresist coated wafer 
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and exposed at 344 mJ/cm2 using a UV flood source (ABM Inc.) for 27 seconds.  After exposure, the 
wafer was heated to 65°C for 5 min and ramped to 95°C for 20 min.  The master was developed in SU-8 
developer for 20 mins, rinsed with isopropyl alcohol and dried with nitrogen.  Then, the master was 
finalized with a 2 hr “hard” bake step at 200°C.  To create a PDMS chip from the silicon master, 
PDMS/curing agent mixed at a 10:1 ratio was poured onto the master and cured for at least 2 hours at 
70°C.  Microchannel reservoirs for buffer and waste were punched into the PDMS using Uni-Core biopsy 
punch (Ted Pella).  Spheres stored in solution were pumped through the channel via negative pressure 
using a 5 mL syringe at the outlet of the channels.  To perform refractive index assays in these devices, 
solutions of ethanol and deionized water were pressure injected using a 5 mL syringe pump.   
 
4.2.5 Digital Microfluidics Fabrication 
 Glass substrates (plain beveled edge, Fisherbrand) were taped along the walls of the vacuum 
chamber dome using copper tape in an evaporative coater.  A pressure of roughly 7.6 x 10-2 torr was 
achieved using a vacuum pump (MOD 1101006418, Franklin Electric) then a turbo pump (Turbovac 151, 
Leybold) was used to further lower the pressure to roughly 10-5 torr.  Aluminum was evaporated by 
resistive heating to coat a thin film on the glass substrates.  A shutter was placed over the metal plate 
holding the aluminum target to controllably coat the glass substrates.  The shutter was opened for 
roughly 5 seconds to coat the glass substrate using a deposition monitor (Infinicon XTM/2).  The vacuum 
was returned to atmosphere and the glass substrates now coated with aluminum were removed.  The 
electrode contact pads (2 x 2 mm) were outlined using a M25 CO2 Laser Engraver (University Laser 
Systems) at power 12.0% and speed 2.6%.  The laser was used to etch away the aluminum coating 
isolating each electrode from each other.  These electrode contact pads were designed to be adjacent to 
each other such that a small 100 μL droplet of solution creates an electrical circuit between 2 electrodes 




Figure 4.1. A DMF substrate.  The electrodes were fabricated by etching aluminum to outline the electrodes shown 
here.  The electrodes are electrically isolated but neighbor other electrodes for droplet actuation.  
 
Then, several drops of silicone oil were dispersed and covered with Saran wrap.  The chip was baked at 
100°C for 1 hr to adhere the Saran wrap to the electrode surface.  A solution Rain-X© and isopropyl 
alcohol in a 1:5 w/w ratio was distributed on top of the chip surface and dried on a hot plate at 80°C for 
20 mins.  The resulting digital microfluidic chip was actuated using a flyback transformer from a CRT 
monitor.  The output of the power supply when a 5 V square wave at 10 kHz is applied is 300 to 1000 V.  
Voltages were carefully applied using well insulated leads.   
 
4.3 Results and Discussion 
 
4.3.1 Light coupling 
The first attempts to couple light microsphere structures used a free-space laser beam focused 
on to the edge of a sphere.3,4  These off-axis Gaussian beams directed at spherical structures exhibit 
resonances that could exhibit quality factors up to 106.3  Free-space light coupling, however, has less 
utility for most practical refractive index sensing applications due to mie scattering.  Light coupling via 
evanescent fields, on the other hand, effectively introduces light with efficiencies in the range of up to 
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80 up to 99.99%.5-7  One example of evanescent field coupling is performed by directing light from a 
laser source at a prism permitting total internal reflection on the prism interface as shown in Figure 4.2.   
 
Figure 4.2. Illustration of an evanescent wave created by TIR on the surface of a dove prism. 
 
This creates an evanescent field component at the prism surface and decays outwardly.  When a 
microsphere is placed within the evanescent field, photons are transferred into the microsphere via 
frustrated total internal reflection.  The photons that are coupled into the microsphere structure travels 
along its circumference ultimately returning to the location.  At this point, the photon can either be 
recirculated in the structure or transferred out of the microsphere back into the prism.  The degree of 
overlap between the resonator and the evanescent wave formed at the light coupling interface has an 
effect on the efficiency of the light coupled in and amount of light coupled out of the resonator.  
Therefore, coupling gap distances can affect the overall sensor performance.     
 
4.3.1.1 Coupling gap distance 
An optimized gap between the resonator and coupling surface can allow sufficient pumping of 
photons into the resonator structure but more importantly reduce the amount of photons that can 
couple out of the microsphere into the prism.  Figure 4.3 illustrates coupling gap conditions that lead to 




Figure 4.3. Illustration of coupling motifs.  (left) under-coupled regime where the resonator has little interaction 
with the evanescent wave.  (middle) critically coupled regime where a slight distance between the resonator and 
dove prism is introduced. (right) over coupled regime where the resonator rests directly on top of the dove prism. 
 
The evanescent wave decay length, d, is given by:8 
 
𝑑 =  
𝜆0
4𝜋𝑛1
(𝑠𝑖𝑛2(𝜃 − 𝑛2)−1/2                                          Equation 4.1 
 
where λ0 is the wavelength of light, n1 is the refractive index of the prism, θ is the angle of incidence, n2 
is the refractive index of media at the interface of the coupling prism and n is (n2/n1).  For example, a 
system with λ0 = 633 nm, θ is 65°, dove prism, n1 = 1.515, and solution of water, n2 = 1.333, the decay 
length is roughly 153 nm.  In Figure 4.3, the left-most motif is an under-coupled system where the 
distance between the resonator and prism surface, lcoup, is much greater than d.  This leads to very little 
overlap of the evanescent tail with the resonant mode of the microsphere.  This under-coupled regime, 
leads to very few photons being pumped into the resonator.  For sensing, this regime may exhibit lower 
sensing metrics as low number of photons lead to low electric field densities within the resonator 
structure available for surface sensing interactions.  In contrast, the far right image of Figure 4.3 shows 
the over-coupled regime where the large overlap of the evanescent wave and the microsphere leads to 
efficient photon pumping.  However, due to the close proximity the microsphere and prism, light 
scattering losses dominate due to higher photon out coupling rates.  This results in low quality factors 
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with lower sensor performance.  The ideal coupling is a balance of the two previous regimes illustrated 
in the middle of Figure 4.3.  This is termed as critical coupling where light is efficiently pumped into the 
resonator and the slight gap between the two surfaces minimizes out coupling of photons.9-11  This 
regime, therefore, maximizes the field density by efficiently retaining the photons within the 
microsphere structure with lower light loss.  High field densities lead to greater interaction between the 
recirculated light and the microsphere’s local environment.12,13  This presents advantages for sensing 
applications where improved field densities lead to higher sensitivities.   
 In practice, to achieve critical coupling, a device that physically controls the distance between 
the two surfaces, such as a micromanipulator or pedestal, can be used.13,14  This configuration utilizes a 
resonator fabricated at the tip of a capillary and is micromanipulated by holding its stem.14-16  A tapered 
fiber is meticulously aligned at a particular distance from the microsphere to achieve critical coupling.  
This platform is less amenable for fluidic exchange systems due to the bulkiness of the fiber alignment 
systems.  Instead of micromanipulating the more thinned fiber, stem-held spheres were introduced to 
maintain optimized gap distances.  These stem-held spheres have been introduced into microfluidic 
devices,17 the aligning of a fiber optic within a microfluidic cell makes mass fabrication a challenge and 
can be difficult to maintain.  Here, we introduce an index matched gap material to achieve critical 
coupling for improved sensor performance using a prism light coupling configuration. 
The material, AL-2233 (Fiber Optic Center, New Bedford, MA), is a transparent polymer with a RI 
of 1.33, is traditionally used as a low refractive index light guide cladding or as anti-reflection coatings.  
For our purpose, this material provided a thin coating of a RI similar to that of water.  Using an index 




Figure 4.4. Illustration of an index matched optical film used to critically couple light into the resonator. 
 
The light undergoes TIR at the interface between the prism and refractive index coating 
matched to that of water.  The evanescent wave extends through the coating critically coupling into the 
resonator.  The thickness of the film was increased in layer increments where each coating application 
would add a thickness of roughly 60 nm.  The quality factors of spheres with the index matched coating 
substrate showed the potential of exhibiting higher quality factors, up to 106, using a prism coupling set 
up compared to the typical 104 Q-factors observed as shown in Figure 4.5.   
 
 
Figure 4.5. WGM spectrum shown on the left was obtained using the schematic shown in figure 4.4 where the 
sphere was placed on top of an optical film for critical coupling.  The WGM spectrum on the right was obtained 




However, some microspheres in the gap prism configuration continued to exhibit lower quality factors.  
This may be attributed to uneven coating methods.  A characterization of the coating profile studying a 
large coating area could perhaps elucidate this.  Initial results, however, show that a gap between the 
coupling surface and resonator statistically improved the overall Q-factors as expected.    
The gap height or film thickness was characterized using a 2D stylus profilometer (Tencor 
Alphastep 200).  We were limited to measurements on the edges of the film coating where the height 
contrast provided estimates of the film thickness.  The highest quality factors were observed on film 
thicknesses of ~250 nm ± 20 nm.  Compared to the evanescent length previously calculated of 153 nm, 
the optical coating is much thicker.  This is possible because the exponentially decaying evanescent 
wave still has some electric field density beyond the calculated evanescent decay length allowing 
photon coupling.  Improvements in quality factors can translate into higher sensor performance in 
metrics, such as sensitivity and limits of detection however must be proven with more rigorous sets of 
studies.   
 
4.3.1.2 Fiber coupling 
Several methods can be used, such as fiber coupling, prism coupling and waveguides, to 
evanescently couple light into microspheres.  We have primarily utilized prisms to couple light into 
resonators taking advantage of the ability to excite a field of spheres with easy alignment.  Prisms 
exhibit efficiencies around 80 – 90%, where the loss is mainly due to the phase mismatch.  Fiber optic 
waveguides, on the other hand, can provide almost perfect coupling capable of coupling efficiencies up 
to 99.99% in previous studies.5  While fibers have been used to couple light into WGM structures, more 
unique platforms using tapered fibers as a sensor device have yet to be fully explored.   
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One group led by Teraoka have developed a more robust dip sensor platform by bending the 
stem of a fiber, with a sphere at the end, roughly 90° to align two optical fibers.18  One fiber acts as the 
light feed and the other fiber as a light monitor.  They demonstrated a repeated dipping measurement 
between water and a 0.10 wt % sucrose solution.18  These initial demonstrations show the promise of 
WGM light coupling in a robust manner, however, they are relatively difficult to fabricate primarily due 
to the difficulty in aligning two fibers precisely parallel to be able to record the resonators WGM spectra.  
These fabrication challenges can be alleviated using WGM imaging where we require just one fiber as 
the light feed and use a camera as a method to readout WGM resonances.  Here we explore the use of 
fiber optic coupling for applications as a dip sensor using WGM imaging.   
Dip sensors have the advantage of being robust and easy to use devices.  They are compact by 
design and thus are amenable to point-of-care testing.19  Polished or tapered fibers are more compact 
and can be incorporated as a dip sensor.  The light from a fiber optic undergoes TIR through the core of 
the fiber creating an evanescent wave that can be coupled into the resonator.  Figure 4.6 shows a fiber 
that was tapered using a laser-based micropipette puller (Sutter instrument, Novato, CA).  The taper 
portion of the fiber was thinly coated with a PDMS solution diluted in 50% ethanol solution.  The 





Figure 4.6. An image of a thinned fiber optic with a 53 um microsphere bonded to the fiber using a thin coating of 
PDMS. 
 
This device was used as a dip sensor by measuring the refractive index changes when placed in a droplet 
of water versus a droplet of 5% glycerol with rinsing steps in between.  Measurements were repeated a 
total of five times between the two solutions.  Figure 4.7 shows that the resonant wavelength correctly 
senses the refractive index change between the two solutions of water (n = 1.333) and 5% glycerol (n = 




Figure 4.7. The resonant wavelength was measured while the fiber optic dip sensor was alternatingly placed into a 
droplet of water and a droplet of 5% glycerol. 
 
The standard deviations for the measurements in solutions were 5 pm and 8 pm for water and glycerol, 
respectively.  We also note that this light coupling scheme routinely exhibited quality factors at ~105, 
roughly an order of magnitude higher than prism coupling.  These initial results show the promise of 
sensing for droplet sensing using microsphere resonators in a dip sensor platform using WGM imaging.  
However, for routine uses of these dip sensors, using fluorescent dye as a reporter for WGM resonance 
is a drawback due to photobleaching inhibiting long term use.  Therefore, an alternative scattering 
method for WGM measurements is presented to overcome this challenge.     
  
 
4.3.2 Scattering Signals for WGM measurements 
 Fluorescently tagged microsphere resonators provide a unique platform for multiplexed 
detection.1  For long lasting and robust diagnostics, platform where the WGM signal must be measured 
for long repeated uses, photobleaching is a limitation.  On the other hand, evanescently scattered 
signals, which can be used to track resonances, provide a consistent signal, where its intensity solely 
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depends on the intensity of the light source.  These signals can be measured using less expensive CMOS 
cameras reducing the cost of the platform.  Here, evanescent scatter signals are demonstrated as a 
useful alternative for tracking WGM resonances in sensing applications. 
 
4.3.3 Evanescent wave scattering 
Previously, we have described the formation of the evanescent wave when total internal 
reflection occurs at the interface between two different refractive index media.  When WGM 
microspheres are placed in the evanescent wave, the energy transfers into the material and scatter 
light.  The intensity of the scattered light has been determined to be a function of distance between the 
surface and microsphere described by the equation:20,21 
 
𝐼𝑠𝑐(ℎ) = 𝐼𝑠𝑐,0exp (−2𝑘2𝛽 ∗ 𝑑)                                          Equation 4.2 
 
where Isc is the scattering intensity, d is the distance between the surface and microsphere, k2 is the 
wave number and β represents the decay constant.   The exponential relationship between the Isc and d 
has shown utility for measuring electrostatic22,23, Van der Waals23,24, depletion25,26 and steric 
interactions27.  Here, we exploit these scattered intensities for a different application.  The strong 
scattering intensity exhibited by a microsphere placed close to the light coupling surface can measured 
as a tool for tracking WGM resonances.    
 WGM imaging, as mentioned previously, can visualize the light path and exhibit mode patterns 
which may have unique applications.  However, the fluorescent dye photobleaches with prolonged use 
which is a drawback for real time signal monitoring.  Scattering WGM, on the other hand, relies on 
signals formed by the evanescent wave scattering signals that only depend on intensity of the light 
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source.  Figure 4.8 shows images from a CMOS camera using scattering WGM in transmission light (left) 
and no light (right).   
 
Figure 4.8. (left) Transmission image of 53 um spheres on top of a dove prism.  The evanescent scattered spots can 
be seen as red dots on the edge of the spheres. (right) The background light is turned off to visualize the scattering 
spots for WGM  measurements. 
 
The resonant wavelength can be determined by monitoring the intensity of each scatter spot while 
tuning the laser wavelength similar to WGM imaging.  The bright, laser power dependent signal provides 
a flexible and consistent signal for which to perform WGM refractive index and immune-specific assays.  
These images were captured using an inexpensive CMOS camera (~$300 vs ~$6,000 for a CCD).  These 
USB cameras are compatible with LabView automation which can markedly improve data handling 




4.3.4 Data analysis programming: LabViews 
The ability to excite a large field of spheres with high signal intensities using scattering WGM 
enables a platform where hundreds of resonances can be measured simultaneously in a short 
experiment (less than a minute).  However, analysis of data for hundreds of resonators is done 
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manually, where each resonance spectra is fit using a lorentzian curve using Origin software taking 
roughly 5 minutes for each resonator and calibration point.  To truly improve the throughput of analysis, 
an automated analysis program was devised.   
LabView programs have a variety of functions that can interface most current instruments to a 
computer portal.  Their programming features for current USB cameras (LabView Vision) along with 
available mathematical functions were used to automate the analysis of WGM spectra.  The user-
interface of the program is shown in Figure 4.9.  The image stacks obtained during the tuning of the 
laser is organized into frames.   
 
 
Figure 4.9. The collected scattering WGM image stacks are analyzed by identifying individual scattering spots first. 
Then the program fits each WGM spectra to a Guassian peak to extract the resonant wavelength.  The data is 
recorded to a user-friendly file for subsequent analysis. 
 
Immediately, each evanescently scattered spot is identified and cataloged into arrays.  The intensity 
versus laser wavelength plot is graphed and fit to a Gaussian curve.  We note here that the WGM 
spectra are Lorentzian in shape, however, identification of the resonant wavelength can also be 
obtained using a Gaussian curve.  The scattered spots and calculated resonant wavelengths are paired 
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and output into a file easily transferrable to an Excel spreadsheet.  Using this program, the time required 
for WGM assay and analysis was reduced to less than 10 mins for hundreds of resonators.  The following 
refractive index and IL-6 immunoassay data were obtained via this high throughput analysis program.  
 
4.3.5 Refractive index and IL-6 Measurements  
 Using a low cost set-up for the sensitive detection of analytes has a tremendous impact on the 
adoption of the technique.  Therefore, enabling the use of a lower cost CMOS camera (which typically 
cost ~$300 USD compared to ~$6,000 CCD camera) to measure the intense scattering signals to track 
WGM is a significant advantage.  To verify that evanescently scattered light can be utilized as non-
photobleaching signal needed for WGM assays, the following refractive index assay was performed and 
the results are shown in Figure 4.10.  For these measurements, sequential 10 µL injections were made 
to obtain this calibration plot.  Figure 4.10 indicates the linear trend (R2 = 0.998) between the resonant 





Figure 4.10.  The WGM spectra are shown here as a 3-D plot with refractive index on the Z-axis.  The resonant 
wavelength shifts changes linearly with the refractive index of the solution.  The resonator using scattering WGM 
exhibited quality factors of 2.0 x 10
5
, sensitivity of 9.5 nm/RIU and LOD of 5.1 x 10
-4
 RIU.   
 
The quality factor of this particular resonator was 1.8 x 105 and exhibited a sensitivity of 9.5 nm/RIU and 
a limit of detection of 5.1 x 10-4 RIU comparable to the metrics obtained using WGM imaging (Q-factors 
= 104 – 105, sensitivity = 10 nm/RIU and LODs = 10-4 to 10-5).   
To further investigate the utility of evanescently scattered light as a signal for WGM 
measurements, we performed immunoassays in a field of ~200 spheres tracking the shifts due to 
binding of IL-6 to the surface of 15 resonators simultaneously.  The reduced statistics is not an 
equipment limitation, where all 200 resonances can be measured and recorded.  Rather, it is due to the 
limited laser tuning range (632.98 nm to 633.12 nm, or 140 pm total) such that all spheres may not 
exhibit resonances within this relatively condensed tuning range.   Also, many of these spheres shift out 
of the measurable tuning range, which limits the number of microspheres that can be used in a single 
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assay.  Using a laser with larger scanning ranges can be used to fully take advantage of this WGM 
detection platform to improve the statistics.  Regardless, Figure 4.11, displays calibration plot for IL-6 
with a linear correlation value of R2 = 0.994.   
 
 
Figure 4.11. IL-6  calibration curve using scattering WGM with sensitivity of 205 pm/ng/mL and LOD of 31.00 
pg/mL.  
 
Scattering WGM exhibited generally higher LODs and sensitivities of 31.00 pg/mL and 205.1 pm/ng/mL 
respectively compared to previous WGM imaging immunoassays measuring CA-125, osteopontin and 
prolactin as shown in Table 4.1.  
 
Analyte of Interest Size Sensitivity LOD Exp. Setup 
CA-125 >200 kDa 18 pm/U/mL 0.23 U/mL WGMI28 
Osteopontin 80 kDa 14 pm/ng/mL 270 pg/mL WGMI28 
Prolactin 24 kDa 15 pm/ng/mL 290 pg/mL WGMI28 




Though this is not a direct comparison, for proteins of similar molecular weights we observe improved 
sensitivities and lower limits of detection in the scattering WGM setup.  We hypothesize that the dye 
used in WGM fluorescence imaging access the same surface chemistry sites as the antibodies resulting 
in lower surface densities of antibody for WGM imaging resonators.  Without the need for dye on the 
resonator surface in scattering WGM detection, there may be more functional sites available for the 
antibodies to bind.  Further characterization of antibody surface densities can be performed to confirm 
this observation.  Here, scattering WGM was validated to enable long term continuous measurements.   
 
4.3.6. Optical detection in microfluidics 
The small footprint of WGM detector is highly suitable for separations systems in microfluidics.  
Microfluidic devices platforms have numerous inherent advantages of being miniature, scalable and 
cheap.  The developed technologies have enabled the construction of devices containing multiple 
components with different functionalities.  For example, the sampling, pre-processing, and 
measurement of cell lysate can all be performed in a single miniaturized device.29-32  These 
demonstrations have led to the idea that one could fit an entire “lab on a chip” for a “micro total 
analysis system (μTAS).32  Since the demonstration of the earliest microfluidic systems, the 
advancements in elastomeric materials such as poly(dimethylsiloxane) PDMS have enabled simple 
fabrication.33,34  Further developments of integrating systems such as microvalves, micropillars and 
microwells have expanded microfluidics to a technology found in many applications34, such as 
polymerase chain reaction35,36, cell counting and sorting37,38, drug screening39, electrophoretic 
separations40-42, DNA sequencing43, single cell manipulation44 and immunoassays45.  This section will 
focus on the comparison of optical detectors that are commonly utilized for immunoassay applications.  
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Within a broad class of optical detectors, intensity based detectors that provide either 
fluorescent or luminescent signals are most commonly employed in microfluidic systems.  Both forms of 
intensity based detection have advantages of being relatively easy to incorporate and being amenable to 
small volume systems.  They provide high sensitivities and fast response useful for high throughput 
microfluidic systems.  Fluorescence detection is achieved by incorporating labels such as a fluorophore 
or quantum dot to the analyte of interest.  Luminescence signals can be produced by enzymatic reaction 
of a luminogenic substrate like luminol or luciferin derivatives or electron transfer process with an 
applied potential.  While these approaches provide sensitive and easy detection platforms, the 
requirement of a label limit its application as a broad, general detection scheme for microfluidics.  
Labelling steps can be avoided reducing the cost and assay duration in microfluidic platforms by utilizing 
label-free detection. 
Several common label-free platforms have been demonstrated in microfluidics platforms.  To 
conduct SPR imaging measurements for multiplexed detections, additional microfluidic networks and 
gold surface patterning must be performed.  Kanda et al. achieved a lateral resolution of 2 µm of their 
gold patterns and detected the binding of anti-bovine IgG to bovine IgG patterned on the surface.46  Luo 
et al. utilized pneumatic valve microfluidic device to pattern an array of gold patches with antibodies.47  
A 96-component array was fabricated using this approach.  Krishnamoorthy et al. used electrokinetic 
flow focusing on a SPR imaging surface to selectively deliver samples over a single row of an array.48  
This label-free platform in microfluidics achieves sufficient lateral resolution enabling multiplexing.  
However in all of these examples, additional strategies such as microvalves, flow focusing or gold 






4.3.7 WGM integrated in microfluidic devices 
There has been a demonstration of WGM resonators used in a microfluidic platform by Keng et 
al.17  The group placed a microsphere held by a capillary stem in a microfluidic cell molded from silicone.  
A thin fiber optic was placed near the resonator to couple light into the structure.  After the microsphere 
and fiber optic was aligned for WGM detection, to enclose the microfluidic device, silicone was molded 
over the capillary stem and fiber optic to create a fluidic seal.  Though this device was capable of 
detection in a small volume system capable of detection down to single particle levels, where Brownian 
motion of polystyrene particles were measured, the limited flexibility in the fabrication of the device is a 
major drawback in most microfluidic devices.17  Instead it would be ideal for WGM resonators to be 
integrated in a less obstructive design.  Here, we show several prototypes of microfluidic devices for the 
integration of a WGM microsphere detector.   
 
 
Figure 4.12. The 16-channel microfluidic device is shown on the right where each channel tapers from a 100 um 
widths, on the right side, down to 1 um, on the left side.  The tapering design enables 53 um microspheres to be 
placed within the channel for detection.  The inset is a magnified view of one of these channels of both 
transmission and fluorescence image of the microspheres.  The enhanced ring of fluorescence indicates a WGM 
resonance used for refractive index sensing. 
 
Figure 4.12 is an image of a 16-channel microfluidic device.  All of the channels have a common 
inlet which then splits into 16, 100 µm wide, channels.  Each channel narrows gradually towards the 
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outlet to a width of ~1 µm.  The tapering of the channels holds the microspheres along the channel.  The 
stability provided by the narrowing microfluidic walls hold the spheres firm during flow injections.  Each 
channel can be loaded by controlling the outlet pressure, where one can envision the placement of 16 
different antibody coated microspheres addressed to their respective channels.  Scattering WGM was a 
slight challenge due to the scattering of light by the PDMS surfaces.  Thus, WGM resonances were 
visualized using fluorescently labeled spheres as shown in the inset of Figure 4.12. 
Another prototype including WGM resonators is shown in Figure 4.13 where a diamond well 
placed at the end of a single microfluidic channel of a T-microchip design is used to hold a microsphere.  
These designs are used for microchip-electrophoresis for the separation of primary amines, oxidative 
stress biomarkers and cell lysate material.40,44  WGM microspheres placed at the end of the channel can 
serve as a general detection scheme.  This can have applications as a detector for microchip capillary 
electrophoresis where 
 
Figure 4.13. (left) A PDMS chip with a 60 um wide diamond-shaped well was fabricated at the end of a microfluidic 
channel.  (right) A 53 um WGM resonator is placed into the diamond well for WGM detection. 
 
First, the demonstration of refractive index detection in a microfluidic design, as shown in Figure 
4.13, respond to changes in refractive index as resonance shifts when solutions of water and 5% ethanol 
were delivered through the microfluidic channels (data summarized in Table 4.2).    
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Table 4.2. The resonant wavelength in both water and 5% ethanol solution were measured and 
recorded below.  A change of roughly 0.001 RIU corresponds to a resonant shift of 29 pm 
leading an estimated sensitivity of 20.7 nm/RIU   







Quality Factor 6922 
Projected sensitivity 20.7 nm/RIU 
 
The ease with which microspheres can be placed in microfluidics allows WGM detection in a variety of 
microfluidic channel designs.  These initial results hold significant promise for WGM resonators as 
sensitive, flexible and low-cost detectors in microfluidic devices.   
 
4.3.8 WGM detection for droplet microfluidics 
Droplet microfluidics (DMF) is an emerging type of microfluidics that facilitates the transport of 
discrete droplets of fluid across the surface of an array of electrodes.49,50  Electrowetting properties of 
fluids allow the precise positional control of micron-sized fluids within a device.  When a voltage is 
applied, the surface tension of the liquids decreases leading to lower contact angles.  These 
instantaneous changes in surface tension can propel droplets to selected locations useful for mixing, 
merging and directing fluid droplets.49,51  Jebrail et al. outlines the typical fabrication process, starting 
with plate coated thinly with chromium.52  Photolithography and etching process creates the electrode 





Figure 4.14. Schematic of a Digital Microfluidic Device.  A glass substrate with actuation and ground electrodes 
fabricated on its surface is coated with an insulating layer and a hydrophobic layer.   
 
 A film ~2.5 µm of Parylene-C is then vapor deposited on top of the patterned electrodes to serve as an 
insulator.  To create a hydrophobic surface for facile droplet movement, Teflon-AF is spin coated to a 
thickness of ~50 nm.  These materials provide the best insulating and hydrophobic qualities for a robust 
system.52  However more commonly attainable material such as Saran wrap (insulating film) and Rain-X 
(hydrophobic coating) can be utilized as DMF devices as shown in Figure 4.15.  This device was initially 
tested for droplet actuation across several contact pads.   
 
 
Figure 4.15. An image of a digital microfluidic device fabricated using aluminum electrodes, silicon oil, Saran wrap 




Droplets actuated in an open platform require higher potentials applied across the electrodes.  
Higher voltages lead to heating within the droplet eventually causing evaporation of droplet fluids.  To 
minimize this, voltages were applied in short 1 second intervals.  This allowed for sufficient forces 
required for fluids to glide across towards neighboring electrode pads while minimizing droplet 
evaporation.  The devices showed reproducibility of droplet actuation in an open air configuration 
where the films of the device would damage after ~5 to 10 actuation voltages applied.  Longer lasting 
devices were fabricated instead using Teflon AF coated surfaces which improved the device lifespan.   
DMF devices employ similar detection strategies as microfluidics where fluorescence is most 
commonly used.  Initial results using tapered fiber WGM microsphere measurements, described 
previously in 4.3.2, demonstrate the potential of droplet analysis in an effort to integrate a label-free 
detection system in DMF devices.  Applications of this device can enable a true “lab-on-a-chip,” where 
whole blood spots can be measured.31,52  
Currently, DMF devices have been used to measure amino acid concentrations in dried blood 
spots.52  Blood from newborn were introduced into the device.  Once samples were loaded, all of the 
extraction and analysis were performed on-chip.  Offline MS/MS and fluorescence detection methods 
were employed to measure methionine, phenylalanine and tyrosine in concentrations of tens of µM.52  
Label-free sensing via WGM resonators has the potential to enable lower detection limits coupled with 
all the inherent advantages of droplet analysis in DMF devices.  Coupling WGM detectors with 
microfluidic or digital microfluidics for immunoassays requires continuous or repeated monitoring of 
WGM resonance.  While WGM imaging allows the tracking of multiple sensors simultaneously, the use 
of the dye as a resonance reporter as described previously can have limited use for these applications.  
Photobleaching of the dye, used as a resonance reporter over the course of long measurements, is a 
challenge.  Additionally, chapter 3 measured decreased quality factors as a result of increased dye 
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concentrations which can limit sensor performance.  Therefore, for future microfluidic applications, the 
proposed evanescent wave scattering signals will be utilized. 
   
4.4 Conclusions 
In conclusion, a wide investigation of WGM resonator platform for sensing was performed.  
Light coupling gap distance between the resonator and its coupling surface was explored.  Here we 
showed that refractive index matched film such as AL-2233 can be used as an optical gap to improve 
quality factors for a field a spheres.  In another effort to improve quality factors, a fiber light coupled 
WGM system was introduced.  Additionally, the discussed fiber light coupled WGM system with utility as 
dip sensors for modular, point of care sensing.  Alongside these developments, WGM resonators were 
integrated to digital microfluidic and PDMS microchannels devices for more automated fluidic 
implementation.  We envision that the fiber-WGM device is well-suited as droplet sensors for digital 
microfluidic devices where detection schemes are largely limited to labeled detection platforms.  
Opportunities for WGM resonators within PDMS microchannels were initially explored, where the small 
footprint and flexibility of WGM resonators can be used for sensitive, label-free detection for these 
devices.  Finally, the development of a scattering WGM detection scheme with automated analysis 
promises high throughput, longer lasting, sensitive and low cost platform for the development of a 
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4.6  Appendices 
 
Appendix 1 – The front panel of the LabView File: Scattering Analysis Program v2.vi.  The camera is initialized and is 
coordinated with the laser tuning such that each laser tuning increment results in  an captured image.  Then the 





Appendix 2 – This portion displays data from the analysis portion and shows a Gaussian peak fit for identification 
of the resonant wavelength.  Quality factor is also calculated and displayed here.  A feature of this program is that 
previously recorded video images can be reopened concurrently to compare data shifts.   
 
 
Appendix 3 – This code portion shows the laser tuning module where the computer pairs with tunable laser 





Appendix 4 – This loop shows how the laser is tuned in increments.  Immediately after the piezo voltage is 
increased the camera captures an image then compiles the image into a stack of images.  
 
 





Appendix 6 – This portion is analyzes and records each WGM spectra and also calculates the best Gaussian peak fit.  
The data obtained can be adjusted to narrow the tuning range to focus on a particular peak of interest.  The final 




Chapter 5  
 
 
WGM Refractive Index Sensing with CE 





5.1.1 Introduction to capillary electrophoresis 
Capillary electrophoresis (CE) achieves rapid, high-resolution separations for a broad class of 
analytes based largely on differences in mass-to-charge ratio.  There are a host of CE techniques such as 
capillary zone electrophoresis (CZE), capillary gel electrophoresis (CGE), micellular electrokinetic 
capillary chromatography (MEKC) and capillary isoelectric focusing (CIEF).1,2  The versatility, small sample 
volumes required, large plate numbers, and relative simplicity of the equipment have made CE a popular 
choice for many analytical challenges.  Applications in clinical analysis3,4, environmental monitoring5,6, 
and proteomics5,7 have all exploited the useful characteristics of CE to efficiently separate species of 
interest.3,7-9  Here, we will briefly discuss the fundamentals of CE and present opportunities for WGM 
resonators as a refractive index detector compatible with CE.   
 
5.1.2 Electrophoretic mobility 
In electrophoresis, sample ions move in the presence of an electric field based on their 
electrophoretic mobility.  The term electrophoretic mobility, µEM, describes the magnitude of force that 
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the ion will experience based on their net charge, and translation friction coefficient as shown in 
Equation 5.1:10 
 






                                                       Equation 5.1 
 
where q is the net charge, f is the translational friction coefficient for a small sphere given by Stokes’ law, 
η is the viscosity of the solvent and r is the hydrated radius.  The rate at which these ions migrate is 
dictated by their charge to hydrated radius or more simply, charge to size ratio.  Each sample ion 
exhibits velocities that are equal to the product of their electrophoretic mobility and electric field 
strength as shown in Equation 5.2:10 
 
𝜈 =  𝜇𝐸𝑀 ∗ 𝐸 
 
where ν is the velocity and E is the electric field.  Therefore, sample ions can be separated by exploiting 
their differences in electrophoretic mobilities.   
  
5.1.3 Electroosmotic flow 
To perform electrophoresis experiments, a channel is filled with an electrolyte buffer followed 
by a small sample injection, which are then separated.  This is achieved by applying a voltage across the 
channel to produce electroosmotic flow (EOF).  The chemical makeup of the channel surface is typically 
glass and silica which, at buffer pH greater than 3, generate negatively charged surfaces due to the 
ionization of the silanol groups.  The negatively charged walls electrostatically attract cations to its 
surface due to its potential field.  At a certain potential, called the zeta potential, cations adhere to the 




Figure 5.1. A capillary containing buffer solution creates an electric double layer as a result of zeta potential 
distributions.  The inset shows a magnified view of the electric double layer. 
 
There also exists a second diffuse layer that is closely associated with the surface in an attempt 
to neutralize the negatively charged walls.  This results in an electrical double layer where the absorbed 
layer is fixed and the diffuse layer is mobile shown in Figure 5.1.  When an electric field is applied to the 
system the positively charged ions in the diffuse layer are drawn towards the cathode creating a bulk 
flow that moves all analytes regardless of their charge.  This EOF exhibits a plug flow profile that is 
significantly flatter towards the center with a slight drag along the walls.  Laminar flow has a parabolic 
distribution of flow velocities where the flow at the walls is significantly slower than the flow in the 
center of the channel.  EOF however has a flat flow velocity profile resulting in less broadening as shown 
in Figure 5.2.  Capillary electrophoresis use the flat flow profile EOF and differences in sample ion 




Figure 5.2.  Illustration of laminar and EOF flow velocities.  EOF exhibits a flatter flow profile compared to laminar 
flow. 
 
5.1.4 Refractive index sensing in CE 
Since the introduction of capillary electrophoresis, a number of detection schemes have been 
developed to quantitate analyte bands separated in CE.  The choice of detection scheme is dictated by 
the nature of the analytes and the required performance metrics. The most popular method uses UV 
absorbance measurements.  UV detection is easily integrated, inexpensive, and generally applicable.11  
For improved detection limits, methods based on fluorescence can be implemented but requires either 
an intrinsic fluorophore or additional sample derivatization steps.12  Likewise, electrochemical detection 
has been widely employed for its favorable specificity and sensitivity, but requires electro-active species. 
13  
Refractive index (RI) sensing, on the other hand, provides a general detection method that is 
widely applicable for measuring the separation of ions, small molecules, or biomolecules.14-22  RI 
detection is concentration sensitive, non-destructive, and can detect species lacking strong UV 
absorption features.  While developed largely for liquid chromatography, CE applications using RI 
detection have been reported using a variety of techniques.  Most approaches use some form of 
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interferometry given its exquisite detection metrics, but other methods such as surface plasmon 
resonance (SPR) have also been reported.19  These approaches offer detection limits with reported 
values ranging from 10-5 to 10-8 RIU (refractive index units).14,17-19,21  
With a notable exception17, the figures of merits for these approaches are often highly 
dependent on the inner diameter of the capillary or require modifications to the capillary such as 
removing the protective coating (interferometry) or introducing a break to shunt current (SPR).15,19,23  
Here we explore the use of small-footprint RI sensors integrated with CE to develop an end-capillary 
detector that does not require modifications of the capillary, has low detection limits, and is easily 
modified for specific sensing applications.  
 
5.1.5 WGM detectors for separation systems 
Whispering gallery mode (WGM) resonators are small spherical dielectric structures that confine 
light through continuous total internal reflection.  Light evanescently coupled into a WGM resonator is 
efficiently recirculated when the resonance condition as previously described by equation 2.3.24-26  As 
seen in this equation, WGM resonances shift in response to changes in surrounding refractive index.  
Moreover, despite their small size, WGM resonators have a long effective sensing pathlength as light 
recirculates within these high-Q resonators.  We and others have reported the utility of WGM 
resonators for biosensing, where the resonator surface is functionalized for the specific detection of 
proteins or oligonucleotides.27-31  However, less has been reported using WGM sensors for bulk 
refractive index measurements in analytical separations.  
 
5.1.5.1 Liquid core optical ring resonator for Capillary Flow  
A unique on-column WGM detector was introduced by Fan and coworkers using tapered 
capillaries with thinned walls capable of supporting WGM resonances.20  The capillary wall thickness was 
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etched to less than 10 μm to enable circulating light to sense RI changes in the fluid interior.  Using this 
liquid core optical ring resonator (LCORR) arrangement, electrosmotic flow (EOF) was used to drive 
neutral glycerol plugs through the thinned capillary section where changes in the WGM resonance were 
monitored.  Estimated detection limits of 10-6 RIU were reported based on glycerol calibration curves 
and noise experiments performed separately.20  This impressive demonstration showed the promise of 
coupling WGM detection with CE; however, the tapering and chemical etching required produces highly 
specialized and fragile capillaries.   
 
5.1.5.2 Microring resonators as a detector for Liquid Chromatography 
More recently, Bailey and coworkers integrated WGM detection with HPLC using 
microfabricated microring resonators.21  Using this robust coupling, they detected the separation of 
ibuprofen and simvastatin using gradient elution.  Non-isocratic separations are challenging for 
refractive index detection since changes in run buffer refractive index leads to complicated backgrounds.  
The large dynamic range (0.1 RIU), however, enabled peak detection despite the complicated 
background with a reported detection limit of 1.5 x 10-6 RIU using a commercialized system.21   
 
5.1.6 Opportunities for microsphere based WGM in capillary electrophoresis 
The small footprint of WGM resonators and their universal refractive index sensing is well suited 
for integration with the small-bore capillaries used in CE.  Here we show that easily implemented end-
capillary geometry enables WGM resonators to be coupled with CE using unmodified, commercially 
available capillaries.  This flexible geometry also enables simultaneous on-column UV detection to help 
validate the approach and optimize detection metrics.  This approach will be especially useful for future 
biosensing applications where surface functionalized WGM resonators specifically detect and quantify 
species eluting from the capillary.   
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Using WGM resonators for bulk refractive index sensing, as required for a general separation 
detector, can lead to modest detection limits.  This is in contrast with biosensing, where specific 
recognition elements on the WGM resonator surface concentrate analytes in the evanescent field, thus 
maximizing response.  Similar challenges have been discussed when integrating SPR detection with CE.19  
To begin addressing this analytical challenge, we introduce a modulation approach using phase sensitive 
detection to measure small shifts in the WGM resonance.  This approach enables real-time monitoring 
of WGM resonance shifts using phase sensitive detection, improving both analysis time and signal-to-
noise.  Using this scheme, detection limit improvements of two orders of magnitude is observed when 
directly compared to traditional WGM resonance tracking measurements.  The utility of PS-WGM 
detection as a real-time, low detection limit detection scheme is demonstrated through the CE 
separation of the non-UV absorbing ions: sodium, lithium, and potassium.   
 
5.2 Materials and methods 
 
5.2.1 WGM Resonator Measurement  
The output from a tunable diode laser (Vortex II TLB-7004, <500 kHz linewidth, 160 GHz mode-
hop free tuning, New Focus, Santa Clara, CA) centered at 633.020 nm is focused into a Dove prism 
(Edmund Optics, Barrington, NJ).  Light entering the Dove prism is directed towards a glass substrate at 
an angle leading to total internal reflection.  The associated evanescent field excites resonances in 53 
μm barium titanate resonators (53 μm ± 3% diameter, MO-SCI, Rolla, MO) on the glass substrate surface 




Figure 5.3. Schematic showing end-capillary WGM refractive index sensing coupled with CE.  The output of a CE 
capillary (75 μm I.D., 363 μm O.D.) is positioned above a 53 μm diameter WGM resonator as shown in the inset.  
To monitor shifts in the WGM resonance as analyte bands elute from the capillary, light from a tunable diode laser 
is directed into a Dove prism, creating an evanescent field that couples light into the resonator.  As the excitation 
wavelength of the laser is scanned, scattered light from the resonator is collected from below and detected on a 
PMT.   
 
A microwell on the substrate surface confines the resonator in ≈500 μL of run buffer as shown in Figure 
5.3.  Evanescently scattered light from the resonator is collected from below using a 10X objective 
(Olympus UMPlanFL NA=0.3, Center Valley, PA) and detected on a photomultiplier tube.  
 
5.2.2 Capillary Electrophoresis/WGM Interface   
WGM detection was integrated with capillary electrophoresis (CE) using a custom-built 
apparatus.  The inlet of the 70 cm (unless otherwise specified) CE capillary (75 μm I.D., 363 μm O.D.; 
PolyMicro Technologies, Phoenix, AZ) was equipped with a T-valve connected to a custom pressure 
injection system with 0.01 second accuracy.  The outlet of the capillary was held in a xyz 
micromanipulator (Model A LHFF, Line Tool Co., Allentown, PA) to precisely position it above a WGM 
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resonator.  The capillary outlet partially surrounds the resonator on the glass surface and helps hold it in 
place.  Further procedures to immobilize the resonator on the surface were not required.  
Electroosmotic flow was driven with a high voltage power supply (Spellman CZE1000R, Valhalla, NY) 
connected through molybdenum wires running parallel to both the inlet and outlet of the capillary as 
shown in Figure 5.4.   
 
Figure 5.4. Schematic of the fluid volume and electrical connections used for CE separations.  The ground electrode 
runs parallel to the capillary which encapsulates the WGM resonator.   The effluent interacts with the resonator as 
it flows past and diffuses into the 500 µL buffer reservoir.   
 
For all separations, UV detection (SpectraSYSTEM UV1000, ThermoScientific, San Jose, CA) was also 
implemented using a window created 50 cm from the capillary inlet by removing the capillary coating.  
Sucrose solutions of concentrations ranging from 0.02% to 20% (2.7 mM to 2.8 M) were used to test 
flow profiles of this interface. 
 
5.2.3 WGM Spectral Shift Detection   
A triangle waveform from a function generator (BK Precision 3011; Yorba Linda, CA) is used to 
scan the tunable diode laser.  For spectra collection, the clock signal from the function generator 
synchronizes PMT data collection (NI USB-6251 DAQ, National Instruments) using an in-house LabView 
program.  The LabView code is provided in the appendix at the end of this chapter.  Spectra as a function 
of time are collected and fit to a Lorentzian lineshape to extract peak wavelengths.   
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5.2.4 Phase Sensitive WGM Detection (PS-WGM)   
To track WGM resonances using phase sensitive detection, the laser wavelength is modulated 
with the triangle wave over its entire tuning range (632.920 nm to 633.120 nm) at 215 Hz.  The output of 
the PMT is sent to a track-and-hold circuit (Mattson Mini Modular Model: SH1-B), which is triggered to 
hold the last valued received by the PMT before the down scan of the triangle wave.  This simplifies the 
measured spectrum to one peak per complete cycle.  The output of the track-and-hold circuit is sent to a 
dual-channel lock-in amplifier (Stanford Research Systems SR830, Sunnyvale, CA) referenced to the laser 
modulation signal.  The phase signal is detected which reflects spectral shifts of the WGM resonator 
with respect to the laser modulation.  An in-house LabView program, code provided in the appendix, 
was used to communicate with the lock-in amplifier and record phase shifts in real-time. 
 
5.2.5 Cation separation using UV and PS-WGM detection 
To establish the validity of the PS-WGM as a detection scheme for routine capillary 
electrophoresis separations, a three cation separation system was adapted.  The separation of the three 
ions was optimized on a 70 cm length capillary (75 µm I.D., 363 µm O.D.) with the UV detector 
positioned 50 cm from the capillary inlet.  The ion mixture was pressure injected with a volume of 4.9 nL 
resulting in loadings of 22, 28 and 39 pmol (4.5 mM, 5.7 mM and 7.9 mM) of K+, Na+ and Li+ ions 
respectively.  For indirect UV detection, the pH 5 run buffer included 5 mM of UV absorbing imidazole.  
The high ionic strength of the imidazole raises concerns over Joule heating so the separation voltage was 
minimized to 24kV, below the measured nonlinear region of the Ohm’s plot.  Before each run, the 
capillary was thoroughly rinsed with at least three capillary volumes each of 0.1 M NaOH, water and the 
5 mM imidazole run buffer.  PS-WGM detection was done at the outlet (Ld = 70 cm) similar to previous 




5.3 Results and discussion 
5.3.1 CE-WGM Interface 
The interface between a spherical whispering gallery mode (WGM) resonator and CE capillary is 
depicted in Figure 5.3.  The magnified view, Figure 5.4, shows the relative size of the CE capillary (inner 
diameter 75 μm) and WGM resonator (53 μm diameter).  Excitation light directed into a Dove prism 
leads to total internal reflectance at the sample interface, creating the evanescent field required to 
couple light efficiently into the WGM resonator.  Light evanescently scattered from the resonator is 
collected from below and detected on a photomultiplier tube (PMT).  As the excitation wavelength of 
the tunable diode laser is scanned, scattered intensity versus wavelength measures the WGM spectrum.   
To align the CE capillary above the resonator, the capillary is held in a three-axis 
micromanipulator.  WGM resonators are sensitive to changes in the surrounding refractive index (RI) 
and the relative position of the capillary outlet to the resonator affects how efficiently eluting analyte 
bands are sensed.  While completely engulfing the resonator will maximize RI response, the obstruction 
leads to unacceptable back pressures which broaden the bands in the separation.  To optimize the 
geometry, the capillary was gently lowered around the resonator until just contacting the substrate.  
The capillary was then moved away from the surface in ~10 µm increments, while the peak from a 
pressure plug of 5% NaCl solution was measured.  For the particular capillary and resonator dimensions 
studied, optimal peak shape and resonator response was obtained with the capillary end positioned 
raised approximately 20-30 µm with respect to the glass substrate as shown schematically in Figure 5.4.  
The outlet of the capillary is immersed in a ~500 µL volume of buffer, which allows sufficient diffusion of 






5.3.2 CE-WGM and electroosmotic flow compatibility 
WGM detection is compatible with the high voltages required to produce electroosmotic flow 
(EOF).  The flow is sufficient to drive sample plugs past the detector resulting in reversible WGM spectral 
shifts.  The sample plug profile was characterized as shown in Figure 5.5.   
 
 
Figure 5.5. Reversible shift in WGM resonance as a 38 nL injection of 5% NaCl elutes from the capillary.  The NaCl 
plug corresponds to a change of 8.7 x 10
-3
 RIU in the 5 mM imidazole run buffer and was driven by the EOF 
generated through a 30 kV applied potential as shown schematically in the upper left.  The waterfall plot below 
shows the WGM spectra as a function of time collected every 0.5 s.  Spectra extracted from the indicated locations 
illustrate the reversible shift in the WGM resonance as the plug elutes from the capillary.   
 
A 5% NaCl solution was pressure injected at 5 psi for 1 second into a capillary filled with 5 mM imidazole 
buffer (pH 5).  This was driven by EOF past the WGM detector using a 30 kV potential.  The false color 
waterfall plot in Figure 5.5 records the WGM spectrum as a function of time, collected at a rate of 2 Hz.  
A Gaussian plug profile is observed in the waterfall plot as the WGM spectra reversibly shifts in response 
to the migrating plug.  Three representative spectra extracted from the indicated locations (A, B and C) 
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in the waterfall plot and displayed in the right of Figure 5.5, along with a schematic representation of 
the plug locations.   
 
Figure 5.6. (A) WGM spectra as a function of time (0.5 s per spectrum) showing shifts from sequential injections of 
sucrose in increasing concentration (1%, 2.5%, 5%, 10% and 20%).  Each injection volume of 22 nL in 5 mM 
imidazole buffer was driven past the WGM detector using the EOF from a 30 kV applied potential.  (B) Each vertical 
slice from the waterfall plot is fit to a Lorentzian line shape to extract the peak wavelength, which is plotted as a 
function of time to generate an electropherogram.  (C)  The peaks in B are integrated and plotted versus RI of the 
sucrose solutions to generate the linear calibration plot.  Propagation of the uncertainty in the peak height and 
width are used to calculate the error bars, which are within the points shown.   
 
The linear response of WGM detection with increasing analyte concentration is shown in Figure 
5.6.  In this measurement, sucrose solutions of increasing concentration (1%, 2.5%, 5%, 10% and 20%) 
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were injected at 5 psi for 1 sec in approximately one minute intervals into the CE column.  Injected 
volumes of approximately 22 nL in the 5 mM imidazole run buffer were driven with an EOF generated by 
a 30 kV potential.  The electropherogram, shown in Figure 5.6a, contains five successive peaks with 
increasing spectral shift, corresponding to the increasing sucrose concentration.  Each WGM spectra 
(vertical line-cut) in the waterfall plot (Figure 5.6a) is fit to a Lorentzian line shape to extract the peak 
wavelength at each time point. A plot of peak wavelength versus time is shown in Figure 5.6b.  The 
electropherogram in Figure 5.6b is baseline adjusted and integrated to extract peak areas used to 
produce the linear calibration curve shown in Figure 5.6c.  In these initial measurements, a small blue 
shift in the baseline arose from thermal drifts that were subsequently eliminated using longer 
equilibration times with the CE voltage on.   
While these measurements illustrate the feasibility of coupling end-capillary WGM detection 
with CE, the approach outlined above results in modest detection limits.  Characterizing the response 
with pressure plugs of both NaCl and sucrose at varying concentrations, we measure detection limits 
ranging from 1.3 x 10-4 to 7.6 x 10-5 RIU with the CE-WGM platform.  These limits were measured using 8 












5.3.3 Phase Sensitive Detection for WGM Resonance Tracking   
 
Figure 5.7. Schematic diagram showing the sequence used for phase sensitive detection of WGM resonances.  (A)  
A triangular waveform from a function generator is used to modulate the wavelength from the tunable diode laser 
and provide the reference signal for the lock-in amplifier.  (B)  WGM resonances detected at the PMT exhibit 
mirror image peaks as the same resonance is detected on the up scan (blue) of the triangle wave and then again 
on the down scan (red) as the laser resets back to the starting wavelength.  (C)  The PMT output is sent to a track-
and-hold circuit, triggered using the triangle wave, to eliminate the second peak in each cycle.  The removal of the 
redundant peak results in one measured WGM resonance per modulation cycle, thus enabling spectral shifts to be 
quantified through changes in phase with respect to the laser modulation.  (D)  The simplified spectrum is sent to 
the lock-in amplifier, where shifts in the spectra are detected through phase changes with respect to the reference 
signal.   
 
To improve detection limits, we introduce a modulation scheme for measuring resonance shifts 
using phase sensitive detection.  The scheme is shown in Figure 5.7 and revolves around modulating the 
excitation wavelength from the tunable diode laser while using phase sensitive lock-in detection to 
monitor shifts in the WGM resonance.  
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A triangle waveform is used to tune the frequency of the tunable diode laser as shown in Figure 
5.7a.  As the voltage increases during the up scan of the triangle wave, the laser output tunes to longer 
wavelengths.  When the waveform transitions to the down scan, the decreasing voltage tunes the laser 
to shorter wavelengths and eventually returns it to its initial value before starting the next cycle.  
Excitation light from the laser is directed into a dove prism, creating the evanescent field required to 
couple light into the resonator.  Increases in the evanescently scattered light from the resonator reflect 
resonances, which are detected with a PMT.  As shown in Figure 5.7b, a peak reflecting a WGM 
resonance is observed on the up scan of the waveform and then again on the down scan as the laser 
wavelength is reset.  This results in the mirror image detection of the same WGM resonance during one 
complete cycle of the triangle waveform.   
Assuming a band eluting from the CE column increases the refractive index around the 
resonator, a red shift in the WGM resonance will be observed as shown in Figure 5.7b, this will shift the 
peak observed on the up scan to the right while the peak measured on the down scan will shift to the 
left with an equal magnitude.  The second peak measured on the down scan, therefore, causes 
problems for using phase measurements to track spectral shifts.  One way to eliminate the second peak 
is to use a sawtooth waveform to modulate the laser.  The rapid reset of the laser wavelength on the 
falling edge of the sawtooth waveform prevents the PMT from registering the second resonant peak.  
This approach, however, is limited to slow modulation frequencies for lasers using piezoelectric tuning 
elements as high frequency Fourier components in the waveform lead to ringing.  A more flexible 
approach enabling higher modulation rates is outlined in Figure 5.7. 
To eliminate the second peak on the down scan, the output of the PMT is sent to a track-and-
hold circuit.  The track-and-hold passes the output of the PMT until a triggering event is received.  Upon 
triggering, the track-and-hold circuit will output the last voltage level received and hold that output until 
reset.  In Figure 5.7c, the track-and-hold passes the signal from the PMT on the rising slope to register 
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the WGM resonance.  When the scan voltage reaches its maximum value, the track-and-hold circuit is 
triggered.  This holds in the last voltage level received from the PMT and outputs this value during the 
down scan.  Once the laser wavelength has been reset to its initial value, the track-and-hold is unlatched 
and the process is repeated as shown in Figure 5.7c.   
The output of the track-and-hold circuit simplifies the signal to just one peak per complete cycle, 
thus enabling phase detection of the resonant shift.  The track-and-hold output is then sent to the input 
of a dual channel lock-in amplifier referenced to the laser modulation frequency.  The phase signal is 
monitored to detect shifts in the resonant peak with respect to the laser modulation waveform, thus 
enabling real-time tracking of RI changes as shown in Figure 5.7d. 
 
5.3.4 Phase sensitive-WGM comparison to spectral WGM   
Refractive index sensing with WGM resonators is most often used in specific sensing 
applications where binding of analytes to surface immobilized recognition molecules leads to significant 
changes in the local refractive index.28,29,32  Using WGM detection to monitor bulk refractive index 
changes, as needed in separations, leads to less favorable detection metrics since the response is not 
enhanced by concentrating species at the sensor surface.  These challenges have been discussed 
previously using other RI detection platforms and can be addressed by chemical or molecular 
functionalization to increase the affinity of ions at the sensor surface.19,33  Here, the use of a phase 
sensitive detection greatly improves detection limit metrics without the need for sensor surface 




Figure 5.8. Calibration plots measured using (A) spectral collection and (B) the phase sensitive detection outlined in 
Fig. 4.  To ensure a direct comparison, the same resonator was used for simultaneous measurements.  In (A), 
spectral measurements lead to a LOD of 7.6 x 10
-5
 RIU and are unable to detect changes from the first few 
injections at low concentration.  With phase sensitive detection in (B), these injections are clearly detected and the 
LOD improves significantly to 2.8 x 10
-7
 RIU (error bars within the points).  Included error bars are smaller than the 
symbols shown and are calculated from the noise at each point following equilibration.    
 
To directly compare typical WGM spectral shift measurements with phase sensitive WGM (PS-
WGM) detection, spectral and phase data were collected simultaneously from the same resonator in a 
single assay.  Figure 5.8 shows refractive index calibration plots measured using conventional spectral 
measurements compared with the phase sensitive approach.  NaCl solutions were used to increase the 
refractive index in stepwise fashion and both calibration curves were measured using the same 
resonator, which had a Q-factor of ~105.  We note that Q-factors vary between resonators which can 
cause differences in sensitivities.34,35  By using the same resonator to collect both spectral and phase 
data during the RI assay, a direct comparison between the two methods can be performed.  The linear 
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response of the phase sensitive measurements track the response measured using spectral 
measurements, validating the phase sensitive approach.   
For the phase sensitive approach, the laser wavelength was modulated at 215 Hz over its entire 
tuning range (632.920 nm to 633.120 nm).  Using a time constant of 1 sec, the enhanced signal-to-noise 
obtained with the phase sensitive method leads to a limit of detection (LOD) of 2.8 x 10-7 RIU (27 μM 
NaCl), compared with an LOD of 7.6 x 10-5 RIU (7.5 mM NaCl) measured using spectral measurements 
with the same resonator.  Phase sensitive detection, therefore, results in almost 300 fold improvement 
in LOD while streamlining both data collection and analysis time.  Both approaches typically exhibit a 
dynamic range of 3 to 4 orders of magnitude which is limited by the laser tuning range (200 pm).   
 
5.3.5 CE-PS-WGM Separation 
 
Figure 5.9. (A) Overlay of 5 separate runs following injection of sucrose plugs (0.09%, 0.12%, 0.25%, 0.5% and 1%) 
detected using PS-WGM.  The sucrose injected ranged from 26.5 to 283 pmol in a volume of 9.7 nL (2.7 to 29 mM).  
The inset shows an expanded view for the two lowest concentrations, detected with a S/N ratio greater than 8.  (B)  
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Peak area is plotted against sucrose injected, showing good linearity.  Error bars represent standard deviation from 
3 separate measurements. 
 
Having validated the PS-WGM detection scheme, Figure 5.9 shows initial studies to characterize 
its integration with CE.  In Figure 5.9a, sucrose bands migrating through a 55 cm capillary using EOF are 
detected with end-capillary PS-WGM detection.  Figure 5.9a overlays five different electropherograms 
collected as sucrose injections increased from 27 pmol to 283 pmol in an injected volume of 9.7 nL (2.8 
mM to 30 mM).  At a pH of 5, sucrose is neutral leading to a migration time of 5.6 minutes.  The relative 
standard deviation (RSD) in migration times between all five injection are less than 3%, illustrating the 
reproducibility of the integrated system.  This suggests that the placement of the resonator at the outlet 
of the capillary does not cause significant turbulent flow profiles.  The expanded view in the inset shows 
the detection achieved, with a signal-to-noise of 8 measured at the lowest injection of 2.8 mM sucrose.  
The linear trend in peak area versus sucrose injected is plotted in Figure 5.9b.   
The integration of PS-WGM detection with CE shares the advantage that other refractive index 
sensors have as universal detectors of analytes.  Techniques such as WGM and SPR, however, can also 
be easily expanded for specific detection as demonstrated by Whelan et al.  While surface plasmon 
resonance and optical resonators have been well adopted for HPLC, demonstrations of CE separation 
using resonators are limited.  Here validation of the CE-PS-WGM approach which takes advantage of the 
small footprint of the resonator and universal detection properties is performed.  Specifically three non-




Figure 5.10. Separation of a three component mixture of potassium, sodium and lithium ions (22 pmol, 28 pmol 
and 39 pmol respectively) detected with (A) UV and (B) PS-WGM.  The separation was optimized using a 70 cm 
capillary with the UV window located 50 cm from the inlet.  The ions are separated in 5 mM imidazole at pH 5, 
using an injection volume of 4.9 nL and an applied potential of 24 kV.  The electropherogram in (A) shows good 
separation with characteristic peak shapes reflecting the ion migration in the background electrolyte.  End-capillary 
PS-WGM detection in (B), measured during the same separation, yields very similar results thus validating the 
approach.  Characteristic peak shapes are similar and additional 20 cm of capillary travel to the detector does not 
significantly broaden the peaks and slightly improves resolution.   
 
In Figure 5.10a, the separation of the three ions was optimized on a 70 cm length capillary (75 
µm I.D., 363 µm O.D.) with the UV detector positioned 50 cm from the capillary inlet.  The sample of ion 
mixture was pressure injected with a volume of 4.9 nL resulting in loadings of 22, 28 and 39 pmol (4.5 
mM, 5.7 mM and 7.9 mM) of K+, Na+ and Li+ ions respectively.  For indirect UV detection, the pH 5 run 
buffer included 5 mM of UV absorbing imidazole.  The high ionic strength of the imidazole raises 
concerns over Joule heating so the separation voltage was minimized to 24kV, below the measured 
nonlinear region of the Ohm’s plot.  Before each run, the capillary was thoroughly rinsed with at least 
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three capillary volumes each of 0.1 M NaOH, water and the 5 mM imidazole run buffer.  This resulted in 
reproducible EOFs between each run and consistent peak shapes and migration times. 
The UV electropherogram shown in Figure 5.10a reveals the separation of K+, Na+, and Li+ ions 
and exhibits distinctive peak shapes that are consistent with previous studies.9,36  The potassium ion 
elutes first and has a higher mobility than the background electrolyte (BGE).  This leads to the sawtooth 
shaped peak that gradually rises on the leading edge and abruptly falls on the trailing edge.  Lithium ion, 
on the other hand, elutes last and has a lower mobility than the BGE.  This leads to an asymmetrical 
peak shape that mirrors that of potassium, now quickly rising on the leading edge while gradually 
decreasing on the trailing edge.  Finally, the middle peak due to Na+ is more symmetric reflecting a 
similar mobility with BGE.   
Figure 5.10b shows the same ion separation run as that in Figure 5.10a, but with end-capillary 
detection using PS-WGM.  For these measurements the laser wavelength was modulated at 215 Hz over 
the entire tuning range (632.920 to 633.120 nm) and a 300 ms lock-in time constant was utilized.  Three 
baseline separated ion peaks are observed with the same distinctive peak shapes as that detected 20 cm 
upstream using UV absorbance.  Table 5.1 compares the plate number and RSD values for UV detection 
at a length to detector (LD) of 50 cm and PS-WGM detection with an LD of 70 cm.  The additional 20 cm 
of travel for PS-WGM detection results in increased diffusion of the peaks, which is reflected in the 
lower plate numbers reported in Table 5.1.  The extra capillary length for PS-WGM detection, however, 
results in slightly increased resolution of the ions with both arrangements showing RSD values of less 







Table 5.1. Theoretical plates are calculated from Fig. 7 and adjusted to length to detector.  The 
extra 20 cm travel to reach the PS-WGM detector results in lower plate numbers due to 
diffusion of the ions.  RSD values less than 3.7% were achieved for all ions (N = 3).   
 
 
These results show that PS-WGM integration with CE enables real-time detection of small 
refractive index changes (10-7 RIU) without any modification to the capillary or microresonator.  For the 
future, WGM microresonators are easily functionalized and often used in biosensing applications.  Using 
the same approach outlined here, integrating specific sensing with CE using modified WGM resonators is 
conceptually straightforward.  For applications such as serum protein CE, where the complicated nature 
of the mixture leads to proteins separated broadly by class, integrating specific sensing can target 
specific species within a band. 
 
5.4 Conclusions and outlook 
 
We demonstrate integration of end-capillary WGM refractive index sensing for peak detection in 
CE separations.  Unlike most refractive index detectors for CE, no physical modification of the capillary is 
required, the approach is compatible with a wide range of capillary types, and the method is modular 
and easily extended for specific sensing applications.  While we demonstrate the approach using 53 µm 
diameter resonators, we can routinely measure resonances in barium titanate microspheres less than 20 
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µm in diameter, enabling integration with smaller bore capillaries.  As shown by others, resonator size 
can help optimize LODs by reducing tunneling and absorption losses.37  To increase performance metrics 
for bulk refractive index sensing, we introduce a novel wavelength modulation approach using phase 
sensitive detection to characterize spectral shifts in the WGM detector.  We show that this method 
improves detection limits two orders of magnitude over simultaneous measurements done using 
traditional spectral collection.  This approach also streamlines the data collection and analysis by 
providing real-time measures of WGM peak shifts.  Phase sensitive detection of WGM shifts are used to 
characterize the CE separation of potassium, sodium, and lithium ions, validating the approach.  The 
small footprint of WGM resonators and the ease with which specific biosensing can be implemented 
through surface functionalization should add powerful new dimensions in separations using small 
capillaries or lab-on-a-chip platforms.  
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5.6  Appendices 
 
Appendix 1 – (A)  These parameters outside the ‘while’ loop reset the waterfall plot before each run and initializes 
the array used for real-time data storage.  (B)  This portion collects the data when triggered by the edge of the 
triangle wave used for modulating the tunable laser.  (C)  This ‘For’ loop builds the array where the PMT signal for 
one tuning cycle of the laser is individually addressed over time.  (D)  This portion allows the data array built in 
real-time to be saved as a .txt or .xls file when a Boolean is pressed by the user.   
 
 
Appendix 2 – (A)  This establishes communication to the SR830 to the LabView interface such that data can be read 
for the SR 830 directly.  (B)  The theta values are read in real time and store them in an array format where each 
data point is sequentially addressed.  Dynamic data is graphed giving the user real-time graphical either .txt or .xls 







Specific Detection of Proteins in Capillary 






 In chapter 5, three cations (Na+, Li+, K+) were separated and detected through bulk refractive 
index changes using phase sensitive-WGM (PS-WGM) and UV detection simultaneously illustrating the 
compatibility of the WGM with CE separations.  Here we extend the utility of the CE-WGM interface as a 
CE-immunoassay technique by placing a WGM resonator with recognition proteins attached to its 
surface.  CE-based immunoassay combines the separation power of CE with the specificity between 
antigen and antibody to achieve 2-dimensional assays.1-4  Many capillary electrophoresis based 
immunoassay approaches require immobilizing the antibody or antigen onto the inner wall of the 
capillary along the separation path.5-7  Attachment of biocapture materials on the walls of capillary is an 
effective approach, however, the capillary must be replaced entirely after several uses.  The required 
use of low pH elution buffers, to disrupt the binding interaction, can also negatively affect the antibody 
function.  We introduce CE-WGM immunoassay as a modular (no capillary modification), post-
separation (no low pH elution buffer) immunoassay as a unique capillary electrophoresis based 




6.1.1 Capillary electrophoresis based immunoassays (CEIA) 
 The current gold standard for the quantification of biomarkers is enzyme-linked immunosorbent 
assay (ELISA) which has played a central role in diagnostic and clinical research for several decades.  
ELISA can be used for the detection of prostate specific antigen (PSA) as a biomarker for early stage 
prostate cancer which has effectively reduced mortality rates.  However, there are many applications in 
which ELISA, as a mono-dimensional immunoassay, suffer from false-positive results.  False positives 
have been described in a number of ELISA tests for diseases such as HIV8, multiple myeloma9 and 
ovarian cancer among many others.  False-positive results in mono-dimensional immunoassays are 
largely a result of the polyreactive nature of antibodies.10-12  This results in non-specific binding of 
antigen which is especially prominent in complex sample matrices such as serum.  Emerging multi-
dimensional techniques which couple immunoassays with a separation system are gaining acceptance in 
diagnostic applications.   
 One such 2-D method is capillary electrophoresis based immunoassays (CEIA), often called 
immunoaffinity capillary electrophoresis (IACE).2,4,13,14  These techniques can be performed as 
homogeneous immunoassays, where antibody and antigens are present in free-solution, or 
heterogeneous immunoassays, where either the analyte or the antibody is immobilized onto a solid 
support.3,4,13  Here we will focus on the review of heterogeneous based CEIA, as it is more closely 
relevant to WGM immunoassays.  
 Heterogeneous CE immunoassays employ an immobilized antibody or antigen as a stationary 
phase for online solid phase extraction.13  The technique relies on the strong affinity of antigen-antibody 
interaction as a means of removing analytes of interest from a sample matrix.  These 2-dimensional 
techniques can significantly diminish false-positive information because non-specifically bound targets 
that are structurally unrelated to the analyte of interest can be differentiated by differences in migration 




Figure 6.1. Procedural illustration of heterogeneous capillary electrophoresis immunoassays.  The sample is 
introduced to the antibody functionalized capillary walls for specific capture of an analyte of interest.  Then a low 
pH elution buffer is used to release the captured analyte for subsequent separation and detection. 
 
Antibodies are covalently attached to the walls at a region near the inlet of the capillary.  Then the 
sample is then injected and driven past this region by laminar flow, allowing a particular antigen to bind 
to the immobilized antibodies excluding all other material.  Once the antibody-antigen complex is 
formed, a small plug of weakly acidic elution buffer is injected to release the captured antigen for 
subsequent detection. 
The most straight-forward method for protein immobilization is to utilize the surface chemistry 
of the walls of the capillary to covalently attach the affinity capture material.  This results in an open 
tubular SPE extraction along the capillary flow path that can specifically bind analytes of interest.  To 
improve the surface area to volume ratio and enhance the number of available binding molecules, small 
beads of either polymeric or glass material can be packed into a glass fiber frits as a junction between 
two separate capillary tubes as shown in Figure 6.2a.15,16  Another design utilized functionalized 
magnetic beads introduced into the capillary and localized via external magnets at a particular region 




Figure 6.2. Illustrations of a two approaches for on-capillary protein immobilization.  The top schematic illustrates 
the use of a polyethylene junction between two capillaries combined with porous plugs to place protein 
immobilized beads along the capillary.  The bottom schematic utilizes protein immobilized magnetic beads with 
externally placed magnets to localize the beads inside the capillary.  
 
A variety of detection methods can be used for heterogeneous CE immunoassays.  Fluorescence 
detection offer low detection limits (low pM) with the use of numerous labeling strategies.  This requires 
a fluorescently labeled secondary to bind to the antibody-antigen complex much like ELISA.  Then the 
elution buffer disrupts the binding interactions leading to the release of fluorescently labeled secondary 
for subsequent detection.  Another approach uses chemiluminescent properties of luminol to provide 
rapid and low background signals.  Luminol (5-amino-2, 3-dihydro-1,4-phthalzinedione) is a common 
chemiluminescent tag that forms 3-aminophthalate through a reaction with hydrogen peroxide under 
basic conditions.  Gold nanoparticles have also been used to catalyze luminol chemiluminescence.  One 
drawback of chemiluminescence is the need for a post-column reaction tube to produce the 
chemiluminescent signal.  The use of additional post-capillary reagents requires tedious optimization of 
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the reaction conditions and suffers from higher assay costs.  Label-free techniques, such as SPR and 
WGM can, therefore, make positive contributions for these applications. 
Despite an impressive list of applications using CEIA in pharmaceutical analysis,19-21 biomarker 
detection22-24 and immunology,25,26 there are some limitations that can be addressed by a re-design of 
the assay steps.  Typically, the capillary is filled entirely with the sample as this technique relies on the 
incubation for the extraction of the analyte of interest.  This leads to waste of precious sample volume.  
Even though the volumes in capillary electrophoresis are relatively small, for several applications such as 
tear sample analysis and pre-natal diagnostics it may be of considerable interest to preserve as much 
sample as possible.  Another drawback of CE immunoassays is that the extraction of different analytes 
then naturally requires newly validated separation conditions.  A high information sample, such as 
serum, contains thousands of biomarkers for a plethora of diseases.  Each disease diagnostic requires an 
entirely new separation step, which practically limits the use of the technique by trained lab technicians.  
It would be beneficial to develop a more modular immunoassay platform combined with CE that 
requires little optimization of the CE separation.  Additionally, most current detection methods used in 
CEIA require the use of fluorescent labels with secondary antibody or chemiluminescent reagents.27  
Using a label-free WGM resonator as an immunoassay at the outlet of the capillary holds considerable 
promise for the development of a modular and label-free immunoassay detector that can be integrated 
without modifications to the separation conditions for a 2-D separations technique. 
 
6.1.2 Opportunities for CE-WGM immunoassays 
 Previous researchers have demonstrated the sensitive, label-free detection of various putative 
biomarkers for ovarian cancer.28  Demonstration of the detection of cancer antigen-125 spiked in a 
serum sample was an impressive feat considering the complexity of the serum sample and chances of 
non-specific binding.28  In an initial investigation, CA-125 detection in serum, compared to its detection 
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in a less complex PBS buffer, exhibited an order of magnitude higher detection limits (1.8 U/mL in serum 
compared to 0.11 U/mL in buffer) and lower sensitivities (1.8 pm/U/mL in serum compared to 18 
pm/U/mL in buffer).28,29  These initial metrics suggest that immunoassays in complex samples can be 
more challenging due to effects such as non-specific binding. 
As non-specific binding is a significant challenge for all label-free biosensors, we propose the use 
of 2-D immunoassays where we first separate proteins then specifically detect a protein of interest using 
WGM resonators.  CE based serum protein electrophoresis stratifies proteins into zones where the most 
abundant protein, albumin, migrates last.  By coupling this separation with WGM immunoassays where 
diagnostically relevant proteins for most cancers migrate prior to albumin, we effectively simplify the 
serum sample matrix in an effort to improve the immunoassay platform.   
 Additionally, placement of the immunoaffinity step after the separation step results in a 
completely modular separation and immunoassay test where the separation is unaffected by the 
immunoassay.  This can be a tremendous advantage because already validated separation methods can 
be coupled with CE-WGM immunoassays to achieve a 2-D immuno-separation system.  We also take 
advantage of the intrinsic benefits of the WGM detection scheme as a label-free, highly sensitive 
detector described in Chapter 2.  Here, we demonstrate a 2-D immune-separation of two proteins as a 
proof-of-concept for a novel CE-immunoassay device.   
 
6.2. Materials and Methods 
 
6.2.1 Instrumentation 
The instrumentation set-up described in section 5.2.1 was utilized in this chapter.  The output 
from a tunable diode laser (Vortex II TLB-7004, <500 kHz linewidth, 160 GHz mode-hop free tuning, New 
Focus, Santa Clara, CA) centered at 633.020 nm is focused into a Dove prism (Edmund Optics, Barrington, 
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NJ).  Light entering the Dove prism is directed towards a glass substrate at an angle leading to total 
internal reflection.  The associated evanescent field excites resonances in 53 μm barium titanate 
resonators (53 μm ± 3% diameter, MO-SCI, Rolla, MO) on the glass substrate surface as shown 
previously in Figure 5.3.  A microwell on the substrate surface confines the resonator in ≈500 μL of run 
buffer.  Evanescently scattered light from the resonator is collected from below using a 10X objective 
(Olympus UMPlanFL NA=0.3, Center Valley, PA) and detected on a photomultiplier tube.  
 
6.2.2 Capillary Electrophoresis-WGM and UV detection 
WGM detection was integrated with capillary electrophoresis (CE) using a custom-built 
apparatus.  The inlet of the 70 cm (unless specified) CE capillary (75 μm I.D., 363 μm O.D.; PolyMicro 
Technologies, Phoenix, AZ) was equipped with a T-valve connected to a custom pressure injection 
system with 0.01 second accuracy.  The outlet of the capillary was held in a xyz micromanipulator 
(Model A LHFF, Line Tool Co., Allentown, PA) to precisely position it above a WGM resonator.  The 
capillary outlet partially surrounds the resonator on the glass surface and helps hold it in place.  Further 
procedures to immobilize the resonator on the surface were not required.  Electroosmotic flow was 
driven with a high voltage power supply (Spellman CZE1000R, Valhalla, NY) connected through 
molybdenum wires running parallel to both the inlet and outlet of the capillary.  For all separations, UV 
detection (SpectraSYSTEM UV1000, ThermoScientific, San Jose, CA) was also implemented using a 
window created 50 cm from the capillary inlet by removing the capillary coating.   
 
6.2.3 Phase detection for WGM resonances 
As previously described in chapter 5, to track WGM resonances using phase sensitive detection, 
the laser wavelength is modulated with the triangle wave over its entire tuning range (632.920 nm to 
633.120 nm) at 215 Hz.  The output of the PMT is sent to a track-and-hold circuit (Mattson Mini Modular 
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Model: SH1-B), which is triggered to hold the last valued received by the PMT before the down scan of 
the triangle wave.  This simplifies the measured spectrum to one peak per complete cycle.  The output 
of the track-and-hold circuit is sent to a dual-channel lock-in amplifier (SR830, Stanford Research 
Systems) referenced to the laser modulation signal.  The phase signal is detected which reflects spectral 
shifts of the WGM resonator with respect to the laser modulation.  Here, all protein binding and bulk 
refractive index measurements were done using phase sensitive detection.  
 
6.2.4 Microsphere functionalization 
 To prepare microspheres for binding assays, proteins were covalently attached by the following 
procedure.  Approximately 0.1 g of 53 μm barium titanate spheres was placed in a 4 mL glass vial.  The 
spheres were rinsed with 10% Contrad (Decon Contrad 70, Fisher Scientific) solution then incubated and 
sonicated in 30% H2O2 (ACS certified, Fisherbrand) for 15 mins.  The resonators were rinsed sequentially 
in water, ethanol (ACS certified, Fisherbrand) and toluene (extra dry, Acros Organics) then reacted in 10% 
(3-aminopropyl)triethoxysilane (APTES, AcroSeal©, Acros Organics) and rotated for 2 hours.  Following 
silanization, spheres were rinsed in toluene then acetone (ACS certified, Fisherbrand).  All solvent were 
then removed from the vial and the spheres were placed in a 60°C oven for 2 hrs.  During the oven 
incubation, the vial was gently agitated until spheres could freely move to ensure no solvent is trapped 
between the spheres.  The spheres were removed from the oven then placed in a vial containing 
molecular sieves overnight to remove any remaining moisture.  The spheres were then reconstituted in 
ethanol and sonicated for 10 mins.  After this step, spheres were placed into a new glass vial, then 
rinsed in water and stored in phosphate buffer saline (PBS, MP Biomedicals).  The new glass vial walls 
should have little to no silanized surfaces for the following step.  A 10% solution of glutaldehyde (25% in 
water, Fisherbrand) was prepared in the sphere vial and rotated for 30 mins.  After the reaction, the 
spheres were rinsed with PBS then transferred to a new glass vial and stored in PBS.  The sphere 
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surfaces now contain free aldehyde groups that can react with primary amines.  Aldehyde functionalized 
spheres were then reacted with streptavidin for at least 6 hrs at 4°C.  Finally, the spheres were rinsed 
then stored in PBS at 4°C for future use.  For the detection of IL-6, biotinylated anti-IL-6 (IL-6 ELISA kit, 
BD OptEIA, BD Biosciences) was incubated for at least 6 hrs to complex with the covalently bound 
streptavidin. 
 
6.2.5 Bioassay procedures for BSA-biotin and IL-6 
 For BSA-biotin and IL-6 assays, microspheres functionalized with streptavidin (for the detection 
of BSA-biotin) or biotinylated anti-IL6 (for the detection of IL-6) were placed on a glass slide and placed 
in a flow cell with a reservoir volume of 500 μL.  To validate the functionalization of the microspheres, 
an assay for each of the two proteins was separately performed.  Injections of a 0.1 μg/mL solution of 
BSA-biotin (lyophilized, Sigma-Aldrich) were made resulting in a concentration range of 0.15 to 0.81 nM 
BSA-biotin. The molecular weight of BSA-biotin (69.4 kDa) was estimated based on manufacturer data 
showing ~12 moles biotin per 1 BSA molecule.  For the IL-6 assay, injections from a stock solution (2175 
pg/mL IL-6) were made to generate a concentration range of 1.8 to 23.8 pM.  Each injection was 
followed by a 10 min incubation period before the phase measurement was recorded.   
 
6.2.6 CE-WGM immunoassay of BSA-Biotin and IL-6 
 The separation of bovine serum albumin-biotin (BSA-biotin) and interleukin-6 (IL-6) was 
optimized on a 70 cm length capillary (75 µm I.D., 363 µm O.D.) with the UV detector positioned 50 cm 
from the capillary inlet.  The sample containing 0.2 mg/mL BSA-biotin and 217 pg/mL IL-6 was pressure 
injected with a volume of 4.9 nL.  The separation of these two proteins was optimized in 10 mM sodium 
phosphate monobasic and 10 mM sodium phosphate dibasic at pH 7.4.  A potential of 18 kV was used in 
this run buffer resulting in a separation current of roughly 47 μA.  UV detection at 50 cm from the inlet 
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and PS-WGM detection at the outlet of the capillary (Ld = 70 cm) were simultaneously collected.  The 
separation was performed using an unlabeled microsphere as a control and a streptavidin-labeled 
microsphere for specific detection of BSA-biotin binding both using the same separation conditions.        
 
6.2.7 Serum protein electrophoresis of Clinical Samples 
 All samples used in our experiments were de-identified and collected for other purposes.  A 
total of 10 serum samples, 5 from multiple myeloma patient and 5 serum sample from a healthy patient, 
was obtained from the University of Kansas Cancer Center Biospecimen Repository Core Facility.  The 
MM patient sample was collected in 2012, post-treatment (Barcode = 003849).  The control sample was 
collected in 1995 (Barcode = 000030).  Additional information of these samples and other available 
samples can be found in the appendix.  Serum protein electrophoresis of these samples was optimized 
on a 70 cm length capillary (75 µm I.D., 363 µm O.D.) with the UV detector positioned 50 cm from the 
capillary inlet.  The sample was diluted at 1:40 serum to water ratio.  A 4.9 nL sample injection was 
separated at 18 kV in pH 10, 7.5 mM sodium tetraborate or 30 mM borate (Sigma Aldrich).   
 
6.3 Results and discussion 
   
In previous studies, we have validated the use of phase sensitive WGM detection in the capillary 
electrophoresis separation of three cations, measuring the bulk refractive changes as these sample plugs 
are driven past the resonator.  These studies revealed that the placement of a WGM detector directly at 
the outlet of the capillary minimally affects the separation profile.  CE-WGM is capable of detecting the 
plug profile as a general bulk refractive index detector, however, the main motivation for interfacing CE 
with WGM resonators was to extend the utility of serum protein electrophoresis by performing an 
immunoassay after the initial serum separation.  To move towards this 2-D separation and specific 
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detection system, we first validate the attachment of biocapture molecules to the sensor surface by 
measuring the specific binding of two proteins.  We also present here several considerations critical for 
the attachment of recognition proteins to the surface of WGM resonators for label-free sensing.  Finally, 
we utilize these functionalized microspheres as a biosensor integrated with capillary electrophoresis for 
the development of CE-WGM immunoassays. 
 
6.3.1 Protein immobilization 
Equation 2.4 introduced previously, illustrates that WGM resonator response (Δλ/λ) is directly 
proportional to the surface coverage of recognition element (σp).
30  It is therefore of great interest to 
maximize the number of recognition elements on the surface that is capable of binding analytes of 
interest.  Heterogeneous immunoaffinity based assays employ immobilized antibodies as a stationary 
phase to capture antigens of interest from the sample matrix.  The simplest method for placing 
recognition elements on a surface is done via passive binding or physical adsorption.  This technique 
utilizes various interactions, such as electrostatic forces and van der Waals, between the surface and the 
biomolecular species.31  Label-free sensors often employ surfactant additives to minimize non-specific 
binding by disruption ionic and hydrophobic biomolecule-surface bonds.32  Direct adsorption via 
relatively weak interactions, can therefore, be easily be disrupted by the addition of these beneficial 
surfactants, resulting in losses of biosensor sensitivity.   





Figure 6.3. Illustration of antibody orientations on a substrate.  (left) Antibody is oriented favorably where its 
binding region faces towards the solution.  (middle, right) Antibody binding regions are less accessible for analytes 
in solution. 
 
It is a clearly advantageous to direct the binding region of the antibody towards the solution 
rather than the substrate.  Immobilization strategies using Protein A/G and streptavidin/biotin to control 
antibody orientation are illustrated in Figure 6.4.   
 
Figure 6.4. Approaches to improve antibody orientations.  Protein A/G specific targets the binding of the Fc region 
of antibodies.  Streptavidin is a tetramer and can bind biotinylated antibody for improved antibody orientation. 
 
Bacterial cell wall proteins A and G selectively bind many antibodies at the Fc region with Kd in the range 
of 10-7 to 10-9 M.33  Prolonged use of these sensors can release antibodies from the protein A/G surface 
leading to losses in sensor performance.  Therefore, for a less reversible and more stable attachment, 
the streptavidin and biotin complex is often utilized as a method to attach antibodies to a surface. 
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Streptavidin is a bacterial form of avidin that exhibits strong binding with biotin and minimal 
nonspecific interaction with proteins.  The streptavidin-biotin bond is nearly irreversible (Kd = 10
-15 M) 
which is stable yet amenable to release of bound material via pH changes.34  Covalent attachment of 
streptavidin to a solid support such as glass can be done by reacting silanol groups on the glass surface 
with primary amine groups on proteins via APTES and glutaraldehyde cross-linking chemistry.35  
Streptavidin is a tetramer containing four binding sites for biotin and therefore the attachment via free-
amines should not greatly impact the accessibility of the binding pocket.  As illustrated in Figure 6.4, 
biotinylated antibodies, which are commercially sold, are bound to surface immobilized streptavidin 
with the binding regions of the antibody available to the solution.  We use this approach in the following 
experiments with additional considerations in the development of a WGM biosensor.  
 
6.3.2 Considerations for barium titanate microspheres for the attachment of recognition proteins 
When starting the protein functionalization process, it is important to consider the abundance 
of surface functional groups to maximize protein surface coverage for sensing.  Barium titanate (BT) 
microspheres have silanol groups that react with the APTES solution to initiate the functionalization 
process.  However, the doping of bigger barium atoms, in chemical compositions of roughly 40% 
(reported by the MoSci), may reduce the number of surface silanol groups available for protein 
attachment.  There is also evidence in previous studies that barium ions may be concentrated at the 
surface of a material further perpetuating the notion that there may be reduced –OH groups available 
for functionalization chemistry.36,37  Therefore, it is advantageous to ensure that all the –OH groups on 
the surface of the microspheres are readily available to initially react with APTES.   
Modifications of the method described by Huckabay et al.28 have been made in an effort to 
improve the number of proteins attached to the surface.  In addition to the described incubation of 
microspheres in hydrogen peroxide under sonication to enhance the activation of –OH groups, we 
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added a 45 second plasma treating step using a plasma reactor (PDC-32G, Harrick).  Plasma treatment is 
a cleaning process that improves the homogeneity of the surface chemistry via the reaction of plasma 
radicals on the glass surface to remove water layers and other contaminants, such as absorbed gases 
and polymer fragments.38  Additionally, the radicals transfer additional energy to the surface, therefore, 
increasing the activation energy to form desirable interfacial binding between silanol and APTES.   
Label-free detection enables the monitoring of this functionalization process, by measuring 
resonance shifts of WGM resonators after the attachment of the recognition element and the binding of 
the analyte of interest.  Here, we discuss the results of the experiment using streptavidin/biotinylated-
anti-IL6 as a model system to assess functionalization.  First we measure the covalently binding of anti-
IL-6 to the glutaraldehyde linker surface using WGM resonators.  After confirmation of antibody 
attachment through WGM resonance shifts, we measure subsequent binding of IL-6 to characterize 
sensitivity and statistics in a 16 microsphere WGM immunoassay.   
 
6.3.3 Anti-IL-6 covalent bonding to glutaraldehyde surface 
 A hydrolysis reaction forms a covalent bond between the aldehyde functional groups on the 
resonator to the primary amines on the antibody.  After the microspheres were incubated in the 
glutaraldehyde solution, we washed the spheres thoroughly in PBS buffer to ensure no unbound 
glutaraldehyde remained in solution.  These microspheres were placed in the flow cell containing 500 μL 
of the anti-IL-6 solution from BD Biosciences.  The resonant wavelengths of a total of 16 microspheres in 




Figure 6.5. Free amine groups on anti-IL-6 binding covalently attaches to glutaldehyde functionalized microspheres.  
The attachment was monitored by tracking the resonant shift over time.  The data includes the resonant shifts for 
16 microspheres in the same assay.  
 
The binding of anti-IL-6 to the surface is observed as red shifts in the resonant wavelength, which over 
time reached a maximum indicating saturation of the resonator surface.  The binding kinetics observed 
in Figure 6.5 confirms that anti-IL6 is, in fact, being attached to the surface.  This confirmation allowed 
us to test the overall sensor performance for the specific detection of IL-6. 
 
6.3.4 IL-6 detection using WGM resonators  
 Post anti-IL-6 attachment, the specific detection of IL-6 was made by introducing a small volume 
435 pg/mL stock IL-6 solution then allowed to incubate for 10 mins before measurement.  Of the 16 
microspheres, eight displayed linear calibrations as shown in Figure 6.6.  The other 8 resonators did not 
exhibit measureable changes in resonant wavelength.  This is a marked improvement in statistics in the 
number of WGM resonators that exhibit binding, where previously ~10% of the spheres result resonant 





Figure 6.6. The calibration curves for IL-6 introduced to anti-IL6 functionalized spheres.  Eight of the 16 
microspheres produced a linear calibration while the remaining 8 observed no measurable change in resonant 
wavelength.   
 
The lower efficiency observed in our experiments is an on-going investigation in the optimization of 
protein-surface attachment.  We do observe binding of the antibody to all 16 spheres, however, only 
observe subsequent analyte binding in roughly 50%.  We suspect several issues, such as loss of protein 
stability during the attachment process, detrimental tumbling of the microspheres during the 
functionalization reactions and low surface functional groups.  We also observe varying sensitivities 
from resonator to resonator, this may be related to the individual quality factors of the resonator, 
however, it should also be noted that sphere to sphere variations in protein surface coverage could also 
contribute to the sensitivities. 
These initial studies, however, using oxygen plasma to clean the surface and increase the 
surface activation energy demonstrate some improvement of the number of WGM resonators that are 
capable of detecting analyte binding.  The improved number of responsive WGM resonators can have a 
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marked impact when moving towards a CE-WGM immunoassay platform where a single sphere, instead 
of a field of spheres, is utilized as a detector.   
 
6.3.5 PS-WGM calibrations for BSA-biotin and IL-6 binding 
 The specific binding of both BSA-biotin and IL-6 were measured using the phase detection 
method introduced in chapter 5.  Phase detection was developed to reduce noise signals ultimately to 
improve the detection limit using a lock-in phase detector.  Phase detection also enabled the real-time 
monitoring of resonance shifts in phase units at sample rates of 200 Hz.  Both of these criteria facilitate 
the use of this setup as a post-CE separations detector, where diffusion of analytes require lower 
detection limits and CE peak widths of roughly 30 seconds require real-time data collection.  
Streptavidin was immobilized on 53 μm BT microspheres for the detection of BSA-biotin 
resulting in a calibration curve shown in Figure 6.7.  A detection limit of 0.65 ng/mL (9.4 pM) BSA-biotin 
and a sensitivity of 0.92 degrees/ng/mL were measured.   
 
 




The molecular weight of BSA-biotin was estimated using the average reported mole ratio between biotin 
and BSA (12 mole biotin:1 mole BSA) in this calculation.  Figure 6.8 is the calibration for IL-6 where anti-
IL-6 functionalized spheres were used.  A detection limit of 0.64 pg/mL (0.03 pM) and a sensitivity of 
0.38 degrees/pg/mL were observed in this IL-6 assay.  Using the same antibody and antigen pairing we 
observe a four-fold improvement in PS-WGM assays compared to the reported limit of detection of 2.5 
pg/mL in commercial ELISA kit (BD Biosciences).  The calibrations for both proteins exhibit good linearity 
correlation values (R2 > 0.997).   
 
 
Figure 6.8. Calibration of IL-6 using PS-WGM Detection with streptavidin/biotinylated anti-IL6 microspheres 
 
6.3.6 CE-WGM immunoassay results 
BSA-biotin and IL-6 were chosen as a set of model proteins to demonstrate the utility of 
separation and specific detection of one the two proteins using CE-WGM immunoassays.  BSA-biotin 
emulates the albumin in a serum protein electrophoresis, as the last detected peak while IL-6 is a 
cytokine that mimics a protein migrating with the beta-2 proteins.  For immunoassays, dissociation 
constants can dictate the overall sensor performance.  The binding conditions for proteins such as pH, 
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ionic strengths and temperature can affect the effective binding constants (Ka) of antibody-antigen, 
which is directly related to the sensitivity and inversely related to limits of detection.  Therefore, we 
optimize the separation of the two proteins under physiological conditions (pH 7.4) to promote the 
preservation of protein structure and function during the CE separation.  
For CE separation, while it is possible to use PBS as a running buffer, the high concentration of 
salts, such as KCl and NaCl at 27 and 1400 mM respectively, causes high ionic strengths leading to slower 
EOF and increased joule heating.  To minimize these effects while maintaining similar buffer 
composition, we used 10 mM of both the monobasic phosphate and dibasic phosphate at pH 7.4.  
Initially, an unfunctionalized WGM resonator was placed at the outlet of capillary as shown in Figure 6.9.  
When an injection volume of 7.7 nL containing a mixture of 0.2 mg/mL BSA-biotin and 435 pg/mL IL-6 
was introduced into the capillary and separated at 18 kV resulting in the electropherogram shown in 
Figure 6.9.  
 
 
Figure 6.9.  (right) Schematic of a CE-WGM interface where an unfunctionalized microsphere was placed at the 
outlet of the capillary to detect protein separations as bulk refractive index changes.  (left) Electropherogram of 
the separation of IL-6 and BSA-biotin.   
 
 The resonator is responding to the bulk refractive index changes due to the protein bands that are 
migrating past the resonator.  IL-6 and BSA-biotin bands are baseline resolved with good resolution 
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(Resolution = 2.3).  Both protein bands returned to baseline demonstrating the detection of these plugs 
as they travel past the WGM resonator at the outlet.  Since the resonator does not have biocapture 
molecules on its surface, any baseline change observed can be attributed to non-specific binding of 
proteins.  However in our experiments, the protein bands returned back to baseline indicating that little 
to no non-specific binding is occurring as shown in Figure 6.9.   
 
Figure 6.10. (right) Schematic of a CE-WGM interface where a streptavidin functionalized microsphere was placed 
at the outlet of the capillary to detect protein separations as bulk refractive index changes and specifically bind 
BSA-biotin.  (left) Electropherogram of the separation of IL-6 and BSA-biotin.  The change in baseline after the BSA-
biotin peak is indicative of specific binding.  
 
To develop a 2-D technique, like western blots, capable of separating and specifically detecting 
an analyte of interest, we tested the utility of CE-WGM by placing a streptavidin coated resonator at the 
capillary outlet.  As shown in Figure 6.10, we specifically detect the binding of BSA-biotin after the initial 
electrophoretic separation between IL-6 and BSA-biotin.  Unlike the previous experiment, we observed 
the specific binding of BSA-biotin to covalently attached streptavidin on the resonator surface as a 
baseline shift after the protein band.  The result is shown in Figure 6.10, where a baseline shift of 41° in 
phase was observed.   
CE-WGM immunoassays are especially unique due to the modularity of the immunoassay 
portion.  CE based immunoassays typically require re-optimization of the separation which limits each 
assay for a single purpose.   A modular CE-immunoassay system, as we demonstrate, requires the 
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validation of only the immunoassay portion which can be done separately from the CE optimization 
enabling the use of existing separations with this technique.  This holds great promise as an 
immunoassay tool performed directly after a serum protein electrophoresis (SPE) test in the clinic.  For 
multiple myeloma applications, the SPE done using CE-WGM immunoassay has the potential to be a 
diagnostic, staging and treatment monitoring tool.  The next step for this project is to detect specific 
proteins in a complex serum matrix during an SPE.  Moving towards that goal, we show initial results of 
clinical samples (obtained from the Biospecimen Repository at the University of Kansas) of both healthy 
and MM patients on CE-UV systems.  
 
6.3.7 Separation of healthy and MM patient serum samples using CE-UV 
A serum sample from multiple myeloma patient and serum sample from a healthy patient was 
obtained from the University of Kansas Cancer Center Biospecimen Repository Core Facility.  Serum 
protein electrophoresis of these samples was optimized from conditions similar to previously validated 
serum protein electrophoresis. The WGM immunoassay for specific biomarkers will be performed after 
the CE separation, thus buffer choices and pH conditions were chosen to minimize the potential of 
misfolding proteins.  Phosphate buffers can also be compatible for serum separations, however, the 
slightly more acidic pH range results in longer separations (18 minutes).  Therefore, borate buffer at pH 
10 was used for faster separations (< 8 mins).  These conditions have proven to be viable for 
immunoassays in previous studies.  The sample was diluted in water in a 1:40 serum to water ratio.  A 
4.9 nL sample injection was separated at 18 kV in pH 10, 30 mM borate.  The healthy patient and MM 
patient sample separations are shown in Figure 6.11a,b.  The M-spike observed in the MM patient 
electropherogram is observed as expected as a result of the overproduction of a monoclonal 
immunoglobulin from the proliferation of an abnormal B-cell clone.  This initial separation study sets up 
the next steps for a combined CE-UV-WGM immunoassay test where specific biomarkers, such as free 
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light chains and lactate dehydrogenase can be measured using WGM directly after the observation of 
the SPE profile using UV.   
 
 
Figure 6.11. The above is a the data from SPE of a healthy (a) and multiple myeloma (b) patient.  The M-spike 
observed in the gamma band of the SPE indicates a monoclonal gammopathy. 
 
6.4 Conclusions  
 
 CE separations coupled with WGM resonators for immunoassays are demonstrated as a 
promising platform as a 2-D immuno-separation system.  The functionalization of resonators with 
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antibodies using streptavidin/biotinylated antibodies demonstrates improvements in the WGM sensor 
response.  We observe detection limits of 0.03 pM for IL-6, which is highly competitive compared to 
ELISA and CEIA of IL-6 protein (0.03 pM) using labeled fluorescence and preconcentration techniques.39  
We introduce the CE-WGM immunoassay platform for the separation of BSA-biotin and IL-6 as a proof-
of-concept.  We observe little to no non-specific binding of proteins even under higher concentrations at 
0.2 mg/mL BSA-biotin.  Additionally, we show the initial separation conditions for clinical serum samples 
for future application as a MM diagnostic tool.  
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Race  Ethnicity Sex 
003849 2004 Multiple myeloma 2012 yes White Non-His Male 
004803 2011 Multiple myeloma 2012 yes 
Black or Afr-
Am Non-His Male 
005663 2013 Multiple myeloma 2013 yes White Non-His Male 
008224 2012 Multiple myeloma 2013 yes White Non-His Male 
008498 2007 Multiple myeloma 2013 yes White Non-His Female 
000030 n/a control 1995 n/a 
Black or Afr-
Am Non-His Female 
000028 n/a control 1995 n/a Other Hispanic Female 
000027 n/a control 1995 n/a White Non-His Female 
000021 n/a control 1995 n/a White Non-His Female 
000016 n/a control 1995 n/a White Non-His Female 
 




Chapter 7  
 
 




 Our goals were to develop WGM optical resonator for their use in the clinical setting.  The 
compact size, high sensitivity and cost effective features of glass microsphere resonators allow 
numerous designs and implementation for instrumentation development.  We have geared this project 
for the application of cancer diagnostics where implementation of an early detection and routine 
screening test can tremendously improve cancer patient outlook.     
 
7.1.1 Immobilization of microspheres and lipid layer detection 
In chapter 3, we discuss the development of a microsphere immobilization approach to enable 
the incorporation of microspheres with fluidic systems.  For immunoassays, fluid exchanges such as 
sample introduction, incubation, washing and regeneration steps all require the movement of fluids.  
These fluid exchanges can perturb the WGM resonance such that the resonant wavelength may no 
longer be tracked during an assay.  To overcome this challenge we modified a method using 
calcium/alconox solutions for WGM resonators optimizing quality factors and microsphere adhesion to 
the substrate.1  This approach enabled WGM resonators to be physically stable during routine fluid 
changes for a more robust detection platform.2  Furthermore, the immobilization method enabled the 
transfer of Langmuir-blodgett (LB) films to immobilized WGM resonators.2  The precise control of the 
composition of LB films allowed a controlled study of sensor performance based on dye concentrations. 
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WGM imaging requires the functionalization of a fluorescent dye to the surface of the 
microsphere to characterize the resonant condition.  Light stored within the resonator cavity 
experiences losses due to the absorption by the fluorophore.  While absorption is known to effect Q, the 
precise dye loading that could be tolerated, however, had not been characterized due to limitations in 
the controlling dye concentration.  The use of LB films, which enable fine compositional control, with 
immobilized microsphere resonators allowed a system where dye loading effects could be determined.  
The LB and microsphere resonator platform also was demonstrated as a biosensor where a bilayer 
containing ganglioside membrane 1 (GM1) was used to specifically detect the binding of cholera toxin-
beta subunit.2  This platform holds promise for membrane mimic studies where the analysis of lipid-
protein and protein-membrane protein interactions can be performed.   
 
7.1.2 Improvements of resonator performance 
 In chapter 4, we explored various aspects of the platform to further improve the Q-factor of the 
resonators.  As the goal was to develop the WGM imaging method, we first focused on ways to improve 
quality factors in the prism light coupling system.  We introduced the use of refractive index matched 
coating to create a gap between the resonator and its coupling surface.  This improved the quality factor 
up to two orders of magnitude while maintaining the ability to excite a field of spheres required for 
multiplexing.  In an effort to further improve the platform, the dye loading study performed in chapter 3 
encouraged us to explore different ways of capturing the WGM resonance signal without sacrificing any 
resonator performance.   Instead of using dye fluorescence, used in WGM imaging, we utilized 
evanescent wave scattering to track WGM resonances.   
Evanescent wave scattering leads to strong signals that appear when a microsphere is placed 
close to the light coupling surface.3,4  Using these signals as a WGM resonance reporter has numerous 
advantages compared to the WGM imaging platform.  Scattering signals are solely dependent on the 
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intensity of the laser output and are not susceptible to photobleaching, as is the case for dye used in 
WGM imaging.  Additionally, the removal of dye from the surface of the resonator improves quality 
factors which can increase sensor performance.  Another benefit of scattering signals is that less 
sensitive and inexpensive cameras can be used which are also compatible with high throughput analysis 
tools such as LabView.  We demonstrated the detection of interleukin-6 with the developed scattering 
WGM platform.  Based on our initial studies, we observe a sensitivity of 205 pm/ng/mL for IL-6, using 
scattering WGM compared to sensitivity of 15 pm/ng/mL for prolactin using WGM fluorescence 
imaging.5  These proteins are similar in molecular weight (24 kDa) and have no appreciable difference in 
binding constants for their respective antibodies.  The sensitivity improvement may be due to the lack of 
the dye molecules.  This allows 1) increased sensor surface coverage with antibodies as they do not 
compete with binding sites with dye molecules. 2) The removal of dye improves resonator quality 
factors which lead to better sensor performance.6,7  Moving forward, the ease of obtaining an 
evanescent wave scatter signal provides a flexible platform when incorporating WGM resonators into 
various fluidic platforms. 
 
7.1.3 Scattering WGM and implementation into microfluidics 
 Scattering WGM allows for a non-photobleaching signal which enables long term tracking of 
WGM resonances for applications such as capillary electrophoresis.  We explored several fluidic 
platforms using microfluidics, digital fluidics and capillary electrophoresis (CE).  Chapter 4 describes T-
channel microfluidic chips with WGM resonators held by a diamond-shaped well that was integrated 
within the channel.  Another design shows the implementation of many microspheres in a 16-channel 
microchip that held microspheres with the tapering in the width of the channels.  The small micron-sized 
microspheres seem well suited for the microfluidic technologies and holds significant promise as 
detectors for these applications.   
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We also demonstrate the detection of refractive index differences in two droplets using a fiber-
sphere as a dip sensor based on WGM resonators.  The advantages of being a modular and hand-held 
type detection platform can be integrated with droplet based microfluidic chips.  The fabrication of the 
tapered fiber and microsphere resonators was described and used to detect the RI difference between 
two droplets alternately dipping the sensor in water and 5% glycerol.  We envision this dip platform to 
be used in tandem with digital microfluidic technology, which offers excellent droplet manipulation 
capabilities.  This platform, however, requires further development with concern as to the translatability 
into a practical, clinic-ready device.   
 
7.1.4 WGM detectors for CE separations 
 In chapters 5 and 6, we introduce WGM resonators to capillary electrophoresis as an end-on 
detector for separations.  Though we initially demonstrate WGM detectors for bulk refractive index 
measurements in a separation of three cations, our ultimate goal is to demonstrate the flexibility of 
WGM as both a general detector and a specific sensor in capillary separation systems.  First, we 
demonstrate that WGM resonators are compatible with EOF such that sample peak profiles are 
undisturbed in the separation of sodium, potassium and lithium cations.8 
Next, we demonstrate the use of CE to separate two proteins (BSA-biotin and IL-6) based on 
their differences in electrophoretic mobility then we utilize WGM resonators coated with streptavidin to 
specifically detect BSA-biotin.  These initial studies provide a unique 2-D detection platform compatible 
with all existing separations.  The CE separation is undisturbed in this technique so all previously 
optimized separation conditions can be used with bioaffinity molecule functionalized WGM resonators, 





7.2 Future Directions 
 There is growing interest in the development of compact devices that can analyze patient 
samples as a point-of-care device.  These devices offer near-patient and quick result turnaround that can 
provide much needed information of the patient state.9,10  To achieve this, the device must be a robust, 
fluidic platform with detection schemes that are inexpensive, compact and highly sensitive.  
Microvolume based fluidic systems such as microfluidics and capillary electrophoresis offer attractive 
characteristics for the development of diagnostic devices.  We have presented initial results and 
demonstrated the potential of WGM resonators as a sensitive, label-free and compact detector in 
various fluidic platforms.  The integration of these detectors into microfluidic devices provides a general 
and flexible detection scheme that can be utilized for diagnostics.  We propose several WGM platforms 
that have the potential to analyze complex matrices such as blood and serum for use as a diagnostics. 
 
7.2.1 Digital microfluidics for blood analysis using WGM 
 Microfluidics is an enabling technology that has catalyzed the field of miniaturized analysis 
systems for numerous applications.11-14  Clinical diagnostics is one of the most promising avenues for the 
implementation of these devices for use as a routine screening tool.  Measurement of physiologically 
relevant fluids can reveal critical information about the patient’s health and can significant aide in the 
treatment of a disease.  Miniaturized systems enjoy benefits of smaller sample requirement, reduced 
reagent consumption and lower cost.  Currently, most microfluidic devices are a based on continuous 
flow and utilize electrophoretic flow (EOF).  However, many common samples such as whole blood and 
urine cannot be pumped using EOF due to their high ionic strengths that lead to excessive joule heating 
and thus efforts have been made to develop alternative pumping mechanisms.11,15  Active pumping 
mechanisms such as centrifugation have attracted a lot of attention in more recent years leading to the 




Commercial devices utilize external pressure sources or passive flow such as capillary action or gravity 
for whole blood analysis in microfluidics.  Devices such as the Biosite Triage Cardiac system and the I-
Stat analyser are popular microfluidic devices for measurement of cardiac biomarkers and blood 
chemistry, respectively.15  Most of these devices have single-use microfluidic modules that become 
disposable.  This typically leads to application specific devices which offer little flexibility and scalability 
in their design.  For blood analysis in a point-of-care setting, it is ideal to have a flexible platform that 
can perform a list of tests on the same microchip.   
 Digital microfluidics uses a non-continuous flow system with precise control of droplet 
movement into distinct locations via electrowetting.14,16,17  These devices can be designed for 
dispensing, transport, splitting, merging and mixing of aqueous droplets.17  Also they have been 
demonstrated to preserve enzyme activity and protein structure on an electrowetting chip required for 
binding assays.11  These devices therefore offer several advantages for the evaluation of biomarkers in 
blood for clinical diagnostics.  Typically detection in these devices uses fluorescence, where additional 
reagents or labeling must be used to generate a fluorescence signal.  Other offline detection schemes 
such as mass spectrometry have been demonstrated but for blood analysis would require expertise in 
mass spectrometry analysis therefore less viable for a point-of-care device.18  As such, we see an 
opportunity for WGM resonator with digital microfluidic systems to provide a general, label-free and 
sensitive detection scheme.   
 We have previously demonstrated the ability to perform sensitive immunoassays within 
droplets using WGM resonators.  Small droplets with improved mass transport enabled initial binding 
rate assays where initial slopes can be related to the concentration of the analyte.19  This has the 
significant advantage of not requiring standard addition for the quantitation of analytes.19  WGM 
resonator in droplet assays provides a rapid, on-chip detection platform for digital microfluidic devices.  
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We hope to combine the on-chip sample preparation using digital microfluidics with small footprint 




This initial design has designated areas for the cleaning of whole blood cells to remove cells in 
preparation for a less complex matrix.  The remaining volume contains diagnostically relevant material 
such as dissolved proteins in a less viscous fluid suitable for WGM resonator detection. Other reagents 
for resonator washing, cleaning and regeneration solvents can be loaded into the chip as shown in 
Figure 7.1.  We hope to take advantages of both WGM resonator and digital microfluidic chips to create 




Figure 7.1. Illustration of a design for blood sample analysis using DMF and WGM resonators.  All of the steps 
required to analyze blood such as, sample cleaning, cell lysing, washing, detection and sensor regeneration can 
be done on this droplet platform. 
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7.2.2 Serum Protein Electrophoresis for Diagnostics 
 As shown in chapter 6, a CE-WGM immunoassay device was developed where the separation 
and specific detection of protein was performed in an integrated platform.  We plan to further develop 
this device and adapt the instrument for serum protein electrophoresis (SPE).  SPE are already 
performed and validated for the clinic as an initial diagnostic screening tool, however, they require 
additional tests such as immunoassays to diagnose for a variety of diseases.20  As shown in Figure 7.2, 
abnormal profiles, of either an increase (multiple myeloma, nephrotic syndrome and hepatic cirrhosis) 
or decrease (anti-trypsin deficiency) of certain peaks, compared to the healthy profile, highlighted in 
blue, can be indicative of the associated diseases.  
 
 
Figure 7.2. (left) CE SPE profile for a health sample containing normal peak intensities in all four zones (gamma, 





Even though CE-WGM immunoassays can be helpful for the diagnosis of all of these diseases, we focus 
primarily on multiple myeloma (MM), where the disease demands constant and routine screening due 
to its 100% recurrence rate.  
 
 
Figure 7.3. A distribution chart of 1,516 SPE tests that exhibited an M-spike.  Of the 1,516 M-spikes observed, 56% 
are attributed to monoclonal gammopathy of unknown significance, 17% are attributed to multiple myeloma.   
 
SPE can exhibit an abnormal spike in the gamma band (M-spike) which may be indicative of 
several conditions as shown in Figure 7.3.  As seen in the figure, out of 1,516 tests, monoclonal 
gammopathy of unknown significance (MGUS) accounts for 56% of M-spikes observed, while only 17% 
are indicative of MM.21  Thus, SPE and M-spike observations alone are not an efficient screening tool for 
MM as most of the cases result in an “unknown significance” diagnosis.  To classify and diagnose 
patients that exhibit M-spikes, there are two serum based immunoassays that hold significant promise 
for multiple myeloma diagnosis, classification and treatment monitoring.  One is an assay measuring the 
ratio of κ to λ light chains, known as the free light chains or Bence Jones protein, that have both 
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diagnostic and prognostic value.22-24  The second is measurement of β2-microglobulin that can improve 
staging schemes for multiple myeloma.25 
 Free light chains are antibody light chains that are not bound to the heavy chains.  They are 
elevated in the serum and urine of MM patients. Additionally, unusual ratios of κ to λ light chains can 
help assess the risk of developing MM.22,24  Free light chains also have short half lives in the plasma 
being cleared within hours versus monoclonal gammopathy (M-spike) proteins that take days to 
weeks.24  Therefore, measurement of free light chains can enable patient surveillance during treatment 
to allow more responsive dosing and adjustment of therapeutics.  Their concentrations in plasma range 
from the medium to high μg/mL which is well within the analytical capabilities of WGM bioassays.     
 Another development for improved staging of MM was recently introduced which has led to 
better prognostic capabilities.  This staging scheme is based on measuring the levels of β2-microglobulin 
and serum albumin.25  While serum albumin levels can be obtained from the initial SPE separation, as it 
is detected in its own band, β2-microglobulin co-migrates with other proteins in the beta-2 band and 
requires separate immunoassays.  An additional biomarker, lactate dehydrogenase (LDH) which is 
involved in tumor initiation and metabolism, can also be included to monitor cancer burden in MM 
patients.  The quantitation of free light chains, β2-microglobulin and LDH can provide useful information 
for patients that either have or are suspected for MM.  Our current developed CE-WGM immunoassay is 
limited to a single functionalized sphere placed directly at the outlet of the capillary.  While it is possible 
to physically direct the outlet of a capillary to a different microsphere as a means to detect another 
biomarker, this would be difficult in practice and cannot easily be automated.  We show initial studies 
using a novel capillary to microfluidics platform, shown in Figure 7.4 that is capable of directing the 





Figure 7.4. CE-Microchip Interface. (a) shows an illustration of at the interface where WGM resonators are placed 
along the microchip channel.  (b) Image of the device is shown where a 365 um O.D. and 75 um I.D. capillary is 
interfaced with a microchip with channel widths of 75 um.  Each channel contains buffer solution with outlets on 
opposite corners of the device.   
  
Figure 7.4a illustrates the diamond-shaped wells integrated along each microchannel that is 
fabricated such that the maximum width of the well is ~5 μm greater than the diameter of WGM 
microspheres.  This ensures that the resonator can be held within the well while being exposed to the 
contents of the microchannel.  The interface between the capillary and the microchip was achieved by 
pre-drilling a hole in the microchip with the size of the outer diameter of the capillary and sealing with 
UV glue.  The resulting device is shown in Figure 7.4b.  The capillary is interfaced at the center of the 
microchip which splits into four subsequent microchannels.  This design enables physical separation of 
contents that exit from the capillary into each channel.  This is achieved by modifying the location of the 




Figure 7.5.  Images obtained of the capillary-microchip interface.  The microchip channels were filled with blue 
solution.  EOF was produced by placing the +HV at the inlet of the capillary and –ground at one of the outlets of 
the microchip.  The EOF is directed towards the ground electrode thus the eluent from the capillary can be 
directed.  (a) Pre-filled microchip (b) Ground electrode placed in bottom left channel outlet. (c) Ground placed in 
top right channel outlet. (d) Ground electrode placed in bottom right channel outlet. 
 
 In this experiment the microchip channels were prefilled with diluted blue food coloring using 
pressure flow as shown in Figure 7.5a.  Afterwards, the capillary was filled with phosphate buffer saline 
(clear solution) and the ground was placed at the outlet of the bottom left microchannel.  This resulted 
in EOF that travels down the bottom left microchannel as shown by the blue fluid being displaced by the 
contents from the capillary, Figure 7.5b. Then, the ground electrode was placed into the bottom right 
microchannel, directing the capillary flow into this microchannel, Figure 7.5c.  The same concept was 
demonstrated for the top right channel in Figure 7.5d.  This device can enable multiplexed detection of 
free light chains, β2-microglobulin and LDH.  These proteins elute in separate bands within the serum 
protein electrophoresis profile as shown in Figure 7.6.  Each channel will contain a WGM microsphere 
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functionalized to bind each analyte for the quantitation of these biomarkers.  The interface takes 
advantage of the already clinically validated SPE test and extends the utility by adding a specific assay.  
 
 
Figure 7.6. Biomarkers related to MM such as free light chains, beta-microglobulin and lactate dehydrogenase 
elute in separate locations in the SPE.  
 
 Several validation steps of the interface must be performed to ensure that there is limited cross-
talk between the microchannel at the interface.  It is important to characterize the amount of cross-talk 
to ensure that each analyte from the SPE separation can be directed to the appropriate WGM resonator 
for specific binding.  Furthermore, a COMSOL simulation of the flow at the interface can elucidate the 
flow physics into each channel when the ground electrode is moved from one microchannel to another.  
However, initial studies using this device hold significant promise as a clinical tool for the multiplexed 
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